RATIONALIZING NANOEMULSION FORMATION FOR ENCAPSULATION, PROTECTION AND DELIVERY OF BIOACTIVE FOOD COMPONENTS by Yang, Ying
University of Massachusetts Amherst 
ScholarWorks@UMass Amherst 
Doctoral Dissertations Dissertations and Theses 
Spring March 2015 
RATIONALIZING NANOEMULSION FORMATION FOR 
ENCAPSULATION, PROTECTION AND DELIVERY OF BIOACTIVE 
FOOD COMPONENTS 
Ying Yang 
UMass Amherst 
Follow this and additional works at: https://scholarworks.umass.edu/dissertations_2 
 Part of the Food Chemistry Commons 
Recommended Citation 
Yang, Ying, "RATIONALIZING NANOEMULSION FORMATION FOR ENCAPSULATION, PROTECTION AND 
DELIVERY OF BIOACTIVE FOOD COMPONENTS" (2015). Doctoral Dissertations. 337. 
https://scholarworks.umass.edu/dissertations_2/337 
This Open Access Dissertation is brought to you for free and open access by the Dissertations and Theses at 
ScholarWorks@UMass Amherst. It has been accepted for inclusion in Doctoral Dissertations by an authorized 
administrator of ScholarWorks@UMass Amherst. For more information, please contact 
scholarworks@library.umass.edu. 
  
 
 
 
RATIONALIZING NANOEMULSION FORMATION FOR ENCAPSULATION, 
PROTECTION AND DELIVERY OF BIOACTIVE FOOD COMPONENTS 
 
 
 
A Dissertation Presented 
by 
YING YANG 
 
 
 
 
Submitted to the Graduate School of the 
University of Massachusetts Amherst in partial fulfillment 
of the requirements for the degree of 
 
DOCTOR OF PHILOSOPHY 
 
February 2015 
 
The Department of Food Science  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© Copyright by Ying Yang 2015 
 
All Rights Reserved
  
 
RATIONALIZING NANOEMULSION FORMATION FOR ENCAPSULATION, 
PROTECTION AND DELIVERY OF BIOACTIVE FOOD COMPONENTS 
 
 
A Dissertation Presented 
By 
YING YANG 
 
 
Approved as to style and content by: 
 
 
 __________________________________________  
David Julian McClements, Chair 
 
 
 __________________________________________  
Eric A. Decker, Member 
 
 
 __________________________________________  
Richard J. Wood, Member 
 
 
 
 _____________________________________ 
Eric A. Decker, Department Head 
Department of Food Science
  
 
 
DEDICATION 
To my loving family who support me all the time
  
 
 
v 
ACKNOWLEDGMENTS 
First, I would like to express my deepest appreciation to my advisor, Dr. 
McClements. I am so privileged to have had the opportunity to be one of his PhD 
students and would like to thank to him for his guidance and all the knowledge he has 
provided me with through the past four years. I would also like to have my thanks to Dr. 
Eric Decker and Dr. Richard J. Wood, for their contribution as members of my 
dissertation committee and also for their helpful advice and professional academic 
suggestions.  
Special thanks go to all Julian lab members. In particular, I would like to 
appreciate Jean Alamed for her great help and sweet friendship. Jean always gives me 
useful advice and suggestion. To Jiajia, Palm, Xuan, Iris, Dingkui, Bicheng, Cheryl, Amir, 
Cheng, Erica and other members in Julian’s lab for their excellent advice and friendship. 
It is so wonderful to have such supportive lab members. I am also grateful to Get, 
Mingyue, Bingcan and all the other colleagues in department for your friendship and 
support. I shall always cherish the times spent together with you. 
At last, I would like to thank my family. To my parents, thank you for your 
endless support and help. I cannot accomplish this degree without you. I feel so blessed 
for having parents like you! 
   
  
 
 
vi 
ABSTRACT 
RATIONALIZING NANOEMULSION FORMATION FOR ENCAPSULATION, 
PROTECTION AND DELIVERY OF BIOACTIVE FOOD COMPONENTS 
FEBRUARY 2015 
YING YANG, B.S., CHINA AGRUICULTURAL UNIVERSITY 
M.S., CHINA AGRUICULTURAL UNIVERSITY 
PH.D., UNIVERSITY OF MASSACHUSETTS AMHERST 
DIRECTED BY: Professor David Julian McClements 
The objective of this thesis was to design and develop novel food-grade 
nanoemulsion-based delivery systems for the encapsulation, protection and delivery of 
lipophilic bioactive food components.  These delivery systems could be widely applied 
in aqueous-based fortified food products, such as beverages, salad dressing and yogurt 
etc. 
Both the low- and high-energy methods could be used for fabricating 
nanoemulsions (r < 100 nm).  The microfluidization method could form nanoemulsions 
at low surfactant-to-oil ratios (SOR < 0.1), but it required the use of high-energy inputs 
and expensive equipment.  On the other hand, the spontaneous emulsification method 
could also form ultrafine emulsions and moreover it was simple and inexpensive, but it 
required much higher surfactant-to-oil ratios (SOR > 0.5) for forming nanoemulsions.  
Q-Naturale® is a natural food-grade surfactant, which is got from the bark of the 
Quillaja saponaria Molina tree.  By using high pressure homogenization 
(microfluidization), Q-Naturale® could form relatively small droplets (d < 200 nm) at low 
  
 
 
vii 
surfactant-to-oil ratios (SOR < 0.1), but the droplets were not as small as those produced 
using Tween 80 under similar conditions (d < 150 nm).  The emulsions formed by using 
Q-Naturale® as the emulsifier were stable to droplet coalescence over a range of pH 
values (2 to 8), salt concentrations (0 to 500 mM NaCl) and temperatures (20 to 90 ºC).  
Thus, the design of “all-natural” delivery system for vitamin E by using Q-Naturale® as 
the emulsifier were then studied.  Ultrafine emulsions could not be fabricated using pure 
α-tocopherol acetate as the oil phase due to its very high viscosity, but they could be 
formed when ≥ 20% MCT was incorporated into the oil phase prior to homogenization.  
In the absence of glycerol, Q-Naturale® was able to form emulsions containing relatively 
small droplets (d < 400 nm) from oil phases containing relatively high vitamin levels (60 
to 80%).  The addition of glycerol into the aqueous phase could help decreasing this 
droplet size.  Q-Naturale® was more effective than Tween 80 at producing small 
droplets with oil phase containing high levels of vitamin E acetate.  
The influence of carrier oil type on the bioaccessibility and molecular form of 
vitamin E encapsulated in Q-Naturale® delivery system was then examined using a 
simulated gastrointestinal model.  The total bioaccessibility of vitamin E after digestion 
was higher for LCT- than MCT-emulsions, which was attributed to the greater 
solubilization capacity of mixed micelles formed from long chain fatty acids.  The 
conversion of α-tocopherol acetate to α-tocopherol after in vitro digestion was also 
considerably higher for LCT- than MCT-emulsions, which may impact the subsequent 
  
 
 
viii 
absorption of the vitamin E.  Morever, by using emulsion titration assay for further 
quantifying the kinetics and extent of vitamin E and vitamin E acetate solubilization in 
model mixed micelles, the solubilization capacities were depended on the composition of 
the mixed micelles: micelle solubilization of vitamin E was increased by the presence of 
phospholipid (DOPC), but did not depend strongly on the presence of free fatty acid 
(octanoic acid or linoleic acid).  The solubilization capacity of the mixed micelles for 
vitamin E was higher than that for vitamin E acetate, which was attributed to differences 
in the ability of the vitamin molecules to be incorporated into the micelle structure.   
Finally, all the key factors impacting on the bioaccessibility of emulsified vitamin 
E, such as calcium ions, phospholipids, carrier oil type etc., were then overall studied 
using a simulated small intestine model.  The addition of calcium (CaCl2) to the SSIF 
increased the extent of lipid digestion in LCT-emulsions, but had little impact in 
MCT-emulsions.  The bioaccessibility of vitamin E increased in the presence of calcium 
and phospholipids (DOPC) in LCT-emulsions, but decreased in MCT-emulsions.  The 
highest bioaccessibility (≈ 66%) was achieved for LCT-emulsions when the SSIF 
contained both calcium and DOPC.  The conversion of α-tocopherol acetate to 
α-tocopherol after in vitro digestion was considerably higher for LCT-emulsions when 
calcium ions were present in the SSIF, but was not strongly affected by SSIF composition 
for MCT-emulsions.   
Overall, the results obtained in these studies will provide guidelines for rationally 
  
 
 
ix 
designing effective nanoemulsion-based delivery systems for encapsulating, protecting 
and delivering lipophilic bioactive components.  These delivery systems could be used 
in various industrial products, such as fortified foods, pharmaceuticals, cosmetics, and 
personal care products in the future. 
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CHAPTER 1 
INTRODUCTION 
Nowadays consumers pay more attention to the safety and healthiness of food 
products, which leads to an increasing interest within the food industries in the 
development of delivery systems for the encapsulation, protection and delivery of 
lipophilic bioactive components, such as ω-3 fatty acids, carotenoids, flavonoids and 
vitamins [1-4].  These days, food industries are interested in fortifying food and 
beverages with various kinds of functional food ingredients, such as flavors, colors, 
vitamins and nutraceuticals and the growth of fortified beverages had been estimated to 
be around 19 % from 2009 to 2014 [5].   
Since most of these bioactive food components (e.g. vitamins, carotenoids, and 
polyunsaturated triglycerols etc.) are lipophilic compounds, O/W emulsions are one of 
the most effective delivery systems for helping these ingredients incorporated into the 
aqueous-based food products.  Typical conventional emulsions have droplets with mean 
diameters between 100 nm and 100 µm.  The droplet sizes in conventional emulsions 
are close to the light wavelength so that they can scatter light strongly which will lead to 
the turbid or opaque appearance of the emulsions [6].  Moreover, conventional 
emulsions have a relatively low thermodynamic stability.  Thus, a considerable amount 
of research has been done to optimize the design and fabrication of emulsion-based 
delivery systems.   
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Recently, food industries are very interested in avoiding using synthetic 
ingredients by using natural “label friendly” alternatives instead [7, 8].  Hence, there has 
been a focus on identifying and characterizing natural emulsifiers that can be successfully 
used in emulsion-based food and beverage products.  Biopolymer-based emulsifiers, 
such as proteins (whey, soy and egg) and polysaccharides (gum arabic and modified 
starch), have been shown to be effective at forming and stabilizing emulsions [8-11].  
However, biopolymer emulsifiers often have limitations in their functional performance.  
Protein stabilized emulsions have lower stability at pH values around their isoelectric 
point, at high ionic strengths, and at elevated temperatures [12].  On the other hand, it is 
often difficult to produce oil droplets with very small sizes (d < 200 nm) using 
polysaccharide-based emulsifiers [9, 10, 13].  Q-Naturale® is an extract isolated from 
the bark of the Quillaja saponaria Molina tree and which contains surface active 
components that are capable of forming surfactant micelles and stabilizing O/W 
emulsions [14-16].  The major components within this extract have been reported to be 
saponins [17, 18], which are high molecular weight glycosides consisting of a sugar 
moiety attached to a triterpene or a steroid aglycone [19]. 
Vitamin E is an essential micronutrient for both humans and animals due to its 
antioxidant and non-antioxidant biological activities.  Vitamin E could work as an 
antioxidant by inhibiting the formation of reactive oxygen species (ROS) during the lipid 
oxidation.  According to the activities of vitamin E in queching free radicals, vitmain E 
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is believed to prevent some chronic diseases that are related with the generation of free 
radicals.  Due to its antioxidant or non-antioxidant activities, vitamin E provides a lot of 
health benefits for human beings, such as enhancing immune systems, anti-inflammation 
by inhibiting the release of reactive oxygen species (ROS) and preventing cardiovascular 
diseases by inhibiting the oxidation of low-density (LDL) [20].   
The term “vitamin E” actually refers to a group of fat-soluble vitamins that are 
widely used as functional ingredients in food, pharmaceutical, and cosmetic preparations 
[21].  Vitamin E is a kind of highly hydrophobic vitamin that cannot be directly 
dispersed into aqueous solutions [22].  Therefore, appropriate emulsion-based delivery 
systems need to be developed for helping dispersing vitamin E into the aqueous 
environment [23].  
A major objective of this study was to carry out research to develop a novel 
emulsion-based delivery systems for lipophilic bioactive food components by using a 
newly available natural emulsifier – Q-Naturale®.  Following fabrication, these delivery 
systems will be evaluated for its physical properties, its chemical and environmental 
stability.  The impact of different delivery systems on the stability and release properties 
of bioactive compounds will also be investigated.  The results gained from this research 
should facilitate the utilization of nanotechnology to design functional delivery systems, 
thereby enhancing bioactive utilization and bioavailability in the diet.   
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CHAPTER 2 
LITERATURE REVIEW 
2.1 Emulsion-based Delivery System 
2.1.1 Emulsions 
Emulsions are systems containing two non-mixable liquids (usually oil and water) 
and in the system one of the liquids is dispersed as small droplets in the other [24-26].  
Emulsions could be found in all kinds of natural and processed foods, such as milk, 
cream, beverages, salad dressings, mayonnaise, sauces, ice cream, coffee whitener, 
spreads, butter, and margarine etc.  Emulsion technology is particularly suitable for the 
encapsulation, protection and delivery of lipophilic functional food ingredients, e.g. ω-3 
fatty acids, oil-soluble vitamins and nutraceuticals.  Variety of emulsion-based delivery 
systems, such as conventional oil-in-water (O/W), multilayer (OM/W), 
water-in-oil-in-water (W/O/W), and oil-in-water-in-water (O/W/W) emulsions, could be 
used for incorporating these food components [26, 27]. 
2.1.2 Emulsion Particle Characteristics 
2.1.2.1 Particle Size 
The particle size of the emulsion droplets would greatly influence some emulsion 
properties, such as the appearance, stability and rheology etc.  Either volume-weighted 
(d4,3=∑dini4/∑dini3) or surface-weighted mean diameter (d3,2=∑dini3/∑dini2) could be used 
for representing the droplet sized, where ni is the number of droplets of diameter di.  The 
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mean particle size of emulsion droplets depends on homogenization conditions (e.g., 
intensity or duration of energy input) and system composition (e.g., emulsifier type and 
concentration) [28].  The particle size distribution could be measured by light scattering 
or microscopy methods.  A monodisperse emulsion refers to the emulsion with droplets 
of the same size while a polydisperse emulsion means the emulsions with a range of 
different droplet sizes (Figure 2.1).  Real food emulsions are usually polydisperse 
emulsions so that the droplet size description of real food is more complicated. 
 
 
 
 
 
 
 
 
      Monodisperse Emulsion         Polydisperse Emulsion 
Figure 2.1 Schematic representation of monodisperse and polydisperse emulsions [28]. 
2.1.2.2 Particle Charge 
Due to the adsorption of ionized emulsifiers, mineral ions, or biopolymers to the 
surface, the droplets in the emulsions often have an electrical charge, which impacts 
many emulsion properties.  The characteristics of the emulsifiers are the key factor 
impacting the droplet electrical charge.  Emulsions formed by using non-ionic 
emulsifier (e.g., Tweens and Spans) usually have no or small charge while emulsions 
formed by using anionic emulsifier (e.g., lecithin and fatty acids) are negative charged 
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and emulsions stabilized by cationic emulsifier (e.g., lauric arginate) have positive 
charge.  
2.1.2.3 Particle Concentration 
Particle concentration refers to the number, mass, or volume of droplets per unit 
volume or mass of emulsion [28].  Because of the core-shell structure of emulsion 
droplets, the overall effective volume fraction (Ceffective) is including both the volume 
fraction of the core (Ccore) and the shell (Cshell).  The effective  volume fraction of 
emulsion droplets could be calculated by the following equation [29, 30]:  
𝐶!""!#$%&!   = 𝐶 1+ 𝑡𝑟 ! 
According to the equation, the real effective volume fraction of the oil droplets 
(Ceffective) in emulsions may be much larger than the real volume fraction of the oil phase 
(Ccore).  This effect could be applied for developing novel emulsion-based food products, 
such as low fat foods with same viscosity at much lower oil concentration. 
2.2 Emulsion Formation 
Generally, there are two main approaches for emulsions fabrication: high-energy 
methods and low-energy methods.  
2.2.1 High Energy Emulsification Methods 
In the food industry, the most common ways for producing food-grade emulsions 
are high-energy methods, such as microfluidization, high-pressure valve homogenization, 
and sonication.  These high-energy methods can be used with a wide variety of different 
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oil and emulsifier types [31-35].  The principles of these high-energy methods are to 
mechanically breakup the oil phase into small droplets which could be dispersed evenly 
within the aqueous phase by applying intense disruptive forces [36].  
2.2.1.1 High Pressure Valve Homogenizer 
High-pressure valve homogenizers (HPVHs) are the most popular emulsification 
method in the food industry.  Usually, a coarse emulsion needs to be prepared first 
before using HPVHs.  As shown in Figure 2.2, after fed into HPVHs, the coarse 
emulsion experiences a combination of intense shear, cavitational and turbulent flow 
conditions, which cause the larger droplets to break into small droplets as homogenized 
products [37].  The final product are strongly depends on the number of passes and the 
pressure applied.  Meanwhile, the characteristics of the material used for 
homogenization (e.g., the disperse-to-continuous phase viscosity ratio, concentration of 
emulsifier) also greatly impact the fine emulsion formation [38, 39].  
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Figure 2.2 Schematic representation of High-pressure valve homogenizers 
2.2.1.2 Microfluidizer 
Microfluidizer can be used for fabricating very small emulsion droplets directly 
from individual oil phase and water phase.  Microfluidizer has similar principle as 
high-pressure valve homogenizers but microfluidizer could generate higher intense shear 
forces.  After fed into microfluidizer, the coarse emulsion flowing was divided into two 
streams and each stream passed through a separate fine channel.  The two streams of 
coarse emulsions would then impinge on each other in an interaction chamber.  As a 
result of that, intense disruptive forces are generated, which lead to highly efficient 
droplet disruption.  Previous researches have shown that the microfluidization is more 
effective at creating more uniform emulsion droplets with smaller droplet size.  The 
major factors for the products of microfluidizer include pressure, number of passes, 
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oil-water interfacial tension, oil-water viscosity ratio, and emulsifier type and 
concentration [8, 33, 40, 41].  
 
Figure 2.3 Schematic representation of microfluidizer 
2.2.1.3 Sonication  
Ultrasonic emulsification is also a kind of high-energy emulsification methods 
commonly used for ultrafine emulsion formation.  Wood and Loomis first reported 
ultrasonic emulsification in 1927 and the first patent of sonication emulsification was 
granted in 1944 in Switzerland [42, 43].  Sonication emulsification was recognized as 
fast and efficient technique for formulating stable, uniform and small emulsion droplets 
[44].  
Sound waves (frequency > 20 kHz) will be used to cause ultrasound-driven 
mechanical vibrations, followed by the formation of acoustic cavitation.  Thus, the 
coarse emulsions will be broken into tiny emulsion droplets by the powerful shocks from 
cavitation bubble collapse [45].  There are several factors which influence the output 
droplet size of the sonication emulsification system, such as ultrasonic power input, 
Microfluidization
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processing time, oil concentration, emulsifier type and concentration, mixing ratio of oil 
and surfactant, viscosity of continuous phase, processing time [46].  
 
Figure 2.4 Schematic representation of Sonication 
2.2.2 Low Energy Emulsification Methods 
Ultrafine emulsions can also be produced using a variety of low-energy methods, 
such as phase inversion and spontaneous emulsification methods.  
 Compared with high-energy methods, low-energy approaches may have 
advantages for certain applications within the food and beverage industries: they are often 
more effective at producing very fine droplets; they have lower equipment and energy 
costs; they are simpler to implement.  However, at the same time, some potential 
disadvantages may also exist in low-energy systems, such as higher concentration of 
emulsifier, limitations of oil types and surfactant types that could be applied in 
low-energy systems etc. 
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2.2.2.1 Spontaneous Emulsification 
Spontaneous emulsification is a process that emulsions are spontaneously formed 
without the aid of external energy supply when two immiscible fluids with very low 
interfacial tension get in contact with each other [47]. The spontaneous emulsification 
method is originally widely used in the pharmaceutical industry [48, 49]. Systems 
prepared using this method is often referred to as self-emulsifying drug delivery systems 
(SEDDS) or self-nano-emulsifying drug delivery systems (SNEDDS) based on some 
literature. In the spontaneous emulsification method, emulsions will be formed 
immediately as two immiscible fluids placed in contact with each other (Figure 1) 
[50-52]. Practically, this method can be carried out in a number of different ways to form 
ultrafine emulsions: the compositions of the two phases can be varied; the environmental 
conditions can be varied (e.g., temperature, pH and ionic strength); and/or, the mixing 
conditions can be varied (e.g., stirring speed, rate of addition, and order of addition) [53].  
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Figure 2.5 Schematic representation of spontaneous emulsification 
2.2.2.2 Phase Inversion Temperature (PIT) Method 
The phase inversion temperature (PIT) method is also a low-energy method which 
has attracted quite a lot of interests nowadays since it is an organic, solvent-free method 
[54].  Shinoda and Saito first introduced the PIT concept.  The PIT method realizes the 
formation of ultrafine emulsions by utilizing the specific ability of surfactants, usually 
nonionic surfactants such as polyethoxylated surfactants.  Their affinities for water and 
oil were modified in function of the temperature, and therefore to undergo a phase 
inversion. Indeed, the so-called transitional emulsion phase inversion occurs when, at 
fixed composition, the relative affinity of the surfactant for the different phases is 
changed, resulting in a gradual modification of the temperature [55, 56].  Oil, water and 
nonionic surfactants are all mixed together at room temperature and slightly stirred. Then, 
the mixture is gradually heated up.  As a result, the surfactant solubility progressively 
changes from the aqueous to the oily phase.  Above the phase inversion temperature the 
surfactant is fully solubilized in oil and thus the mixture undergoes a phase inversion, 
from an oil-in-water (o/w) to a water-in-oil (w/o) emulsion. 
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Figure 2.6 Schematic diagram of the formation of emulsions by the Phase Inversion 
Temperature (PIT) method [57]. 
2.3 Emulsifier 
Beeswax used in skin lotion by a Greek physician named Galen of the 2nd 
century (in AD 131–203) was the earliest emulsifier on record whereas egg yolk was the 
first emulsifier on record used for food applications and egg yolk was used to help 
mixing liquid oil phase into an acidified aqueous phase of mayonnaise in the early 19th 
century [58].  
Emulsifiers facilitate the formation of emulsions by adsorbing to the interfaces 
between oil and water during homogenization [59, 60].  Emulsifier molecules are 
amphoteric molecules containing both nonpolar and polar regions.  The nonpolar group 
could be aromatic, aliphatic or alicyclic groups while the polar groups include 
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heteroatoms like oxygen, nitrogen, and sulfur and the polar groups in the emulsifier 
molecules are the main reason for making the emulsifier anionic, cationic or nonionic 
[61]. 
The emulsifier plays a critical role in both droplet break-up and coalescence.  
The most important functions during the homogenization process for emulsifiers include: 
(i) aiding in the droplet break-up by decreasing the interfacial tension between oil an 
aqueous phase by reducing free energy needed for breaking large droplets; (ii) forming a 
protective coating around the droplets to prevent the droplets from aggregation and 
re-coalescence [62].  Thus small molecule emulsifiers are the most suitable emulsifiers 
for the nanoemulsion formation according to the requirements of both droplet break-up 
and coalescence as they may quickly absorbed to the interfaces and they have lower 
interfacial tensions.  
Every year approximately 500,000 metric tons of emulsifiers, valued at USD 
600-700 million, are produced and sold in the global market [63]. 
Each type of emulsifier has its unique chemical structure so that each type of 
emulsifier has its special functional properties.  There is no single emulsifier that could 
be applied in all kinds of situations.  The thermodynamic stabilities of emulsions are 
quite low due to the unfavorable contact between the two non-mixable liquids [64].  
Therefore stabilizers will be necessary to prevent the emulsions from breaking down.  
The type and concentration of emulsifier will greatly influence the droplet size 
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distribution and stability of the emulsion [65].  Various emulsifiers, such as small 
molecular weight surfactants, phospholipids and biopolymers, could all be used for food 
application.  Compared with biopolymers, small molecular surfactants are usually more 
effective in fabricating fine emulsions since they can be adsorbed to the newly formed 
droplet surface fast and prevent droplets from re-coalescence.  Small molecular 
surfactants can be used in both low- and high-energy emulsification procedures while 
biopolymers can only be used in high-energy emulsification systems [46]. 
Hydrophilic–lipophilic balance (HLB) is a concept for categorizing emulsifiers.  
Usually, surfactants with a high HLB (8–18) could be used for forming O/W emulsions 
while low HLB surfactants (3-8) could be used for W/O emulsion formation (Figure 2.7) 
[66].  
                 
             W/O emulsions            O/W emulsions 
             Low HLB (3~8)           High HLB (8~18) 
Figure 2.7 Emulsions formed by emulsifiers with different HLB value 
Emulsifier could also be categorized by their electric properties: cationic 
surfactants (lauric arginate), anionic surfactants (rhamnolipid) and non-ionic surfactants 
(sorbitan fatty acid esters (spans), polyoxyethylene sorbitan fatty acid esters (tweens), 
sugar esters and monoglycerides) [67-69]. 
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Table 2.1 Emulsifiers in food products [58, 70] 
Food Products Emulsifiers Functionality 
Peanut butter Mono/diglycerides Dispersion stabilization 
Chocolate Lecithin Viscosity modification 
Citrus beverages Polyglycerol esters, SAIB Clouding (weighting) 
Sponge cakes, desserts Mono/diglycerides Aeration 
Ice cream, whipped 
toppings 
Polysorbate 80, 
polyglycerol esters 
Controlled fat 
agglomeration 
The surface load (Γ) of a surfactant can be calculated from the interfacial tension 
(γ) versus surfactant concentration (c) data using the following formula [16]: 
               (1) 
Here R is the gas constant, T is the absolute temperature, and c is expressed in 
moles per liter [71].   
The surface activity (K) of an emulsifier can be conveniently characterized by the 
following relationship [26]:  
            (2) 
Here c½ is the surfactant concentration where half of the available adsorption sites 
on the oil-water interface are covered by surfactant, and ΔGads is the free energy change 
associated with surfactant adsorption. 
2.3.1 Synthetic Emulsifiers 
Most of synthetic emulsifiers are petroleum/hydrocarbon derivatives and many of 
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them have been used in the food industry for a long time without any evidence of harmful 
effects.  Synthetic emulsifiers were designed to contain naturally or non-naturally 
occurring molecules which prevented them from being metabolized their passage through 
the human bodies GI tract [70].  
• Mono- and Diacylglycerols: Mono- and diacylglycerols are the most common used 
synthetic emulsifiers in the food industry (about 70 % of total emulsifier used in the 
food industry) and they were first synthesized in 1853 by Berthelot [70].  There are 
small quantities of mono- and diacylglycerols in natural fats and oils because of the 
hydrolysis reaction.  The use of mono- and diacylglycerols in the 1930s in the 
margarine industry on a large scale was a great breakthrough in the application history 
of mono- and diacylglycerols [2].  High ratio shortenings containing mono- and 
diglycerides made oil droplets dispersed into the dough better, resulting in the increase 
of the strength in cake batters.  Moreover, the application of mono- and diglycerides 
in ice cream was then patented in 1936. 
• Sorbitan esters and polysorbates: Sorbitan esters and polysorbates (Figure 2.8) are 
both non-ionic emulsifiers.  Sorbitan esters are generated from the simultaneous 
esterification and cyclization reactions that are caused by heating a mixture of fatty 
acids, sorbitol and a catalyst under an inert atmosphere (Figure 2.9).  Sorbitol, which 
is initial material for sorbitan esters, was generated from the hydrogenation of sucrose.  
These days, there is an alternative way for producing sorbitol from D-glucose. 
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D-glucose, which is got from corn syrups (maize) or tapioca, reacts with hydrogen gas 
under pressure in the presence of a catalyst (e.g., nickel phosphate) [72].  
 
 
Figure 2.8 Structures of sorbitan monostearate (Span 60) and Polyoxyethylene (20) 
sorbitan monolaurate (Tween 20) 
 
Figure 2.9 Cyclization and esterification of sorbitol 
2.3.2 Natural Emulsifiers  
For more than 20 years, the food industry has a growing interest in replacing 
synthetic ingredients with natural “label friendly” alternatives such as lecithin, protein 
and polysaccharide in an effort to produce natural food products [7, 13].  Consequently, 
there have been many studies that focus on identifying and characterizing natural 
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emulsifiers that can be successfully used in emulsion-based food and beverage products. 
Natural emulsifiers are obtained from various nuts, berries and leaves.  
• Protein: Protein is one of the most frequently used emulsifier in the food industry. 
Proteins have been considered to be a kind of good emulsifiers because of their ability 
to absorb fast enough to the interface between the oil droplets and the aqueous phase to 
lowering the interfacial tension [26].  The protein film around the lipid droplets is 
highly viscoelastic preventing the rupture or displacement by other surface active 
component [73].  Depending on the protein molecular structure and the ionic content 
of the aqueous medium, the stabilisation of dispersed particles and droplets by 
adsorbed protein can be explained in terms of a combination of polymeric (steric) and 
electrostatic interactions [24, 74].  Emulsions stabilized by proteins, however, are 
often unstable to aggregation at pH values around their isoelectric point, at high ionic 
strengths, and at elevated temperatures [12].  Adsorbed proteins lose their net charge 
around the isoelectric point thereby promoting extensive droplet aggregation. 
Conformation changes of proteins occur above their thermal denaturation temperature 
(Tm) and after interfacial adsorption, which exposes non-polar and sulfhydryl groups 
[75].  
• Polysaccharides: Some polysaccharides such as gum arabic and modified starch 
adsorb at oil–water interfaces.  Hence they have the capacity to function as 
emulsifiers and emulsion stabilizers by means of interfacial action.  Polysaccharides 
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may increase emulsion stability to aggregation and environmental stresses by the 
formation of a thick interfacial layer, increasing the steric repulsion and decreasing the 
van der Waals attraction [28].  However, it is often difficult to produce oil droplets 
with very small sizes (d < 200 nm) using polysaccharide-based emulsifiers [9, 10, 13].  
In addition, due to the low efficiency of polysaccharides for lowering surface tension, 
emulsions stabilized by polysaccharides, require a considerable higher amount of 
polysaccharide, which will increase the manufacturing cost.  
• Lecithin: Certain types of lecithin are also suitable for utilization as natural 
emulsifiers in food and beverage products, e.g., phospholipids derived from egg, soy, 
or milk [67, 76].  However, natural lecithin (which has two non-polar tails) usually 
has to be chemically or enzymatically modified to lysolecithin (which has one 
non-polar tail) before it can be successfully used to stabilize oil-in-water emulsions. 
• Q-Naturale®: Q-Naturale® is a food ingredients just marketed by the National Starch 
company (Bridgewater, NJ) and it is an extract isolated from the bark of the Quillaja 
saponaria Molina tree (an evergreen native to Chile and Peru) and it has surface 
activities of forming surfactant micelles and stabilizing oil-in-water emulsions [14-16].  
The major components within this extract have been reported to be saponins [17, 18], 
which are high molecular weight glycosides consisting of a sugar moiety attached to a 
triterpene or a steroid aglycone [19].  The saponins are surface active substances 
because they contain both hydrophilic regions (such as rhamnose, xylose, arabinose, 
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galactose, fucose, and glucuronic acid) and hydrophobic regions (such as quillaic acid 
and gypsogenic acid) on the same molecule [16, 77].  
2.4 Vitamin E as Lipophilic Bioactive Food Components 
The term “Vitamin E”, which was first characterised in wheat-germ oil and 
lettuce, introduced in 1922 by Evans and Bishop described a dietary factor in animal 
nutrition considered at the time to be especially important for normal reproduction [78].  
“Vitamin E” refers to a group of fat-soluble vitamins that have been widely used as 
functional ingredients in food, pharmaceutical, and cosmetic industries [21].  Vitamin E 
is a highly lipophilic molecule that cannot be directly dispersed into aqueous solutions 
[22].  Thus, it must be incorporated into an appropriate colloidal delivery system prior to 
its dispersion into the aqueous-based food products [23].  A number of previous studies 
have shown that vitamin E can be successfully incorporated into emulsion-based delivery 
systems, such as microemulsions [21, 79], nanoemulsions [80-82], emulsions [23, 83] 
and liposomes .  One major problem of vitamin E is that it is only partially absorbed at 
the intestinal site, which reduces its bioavailability.  Former studies have shown that the 
absorption of fat-soluble vitamins, including vitamin E, will be increased with the 
presence of surfactants or emulsions, compared to when they are incorporated into bulk 
oils [84-86]. 
2.4.1 Structure and Chemical Properties of vitamin E 
Natural vitamin E encompasses eight different forms, the α-, β-, γ- and 
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δ-tocopherols and the α-, β-, γ- and δ-tocotrienols (Figure 2.10).  Eight different vitamin 
E molecule forms have a common structural feature: a chromanol ring and a phytol side 
chain.  α-tocopherol is the only one active form of vitamin E that could be found in 
human bodies so that it is also vitamin E with the largest quantities found in blood and 
tissues [25]. 
α-tocopherol molecules can help protecting membrane lipids against the lipid 
oxidation since α-tocopherol can trap peroxyl radicals which are responsible of the 
initiation of lipid oxidation [87, 88].  The principle oxidation metabolites of 
α-tocopherol are α-tocopherol quinone, α-tocopherol hydroquinone, 
2,3-epoxy-α-tocopherol quinone, and 5,6-epoxy-α-tocopherol quinone (Figure 2.11).  
α-tocopherol molecules could also help stabilizing membranes mechanically due to Van 
der Waals interactions [69].  Vitamin E quinone has the activities of preventing blood 
clotting since it can help inhibiting the activities of vitamin K dependent carboxylase, 
which regulates blood clotting [71].  The digestion procedure of vitamin E is similar to 
vitamin A and carotenoids digestion and α-tocopherol can utilize SR-B1 to enter into 
enterocytes [72].  
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Figure 2.10 Chemical structure of vitamin E 
 
 
 
Figure 2.11 α-Tocopherol and its principle oxidation products [89] 
2.4.2 Food Source and Intake 
Vegetable oils such as olive oil, sunflower oil, safflower oil and nuts are the main 
natural source of tocopherol (Toc) while tocotrienol, a minor plant constituent, is 
abundant especially in rice bran, cereals, grains, palm oil, green vegetables and annatto 
seeds [90].  α-, β-, γ-, and δ-tocopherols and tocotrienols can all be found in natural 
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foods but the amounts of each kinds of vitamin E are quite different. 
Table 2.2 Distribution of tocotrienol and tocopherol in food sources (mg/kg) 
(http://www.ars.usda.gov/ba/bhnrc/ndl)  
Food α-tocopherol (mg) ϒ-tocopherol (mg) 
Olive oil (1 tablespoon) 1.9 0.1 
Soybean oil (1 tablespoon) 1.1 8.7 
Corn oil (1 tablespoon) 1.9 8.2 
Canola oil (1 tablespoon) 2.4 3.8 
Safflower oil (1 tablespoon) 4.6 0.1 
Sunflower oil (1 tablespoon) 5.6 0.7 
Almonds (1 ounce) 7.4 0.2 
Hazelnuts (1 ounce) 4.3 0 
Peanuts (1 ounce) 2.4 2.4 
Spinach (1/2 cup, raw) 0.3 0 
Carrots (1/2 cup, raw chopped) 0.4 0 
Avocado (1 fruit) 2.7 0.4 
Vitamin E uptake into plasma is similar to fat uptake through the small intestine. 
Bile acid secreted into the small intestinal facilitate the formation of micelles containing 
vitamin E and oil hydrolysis products, which passed through the membrane of intestinal 
cells and were then transported as lipoproteins (e.g., chylomicrons) in the lymph and 
blood system [91, 92].  The RDA of vitamin E is 15 mg/day and deficiency might occur 
in case of fat malabsorption or for premature infants.  
Table 2.3 The Recommended Dietary Allowance (RDA) for α-Tocopherol [20] 
Age Males (mg/day) Females (mg/day) 
0-6 months 4 mg 4 mg 
7-12 months 5 mg  5 mg 
1-3 years 6 mg 6 mg 
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4-8 years 7 mg  7 mg 
9-13 years 11 mg  11 mg 
14-18 years 15 mg 15 mg 
19 years and older 15 mg 15 mg 
Pregnancy (all ages) - 15 mg 
Breast-feeding (all ages) - 19 mg 
 
2.4.3 Health Benefits of vitamin E 
Previous researches show that tocopherols have quite a lot health benefits for 
human beings, such as reducing heart disease, delaying Alzheimer’s disease, and 
preventing cancer [93].  Compared with polyunsaturated fatty acids, vitamin E works 
1000 times faster in quenching peroxyl radicals (ROO·) [94].  As vitamin E may 
functions in scavenging peroxyl radicals, it may works as an antioxidant which slows 
down the propagation of free radicals in membranes and in plasma lipoproteins and 
breaks the chain of lipid oxidation [95].  Severe vitamin E deficiency may lead to 
neuromuscular abnormalities characterized by spin cerebellar ataxia and myopathies in 
human beings [96-102]. 
2.4.3.1 Inflammatory 
Inflammation was related with the release of some reactive oxygen species, such 
as O2−, OH
.
, H2O2 and singlet oxygen (1O2).  Previous researches indicated that the 
symptoms in patients who were suffering from several types of acute or chronic 
inflammatory conditions could be relieved with the consumption of vitamin E [103].  In 
many occasions vitamin E works effectively as standard drug treatment but the 
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side-effects were much lower [104]. 
O2- generation will be inhibited as a result of the addition of α-tocopherol to 
polymorphonuclear cells [105-107].  Vitamin E supplements have significant effects on 
inhibiting the release of reactive oxygen species and the section of IL-1 beta from 
monocytes and preventing the monocyte-endothelial cell adhesion.  The inhibition of 
protein kinase C activities, which are caused by α-tocopherol, will result in the inhibition 
of the release of reactive oxygen species and of lipid oxidation [105].  
2.4.3.2 Cardiovascular Diseases (CVD) 
The increase of vitamin E consumption in daily diet has been demonstrated to 
help reducing the risk of death from heart disease in both males and females.  Vitamin E 
shows several potentially health benefits for cardiovascular diseases, such as preventing 
the oxidation of low-density lipoproteins (LDL) and inhibiting the proliferation of 
smooth muscle cell [108].  During the in-vitro studies, vitamin E were found to inhibit 
the oxidation of low-density lipoprotein (LDL) cholesterol, which is the main reason for 
causing atherosclerosis since its atherogenicity will be enhanced due to the oxidative 
damage to LDLs [20].   
Previous researches have been done to study vitamin E uptake in presumably 
healthy people and these people were then studied for several years to find out how many 
of them were diagnosed with or died as a result of heart disease.  People who had more 
than 7 mg/day of α-tocopherol from daily diet were less risky (~35 %) to die from heart 
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disease compared with those people who got less than 3-5 mg/day of α-tocopherol [109, 
110].  Moreover, based on another two large studies, a significant reduce in the risk of 
heart disease will happen in women and men who consumed at least 100 IU of 
supplemental RRR-α-tocopherol (67 mg of RRR-α-tocopherol) daily [111, 112].  
According to a study bases on approximately 90,000 nurses, the highest intakes of 
vitamin E primarily from supplements would prevent heart disease by 30% to 40% [112]. 
2.4.3.3 Immune Function 
Adequate vitamin E has been proved to be essential for the maintenance of the 
immune system.  Vitamin E consumption with higher than recommended dietary levels 
will result in stronger immunity response of human bodies while the deficiency of 
vitamin E will lead to weaker immunity response [113].  For elderly adults who are 
given 200 mg of synthetic α-tocopherol (equivalent to 100 mg of RRR-α-tocopherol or 
150 IU of RRR-tocopherol) per day for several months, an increased formation of 
antibodies in response to hepatitis B vaccine and tetanus vaccine injection could be 
observed [114]. 
2.5 Bioavailability of Vitamin E Encapsulated in the designed delivery system 
96% of American women and 93% of men do not meet the current vitamin E 
recommended dietary allowance (RDA), which is 15 mg (22 IU RRR-) α-tocopherol per 
day [20, 115]; the average intake of α-tocopherol in the US are only s 6.9 mg/day [116]. 
Because of vitamin E’s deficiencies of poor solubility either in water or in most of 
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inorganic solvents and poor stability to O2, light or temperature, vitamin E is treated as 
capsules with the disadvantages of low bioavailability and being hardly dispersed in 
aqueous environemnt.  Conversion of the capsules to water-soluble liquid is the ideal 
ways to overcome the above problems [79].  Vitamin E absorption is greatly influenced 
by the digestion processes and the absorption of diet fat.  The procedure of the 
absorption of vitamin E through the small intestine is quite similar to fat uptake.  Bile 
salts secreted by the intestinal lumen could induce the formation of micelles to 
incorporate vitamin E and the micelles could pass through the small intestinal cell 
membranes and then be transported as lipoproteins in the lymph and blood [91, 95].  
The isomer RRR-α-tocopherol is the form of α-tocopherol exsiting in all natural 
food.  However, although vitamin E supplements usually contain 100 IU to 1,000 IU of 
α-tocopherol, not all the α-tocopherol are isomer RRR-α-tocopherol (d-alpha-tocopherol),  
Which is the most favorable α-tocopherol for human beings.  Actually the most common 
one in fortified foods and supplements is synthetic α-tocopherol (all-rac-α-tocopherol or 
dl-α-tocopherol) containing all eight isomers of α-tocopherol.  Compared with 
RRR-α-tocopherol, synthetic α-tocopherol is less bioavailable since part of α-tocopherol 
isomers present in all-rac-α-tocopherol cannot by utilized by human bodies. 
Previous researches have proved that O/W emulsion which encapsualtes vitamin 
E inside could help increasing the bioavailability of vitamin E in human bodies.  The 
bioavailability of the guest molecules incorporated in the emulsions will be greatly 
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improved expecially as the surfactants stablizing the droplets could enhance 
transmembrane passage across the digestive tract and transdermal drug permeability 
[117].  
During the digestion, fat-soluble nutrients including α-tocopherol need to be 
packaged into micelles to get to be absorbed.  The in vitro model mimics the digestion 
precedure in human bodies and can be used to quantify the fraction of a nutrient that has 
been micellarised and thereby made bioaccessible [118].  According to previous in vitro 
digestion study, the bioaccessibility of α-tocopherol will greatly depend on the food 
source.  The bioaccessibility of α-tocopherol from bananas and bread was 100 % 
whereas the bioaccessible α-tocopherol were only 29% and 22% from cheese and milk 
respectively [119].  
Vitamin E is a kind of fat soluble vitamin transported by lipoproteins so that 
tissue vitamin E transportation will be greatly impacted by lipid and lipoprotein 
metabolism and its tissue depletion takes decades rather than weeks [92].  The 
concentration of α-tocopherol in plasma are regulated by the liver (the α-tocopherol 
transfer protein (α-TTP)) and also by vitamin E metabolism and excretion [92]. 
The absorption and disposition of labeled vitamin E were studied by using 
short-term studies (from 3 to 72 h).  Longer protocols were used for evaluing the 
delivery and transportation of labeled vitamin E to peripheral tissues by administering 
large oral doses (e.g., 400 IU) [120].  Although various tocopherols are absorbed and 
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transported in chylomicrons, α-tocopherol is the only form of vitmain E that will be 
maintained in plasma and tissues [121, 122].  The plasma half-life of 
RRR-α-tocopherol’s plasma half-life (48 to 60 h) is much longer than systhetic 
α-tocopherol (15 h) [123, 124].  Due to the rapid recirculation between the liver and the 
plasma, the entire circulating α-tocopherol pool nearly gets to be replaced everyday[124].  
The fraction of vitamin E absorbed were found to be around 55 to 79% according to the 
study taken from 1960-1970 by utilizing radioactive α-tocopherol during the study [125, 
126].  These days, there are some more accurate studies in which the results were got 
from the observed plasma-labeled α-tocopherol concentrations and absorption ratio of 
α-tocopherol in humans was only 33 % [127].  These studies are very important for 
suggesting people’s daily uptake of vitamin E since only part of the vitmain E consumed 
would be absorbed. 
The fraction of the ingested food ingredients that reaches the systemic circulation 
could be defined as bioavailability (F), which can be got by: F = FB × FT × FM.  In this 
equation, FB - the bioaccessibility coefficient or the lipid fraction released from the food 
matrix into the the GI tract juices; FT - the transport coefficient or the released lipid 
component fraction which is transported across the intestinal epithelium; FM – the lipid 
component fraction reaching the systemic circulation without experiencing 
metabolization [128]. 
As the food components reach the systemic circulation, they will be distributed 
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into different tissues, where they may be stored, utilized or excreted [129, 130].  
Nowadays the in-vitro studies are still good ways for examining the relative 
bioavailability of α-tocopherol from various food sources and also for fast screening the 
effectiveness of different α-tocopherol delivery systems as it is relatively difficult in 
assessing the in-vivo bioavailability of α-tocopherol. 
2.5.1 In-vitro digestion model 
Emulsions will experience diffenent conditions after ingestion, such as dilution by 
mixing with mucin in the mouth, expose to acidic environment in the stomach etc.  
In-vitro digestion models have been widely applied for studying the bioaccessibility of 
encapsulated lipophilic nutraceuticals.  The ideal in-vitro digestion method should 
provide accurate results in a short time and it should act as a useful alternative to animal 
and human models.  In this way, it should work as a rapid screening tool for foods or 
delivery systems with different compositions and structures (Figure 2.12) [131].  
• Mouth: Mouth is the first environment that an emulsion encounters after ingestion.  
After consumption, emulsions will experience a series of processing, such as mixing 
with saliva, temperature change to body temperature, changes in ionic strength and 
pH, contacting with biological surfaces (tongue, teeth, and cheeks) and breaking 
down during mastication [132, 133].  Emulsions will react with digestive enzymes 
in mouth (e.g. lingual lipase, amylase and protease).  As food first passes through 
the mouth, saliva and mucin would induce emulsion flocculation and then a rapid 
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depletion flocculation was observed in all kinds of emulsions.  
• Stomach: Food product passes from the mouth through to the esophagus and then 
enters into the stomach.  The time that food product stays in stomach mainly 
depends the nature of the food, such as composition, size, pH and ionic properites etc. 
[134, 135].  Gastric fluids containing enzymes (pepsin and gastric lipase), minerals 
(Na+, Ca2+ etc.) and various surface-active components are going to mix with food 
products and food products will undergo a very acidic condition (pH ≈ 1–3) 
[136-138].  Meanwhile, food products will also experience mechanical agitation 
because of the stomach motility [139, 140].  The pH value in human stomach was 
between 1 and 3 under fasting conditions and an apparent increase in stomach content 
pH value will be observed after food ingestion and then the pH value will gradually 
decrease over the next hour or so to reach around pH 2 [137, 138, 141].  The natural 
properties (initial pH, composition, structures etc.) of food ingested are the key factor 
that influence the pH-time profile [141].  The high acidic environment in the 
stomach enables enzymes activation, food components hydrolysis, microorganisms 
inactivation.  The ionic strength in stomach will also significantly increase after 
consuming food because of the ions from the food.  Furthermore, gastric lipase 
could also hydrolyze some emulsified triacylglycerols (TAGs) to diacylglycerols 
(DAGs), monoacylglycerols (MAGs), and free fatty acids (FFAs) [142-144].  
Usually when 10–30% of the fatty acids are released from the TAGs, lipid hydrolysis 
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will stop. 
• Small Intestine: Food emulsions will get into the small intestine after passing 
through the stomach.  The secretion of bile salts, phospholipid, cholesterol ester and 
pancreatic fluids will be motivated by the entering of lipids into the small intestine.  
Pancreatic lipase complexing with co-lipase acts at the surface of the emulsified TG 
droplets to hydrolyze TAG to MAG (sn-2 position) plus FFA [128, 145].  Pancreatic 
lipase/co-lipase, called carboxylic-ester hydrolase or bile salt stimulated lipase along 
with pancreatic lipase, is able to split TAG molecule [146].  During the digestion 
procedure in small intestine, natural surface-active components such as bile salts 
impact the digestion and absorption of lipids significantly and bile salts will facilitate 
the formation of micelles containing MAG, FFA and phospholipids and their 
transport by passive diffusion across the intestinal mucosa [147] (Figure 2.13).  
These days, the pH-stat method has been widely used in pharmaceutical and food 
area for mimicking the small intestinal condition and in vitro digestion study 
[30,31,37,38].  The principle of pH-stat is to record the amount of alkali solution 
(0.25 M NaOH) that had to be added to the reaction chamber to maintain the pH at 
7.0 and then determine the percentage of free fatty acids (FFA) released from lipids, 
usually triacylglycerols [148].   
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Figure 2.12 Overview of physicochemical processes that occur when a bioactive 
component trapped within an emulsified carrier lipid is exposed to the small intestine 
[149] 
 
 
Figure 2.13 Schematic representations of the possible changes of emulsions as they pass 
through the GI tract and the physicochemical conditions in digestive tract [128]  
2.5.2 Cell Culture Study of Bioaccessibility of Vitamin E 
Bioavailability, which is defined as the fraction of an ingested nutrient available 
for physiologic use or storage in the body, may be estimated by using an in-vitro model 
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to apply the micelles got from an in-vitro digestion to a Caco-2 intestinal cell culture 
(Figure 2.14) [150].  These days cell culture models have also been commonly utilized 
as part of in-vitro digestion models.  In particular, the Caco-2 cell culture model has 
been widely used as a predictive tool for the absorption of bioactive components from 
foods and nutrient supplements. 
Nowadays the major steps and molecular mediators of vitamin E transportation 
from the luminal micelle phase into the enterocyte have not been well defined yet.  
Vitamin E uptake is rapid, saturable and temperature dependent in Caco-2 cells [151].  
Intestinal cellular uptake of vitamin E from mixed micelles has been traditionally 
recognized as a simple process of passive diffusion but the recent researches indicated the 
importance of the scavenger receptor class B type I (SR-BI) in the cellular uptake of 
vitamin E [152].  α-tocopherol is absorbed by the intestinal absorptive cells via diffusion 
or protein-mediated mechanisms [153].  Vitamin E will be temperately stored in the 
microsome fraction before being secreted by chylomicrons or HDL after an ATP binding 
cassette A1-mediated efflux [151].  The same route as α-tocopherol may probably also 
be used for the transportation of α-tocopheryl acetate in human bodies if it is not 
converted into the latter compound by the intestinal or pancreatic esterase(s) [154-157]. 
The in-vitro digestion/Caco-2 cell culture model provides a rapid, low-cost 
method for fast screening foods and food matrix for studying the bioavailability of 
bioactive components before more definitive human trials [158, 159].  In the present 
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study, we have employed an in-vitro digestion procedure coupled with a Caco-2 cell 
model system to compare the micellarisation, cell uptake and secretion of α-tocopherol 
from supplemented minced meat (pork, beef and turkey) with other supplemented food 
products (apple sauce, bread and mayonnaise).  The Caco-2 transwell model is a 
well-established method for the assessment of nutrient bioavailability from a range of 
foodstuffs [160-162]. 
 
Figure 2.14 Schematics for the Caco-2 cell monolayer model for absorption and 
transport of vitamin E across the intestinal epithelial. 
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CHAPTER 3 
FABRICATION OF ULTRA-FINE EDIBLE EMULSIONS: COMPARISON OF 
HIGH-ENERGY AND LOW-ENERGY HOMOGENIZATION METHODS 
3.1 Introduction 
There is considerable interest within the food and beverage industries in the 
utilization of ultrafine emulsions (also referred to as nanoemulsions) to encapsulate and 
deliver lipophilic functional agents, such as flavors, colors, antimicrobials, micronutrients, 
and nutraceuticals [3, 22, 27, 163, 164].   Ultrafine emulsions can be fabricated from 
food-grade ingredients using relatively simple processing operations, such as mixing, 
shearing, and homogenization [29, 165].  Ultrafine emulsions are thermodynamically 
unstable systems that typically consist of surfactant, oil, and water [34, 39, 166].  
Oil-in-water emulsions contain surfactant-coated lipid droplets dispersed within an 
aqueous continuous phase.  The radius of the droplets in ultrafine emulsions (r < 100 
nm) is relatively small compared to the wavelength of light (λ = 390 to 750 nm) and so 
they tend to be either transparent or only slightly turbid [163, 167].  One of the most 
promising potential applications of ultrafine emulsions is therefore to incorporate 
lipophilic active ingredients (e.g., vitamins, nutraceuticals, and antimicrobials) into 
aqueous-based foods or beverages that need to remain optically transparent, such as some 
fortified waters, soft drinks, sauces, and dips [163].  Another potential advantage of 
these systems is that they often have better stability to particle aggregation and 
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gravitational separation than conventional emulsions due to their small particle size [39].  
In particular, Brownian motion effects become important for small particles (r < 100 nm), 
which counterbalances the tendency for gravitational separation to occur [29].  The fact 
that the interfacial layer of ultrafine droplets makes up an appreciable part of the total 
particle volume means that ultrafine emulsions can be produced that are much more 
viscous than conventional emulsions with the same oil content [34, 39, 166], which may 
have interesting applications in food products where a paste or gel is required.  The 
small size of the droplets in ultrafine emulsions has also been shown to increase the 
bioavailability of certain types of lipophilic substances [168], which may be useful for 
increasing the bioactivity of some nutraceuticals.   
In the food industry, ultrafine emulsions are usually produced using high-energy 
methods, such as microfluidization, high pressure valve homogenization, and sonication 
[31-35].  These methods generate intense disruptive forces that mechanically breakup 
the oil phase into tiny droplets that are dispersed within the aqueous phase [36].  There 
are a number of limitations in using high-energy methods to produce ultrafine emulsions, 
such as high initial equipment and operating costs, high power requirements, potential for 
equipment breakdown, and difficulties in producing very fine droplets from certain kinds 
of food ingredients (e.g., highly viscous oils or slowly-adsorbing emulsifiers) [29].   
Ultrafine emulsions can also be produced using a variety of low-energy methods, 
such as phase inversion and spontaneous emulsification methods [29, 169, 170].  These 
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low-energy methods are based on the spontaneous formation of fine oil droplets in 
surfactant-oil-water (SOW) systems under specific environmental conditions 
(composition, temperature, stirring), which are then trapped in a metastable state [57, 
171].  Low-energy approaches may have advantages over high-energy approaches for 
certain applications within the food and beverage industries: they are often more effective 
at producing very fine droplets; they have lower equipment and energy costs; they are 
simpler to implement.  On the other hand, there are also some potential disadvantages of 
low-energy systems, including limitations on the types of oils and surfactants that can be 
used to form stable ultrafine emulsions, and the fact that relatively high surfactant-to-oil 
ratios (SOR) are typically needed to produce them. 
The purpose of this study was to compare the effectiveness of a high-energy 
method (microfluidization) that is widely used in the food industry to produce ultrafine 
emulsions with a low-energy method (spontaneous emulsification) that has been shown 
to work for many non-food applications. The microfluidizer works on the principle of 
dividing an emulsion flowing through a channel into two streams, passing each stream 
through a separate fine channel, and then directing the two streams at each other in an 
interaction chamber. Intense disruptive forces are generated within the interaction 
chamber when the two fast moving streams of emulsion impinge upon each other, leading 
to highly efficient droplet disruption.  A number of previous studies have shown that 
microfluidization is particularly efficient at creating ultrafine emulsions from food grade 
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ingredients, and have identified some of the major factors that influence homogenization 
efficiency, including oil-water interfacial tension, oil-water viscosity ratio, and emulsifier 
type and concentration [8, 33, 40, 41].  In the spontaneous emulsification method an 
emulsion is immediately formed when two liquids are mixed together (Figure 3.1) 
[50-52]. Practically, this method can be carried out in a number of different ways to form 
ultrafine emulsions: the compositions of the two phases can be varied; the environmental 
conditions can be varied (e.g., temperature, pH and ionic strength); and/or, the mixing 
conditions can be varied (e.g., stirring speed, rate of addition, and order of addition) [53]. 
The spontaneous emulsification method has been widely used to produce ultrafine 
emulsions in the pharmaceutical industry, where they are usually referred to as 
self-nano-emulsifying drug delivery systems (SNEDDS) [48, 49].  
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Figure 3.1 Underlying principles for droplet formation in high-energy (microfluidization) 
and low-energy (spontaneous emulsification) methods of producing emulsions. 
In this study, we compared the efficacy of the microfluidization and spontaneous 
emulsification methods at producing ultrafine emulsions from food grade oils (MCT) and 
surfactants (Tweens), and we then tested the stability of the resulting emulsions to 
environmental stresses that they might encounter in the food industry.  This research 
may be useful for identifying the most appropriate homogenization method for different 
food and beverage applications.  
3.2 Materials and methods 
3.2.1 Materials  
Non-ionic surfactants, POE(20) sorbitan trioleate (Tween 85) and POE(20) 
sorbitan monoolieate (Tween 80), were purchased from Sigma-Aldrich Co. (St. Louis, 
MO).  Medium chain triglyceride (MCT) oil (Miglyol 812) was purchased from 
Coletica (Northport, NY).  
3.2.2 Emulsion preparation  
3.2.2.1 Emulsions produced by microfluidization 
Oil, water and surfactant were mixed together in a beaker, and then blended 
together using a high-shear mixer (Bamix, Biospec Products, Bartlesville, OK) for two 
minutes to form a coarse emulsion. The total weight of each sample was 100 g, and the 
overall composition of the samples was 20 wt% oil (MCT), 0.1 to 20 wt% surfactant 
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(Tween 80 and/or Tween 85), and 79.9 to 60 wt% water (pH 3.5, buffer solution). The 
emulsion premix samples were then passed through a microfluidizer (Microfluidics, 
Newton, MA) three times at 10,000 psi (68.95 MPa) at ambient temperature.  
3.2.2.2 Emulsions produced by spontaneous emulsification 
Initially, oil and surfactant were placed in a container and then blended using a 
high shear mixer for two minutes to prepare a homogeneous solution.  The oil-surfactant 
mixture was then poured into a water phase (pH 3.5 buffer solution) at a rate of about 10 
g per minute with continuous stirring (500 rpm) using a magnetic stirrer for 15 minutes to 
keep the system homogeneous. At this pouring rate, the formation of an optically opaque 
emulsion was observed to occur as soon as the oil-surfactant mixture came into contact 
with the water phase. However, it was noticed that if the oil-surfactant mixture was 
poured into the water phase too quickly (> 20 g per minute) then large clots were formed 
that were difficult to disperse, and therefore we always used slower rates.   
3.2.3 Emulsion characterization 
The particle size distributions of the samples were measured using a static light 
scattering instrument (Mastersizer 2000, Malvern Instruments, Malvern, U.K.). All 
measurements were performed on at least two freshly prepared samples (i.e., new 
samples were prepared for each series of experiments) and were reported as means and 
standard deviations. 
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3.2.4 Surfactant – Oil – Water (SOW) Phase behavior 
The phase behavior of surfactant, oil, and water mixtures was determined using a 
dilution experiment: increasing amounts of water were added to a surfactant-oil mixture.  
Initially, MCT was mixed with surfactant (Tween 80, Tween 85, or 1:1 Tween 80/Tween 
85) at a mass ratio of 1 part oil to 1 part surfactant.  A series of samples with different 
water contents were then prepared by adding increasing amounts of double distilled water 
drop-wise into the surfactant-oil mixtures (25 ± 1 °C). The resulting SOW systems were 
then mixed at a low speed using a magnetic stirrer to ensure the different components 
were thoroughly mixed. After equilibration, the appearance of the systems was observed 
visually and using optical microscopy (Nikon Eclipse 80i, Nikon Instrument Inc., 
Melville, NY).  
3.3 Results and discussion 
3.3.1 Comparison of emulsions formed by high- and low-energy methods 
Initially, we examined the influence of homogenization method and system 
composition on the formation of oil-in-water emulsions.  Our aim was to establish the 
influence of these parameters on the size of the droplets produced using the 
microfluidization and spontaneous emulsification methods, as well as to establish the 
minimum amount of surfactant needed to produce emulsions containing small droplets (r 
< 100 nm).     
Microfluidizaiton: For the microfluidization method, there was a steep decrease in 
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mean particle radius of the 20 wt% MCT oil-in-water emulsions when the surfactant 
concentration was increased from 0 to 2 wt% (SOW from 0 to 0.2), after which the 
particle size reached a relatively constant level (Figure 3.2).  The minimum particle 
radius attained at high surfactant levels was 55 ± 2 nm for all three systems (averaged 
over the data from 5 to 20 wt% surfactant).  The dependence of particle size on 
surfactant concentration can be conveniently divided into two distinct regimes for high 
pressure homogenization [172, 173]: the “surfactant-limited zone” and the 
“surfactant-rich zone”.  At low surfactant concentrations, there was insufficient 
surfactant present to cover the new surfaces created within the homogenizer when larger 
droplets were broken down to smaller ones (Figure 3.1).  Consequently, two or more 
small oil droplets that collided with each other would tend to coalesce because there was 
insufficient surfactant present at their surfaces to prevent them from coming into close 
contact.  Coalescence tends to continue until all of the droplets are covered by sufficient 
surfactant to prevent them from merging together.  Hence, the droplet size in the 
surfactant-limited zone is primarily determined by the type and amount of surfactant 
present.  The minimum mean droplet radius (r32) that is obtained in this region is given 
by the following equation [174]: 
            (1) 
Here, Γ is the surface load of the surfactant (in kg m-2), φ is the disperse phase 
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volume fraction, cS is the total surfactant concentration in the emulsion (in kg m-3) and 
c’S is the total surfactant concentration in the continuous phase (in kg m-3).  This 
equation assumes that all of the surfactant adsorbs to the droplet surfaces, and that the 
droplets do not grow after formation e.g., due to Ostwald ripening or coalescence.  In 
our study, the emulsions contained 20 wt% oil droplets (φ ~ 0.20) and 0.1 to 20 wt% 
surfactant in the aqueous phase (c’S ∼ 1 to 200 kg m-3).  If we assume that all of the 
surfactant adsorbed to the oil-water interface, then we can use the measured values of rmin 
(55 nm) to predict the surface load of the surfactants.  The value of c’S was taken to be 
the minimum surfactant concentration required to reach the smallest droplet radius (i.e., 
the value at the end of the surfactant-limited zone), which was approximately 2 wt% (20 
kg m-3).  Consequently, the value of the surface load calculated for the surfactants using 
Equation 1 was: Γ = 1.5 mg m-2 (1.5 × 10-6 kg m-3), which is close to published values for 
this parameter [174, 175].  In practice, the surfactant molecules will be distributed 
through many different environments (e.g., oil-water interface; micelles and monomers in 
the aqueous phase: and, reverse micelles and monomers in the oil phase), and so not all of 
the surfactant will go to the oil-water interface.  Nevertheless, this amount would be 
expected to be relatively small since the critical micelle concentrations of the Tweens are 
typically very low < 0.002 wt% [176].  In addition, the droplet surfaces may not need to 
be completely covered by surfactant in order for protection against coalescence to occur.  
The above value should therefore only be seen as a rough estimate of the actual surface 
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load. 
 
Figure 3.2 Influence of surfactant concentration on the mean particle radius (r32) of 20 wt% 
MCT oil-in-water emulsions formed by a high-energy method (microfluidization). 
Emulsions were passed through the homogenizer three times at 10,000 psi. 
At relatively high surfactant concentrations there is sufficient surfactant present to 
rapidly cover all of the small oil droplets created within the homogenizer, and so the 
droplet size is limited by the maximum disruptive forces generated by the homogenizer 
rather than by surfactant properties.  In this regime, adding more surfactant therefore has 
little impact on the size of the droplets produced during homogenization.  Previous 
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studies have shown that the particle size can be decreased in this regime by increasing the 
homogenization pressure (P) to facilitate further droplet disruption [8, 41, 60].  
Typically, there is a linear decrease in log(d) with increasing log(P) for oil-in-water 
emulsions prepared using small molecule surfactants in a microfluidizer, with the slope 
depending on homogenizer design.  
In general, the two surfactants and their mixture showed similar trends in their 
particle size versus surfactant concentration dependences, but there were some 
differences (Figure 3.2).  In the surfactant-limited zone, the decrease in mean particle 
size with increasing surfactant concentration was steeper for the Tween 80 than for the 
Tween 85, and the mixture was somewhere in between.  Thus, for the same surfactant 
concentration smaller droplets were produced for Tween 80 than for Tween 85 in the 
surfactant-limited zone.  There are a number of possible explanations to account for this 
difference, e.g., there were differences in the adsorption rate of the surfactants to the 
oil-water interface, or in the ability of the surfactants to stabilize the droplets against 
coalescence within the homogenizer.  Tween 85 is more lipophilic than Tween 80 and 
therefore there will have been a greater fraction of this surfactant initially present within 
the oil phase.  The oil phase is more viscous than the aqueous phase and therefore 
Tween 85 in the oil phase may have moved to the droplet interface more slowly than 
Tween 80 in the water phase.   
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Figure 3.3 Influence of surfactant concentration on the mean particle radius (r32) of 20 wt% 
MCT oil-in-water emulsions formed by a low-energy method (spontaneous 
emulsification). The preparation procedure is described in the manuscript. 
Spontaneous emulsification: The spontaneous emulsification (SE) method was 
also used to prepare 20 wt% MCT oil-in-water emulsions using the same type and 
concentrations of surfactant (Figure 3.3), so as to directly compare the results with those 
obtained using the microfluidization method (Figure 3.2).  The influence of surfactant 
concentration on the full particle size distribution of the samples prepared using the SE 
method is also reported (Figure 3.4).  The SE method was capable of forming 
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emulsions with small mean droplet radius (r < 100 nm), but the amount of surfactant 
required to form small droplets with a monomodal distribution was considerably higher 
than the microfluidization method (Figures 3.3 and 3.4).  For example, a 
surfactant-to-oil ratio (SOR) of < 0.1 was typically required to form small droplets (r < 
100 nm) using the microfluidization method, but a SOR > 1 was required to form small 
droplets using the SE method.  Thus, approximately ten-fold more surfactant was 
needed to produce similarly-sized droplets using the low-energy approach than using the 
high-energy approach.  This clearly highlights one of the major disadvantages of the 
spontaneous emulsification method for forming food-grade ultrafine emulsions.  For the 
Tween 80 and the Tween 80/Tween 85 system, the particle size progressively decreased 
with increasing surfactant concentration with the smallest mean droplet radius being 
obtained at 20% surfactant: r = 77 nm for Tween 80 and r = 55 nm for the Tween 
80/Tween 85 mixture.  For the Tween 85 system there was a decrease in mean particle 
radius from 0 to 8% surfactant, followed by an increase at higher surfactant 
concentrations (Figure 3.3).  A minimum droplet radius of around 87 nm was observed 
at 8% surfactant for this system.  These results show that at low and intermediate 
surfactant concentrations (< 8%) the smallest lipid droplets can be formed with Tween 85, 
but at higher surfactant concentrations the smallest droplets can be formed with the 
Tween 80/Tween 85 mixture.  The full particle size distributions showed that the 
droplets formed were monomodal at sufficiently high surfactant concentrations for the 
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Tween 80 (Figure 3.4a) and mixed systems (Figure 3.4b), and at intermediate 
concentrations for the Tween 85 system (Figure 3.4c).    
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Figure 3.4 The particle size distributions of MCT oil-in-water emulsions formed by 
using different concentrations of surfactants prepared by the spontaneous emulsification 
method: (a) Tween 80; (b) Tween 80/Tween 85; (c) Tween 85. 
The fundamental relationship between system composition and the size of the 
droplets produced by the spontaneous emulsification method is less well understood than 
for high energy methods such as microfluidization.  A number of studies have 
empirically examined the relationship between particle size, system composition and 
preparation conditions [177-180].  Fernandez and co-workers proposed that ultrafine oil 
droplets were formed when water was added to a surfactant/oil mixture due to phase 
inversion: the system went from a W/O microemulsion to a bicontinuous system to an 
O/W emulsion [1].  Recently, Mercuri and co-workers proposed the following 
mechanism for the spontaneous formation of emulsion droplets based on a study of the 
phase behavior and microstructure of ternary mixtures of oil (soybean oil), surfactant 
(Tween 80 and Span 80) and water [181].  When an aliquot of surfactant/oil mixture is 
brought into contact with a water phase a boundary is initially formed between the S/O 
and W phases.  Water then penetrates into the S/O phase causing it to swell, leading to 
the formation of W/O microemulsions and then to liquid crystalline phases.  Eventually, 
a fragment (≈ 50 µm) of the liquid crystalline S/O phase breaks off from the S/O-W 
boundary and moves into the water phase.  These relatively large fragments may then 
further dissociate into the nano-sized lipid droplets eventually formed.  An alternative 
  
 
 
52 
hypothesis proposed by Anton and co-workers to account for spontaneous emulsification 
is the movement of surfactant molecules from the S/O phase into the water phase after 
the two phases come into contact, which leads to spontaneous formation of nano-sized 
droplets at the boundary due to a budding mechanism (Figure 3.1) [50].  In reality, it is 
likely that water will penetrate into the S/O phase and that surfactant will move into the 
water phase, although the relative rate and influence of these two processes is currently 
unknown.  Nevertheless, neither of these mechanisms can currently be used to 
quantitatively account for the influence of system composition on the size of the droplets 
formed by the SE method.   
The fact that a minimum in droplet size was observed for the Tween 85 system at 
around 8 wt% is currently not well understood.  Previous studies have also reported a 
minimum in the droplet size for surfactant-oil-water systems containing Tween 85 and 
MCT [182, 183]. These authors reported that the mean particle size obtained using the SE 
method had a minimum value at a surfactant-to-oil ratio of Tween 85-to-MCT of about 
3-to-7 (0.43-to-1), which is very similar to the value of 8-to-20 (0.40-to-1) found in our 
work.  Pouton and co-workers hypothesized that high concentrations of this surfactant 
led to the formation of viscous gels at the S/O-W boundary that retarded 
self-emulsification by limiting molecular diffusion processes [182, 183].  The influence 
of system composition on the physicochemical characteristics of the SOW systems is 
reported in Section 3.3.  It is clear that further work is required to rationalize the 
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formation of oil-in-water emulsions with specific droplet sizes using the 
self-emulsification approach. 
3.3.2 Stability of the emulsion formed by spontaneous emulsification 
The long-term stability of an emulsion is one of the most important factors 
determining its suitability for application within the food and beverage industries [184, 
185]. For this reason, the stability of the emulsions produced in this study was assessed 
by measuring changes in their droplet sizes and appearance during storage at ambient 
temperature (~20 ºC) for one month.  Emulsions formed using microfluidization 
remained stable to droplet aggregation (there was no change in their particle size 
distribution) and gravitational separation (there was no visible evidence of creaming) 
throughout a 30 day period, which can be attributed to their relatively small particle sizes 
(data not shown). 
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 (b) 
 
Figure 3.5 Influence of storage at ambient temperature on the particle size distribution of 
20 wt% MCT oil-in-water emulsions formed by using different surfactants: (a) Tween 80; 
(b) Tween 85. Like the Tween 80 system, the mixed surfactant system (Tween 80/Tween 
85) was also stable to droplet growth during storage (data not shown). 
For the emulsions formed using the spontaneous emulsification method, light 
scattering measurements indicated that the emulsions stabilized by Tween 80 and by 
Tween 80 / Tween 85 were stable to particle growth during one month storage, with no 
significant change in mean particle radius (Table 3.1) or particle size distribution (Figure 
3.5a).  On the other hand, there was an appreciable increase in the mean particle radius 
of the emulsions stabilized by Tween 85 during storage (Table 3.1), which can be 
attributed to an increase in the fraction of larger droplets present in the particle size 
distribution (Figure 3.5b).  The observed differences in emulsion stability can be 
0 
2 
4 
6 
8 
10 
12 
10 100 1000 10000 
R
el
at
iv
e 
In
te
ns
ity
 (%
) 
Particle Radius (um) 
Day 0 
Day 30 
  
 
 
55 
attributed to differences in the influence of the molecular characteristics of the surfactants 
on droplet coalescence.  It is known that the rate of droplet coalescence tends to increase 
as the hydrophile-lipophile balance (HLB) of non-ionic surfactants decreases from high 
to intermediate values [186].  Surfactants with high HLB numbers (> 15) tend to be 
water soluble, form micelles, and stabilize oil-in-water emulsions, whereas surfactants 
with intermediate HLB numbers (5 to 9) tend to be soluble in both the oil and water 
phases, form lamellar structures, and are not particularly good at stabilizing either O/W 
or W/O emulsions [187].  The physicochemical origin of this effect is that the interfacial 
tension at the oil-water interface tends to become very low as the HLB number tends 
towards 7 (the surfactant curvature tends towards unity), which means the interface 
becomes highly mobile and susceptible to coalescence through “hole” formation [188].  
 Tween 80 
 Tween 80 /Tween 85 
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Figure 3.6 Photographs of the influence of surfactant type and concentration on the 
stability of 20 wt% MCT oil-in-water emulsions produced by the spontaneous 
emulsification method to gravitational separation after 30 days storage. 
Visual observation of the 20 wt% MCT oil-in-water emulsions after 30 days 
storage indicated that homogenization method, surfactant type, and surfactant 
concentration also had a major impact on their stability to gravitational separation.  As 
mentioned earlier, all the emulsions prepared using microfluidization remained stable to 
gravitational separation during storage, which may be attributed to their relatively small 
droplet sizes (data not shown).  A number of the samples prepared by the spontaneous 
emulsification method exhibited evidence of creaming instability after storage, with an 
optically opaque cream layer being observed at the top of the samples and a slightly 
turbid serum layer at the bottom (Figure 3.6).  For the Tween 80 samples, the height of 
the cream layer increased as the surfactant concentration increased, suggesting the 
samples were more stable to creaming at higher surfactant concentrations.  For the 
Tween 85 samples, the emulsions were fairly stable to creaming at low and intermediate 
surfactant concentrations (4 to 12 %), but showed extensive creaming at higher surfactant 
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concentrations (16 and 20%).  For the mixed surfactant samples, the emulsions were 
unstable at the lowest surfactant concentration (4%), were stable at intermediate 
concentrations (8 and 12%), and showed some evidence of creaming again at the higher 
values (16 and 20%). 
A number of factors may contribute to the creaming stability of the emulsions.  
First, the creaming velocity of a lipid droplet increases as its radius increases, so that 
emulsions containing larger droplets will cream more rapidly than those containing 
smaller ones [174].  Consequently, the emulsions prepared with low surfactant 
concentrations are likely to be unstable to creaming because they contain relatively large 
droplets.  The emulsions prepared with relatively low levels of Tween 85 had smaller 
droplet sizes than those prepared with Tween 80 or the mixed system (Figure 3.3), which 
may account for their better creaming stability at low surfactant concentrations (Figure 
3.6).  On the other hand, the relatively poor creaming stability of the Tween 85 samples 
at high surfactant concentrations (Figure 3.6) may be due to their relatively large particle 
size (Figure 3.3).  Second, creaming may be induced at intermediate surfactant levels 
due to the presence of non-adsorbed surfactant micelles that generate a depletion 
attraction between the droplets [189].  The strength of the depletion attraction increases 
with increasing surfactant concentration, and above a critical surfactant level (which 
increases with decreasing droplet size) flocculation may be induced, leading to rapid 
creaming.  This phenomenon may account for the fact that some creaming was observed 
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in the Tween 85 and mixed surfactant systems at high surfactant concentrations, even 
though they had relatively small droplet sizes. 
Table 3.1 Surfactant properties and influence of surfactant type on mean particle radius 
of emulsions formed by spontaneous emulsification after 0 and 30 days storage. The 
surfactant concentration is the value where the minimum droplet size was produced by 
the SE method.  Data for the surfactants were taken from the literature [176]. 
Surfactant Type 
MW 
(g/mol) 
HLB 
CMC 
(mg/100g) 
Surfactant 
Concentration 
Radius 
Day 0 
Radius 
Day 30 
Tween 85 1310 15 1.31 8 % 87 nm 183 nm 
Tween 80 1839 11 0.033 20 % 78 nm 77 nm 
Tween 80:Tween 85 1575 13 - 20 % 55 nm 55 nm 
3.3.4 Phase behavior of SOW systems  
The phase behavior of the system at the oil/surfactant-water boundary plays a key 
role in the formation of lipid droplets by the spontaneous emulsification process [190].  
We therefore used dilution experiments and optical microscopy measurements to provide 
some information about the phase behavior of the SOW systems used in this study. 
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Figure 3.7 Photographs of the influence of surfactant type on the appearance and 
properties of surfactant-oil-water (SOW) mixtures containing different SO-W ratios, but 
a fixed SO ratio (1:1).  Annotation: the numbers x/y represent the mass ratio of SO to W, 
e.g., 9/1 means there was 9 g of surfactant-oil mixture and 1 g of water. 
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Figure 3.8 Micrographs of the influence of surfactant type on the appearance of 
surfactant-oil-water (SOW) mixtures containing different SO-W ratios, but a fixed SO 
ratio (1:1).  Annotation: the numbers x/y represent the mass ratio of SO to W, e.g., 9/1 
means there was 9 g of surfactant-oil mixture and 1 g of water. The small white bar in the 
lower right hand corner of each image represents 10 µm. 
A series of mixtures with different mass fractions of surfactant (S), oil (O), and 
water (W), but with a fixed surfactant-to-oil ratio (S:O = 1:1) was prepared, and then 
their overall appearance (Figure 3.7) and microstructure (Figure 3.8) was measured.  
Visual observations suggested that all of the surfactants exhibited relatively similar 
behavior when the amount of water present in the system was increased: at high SO-to-W 
ratios (low water contents) a viscous transparent oily solution was formed; at 
intermediate SO-to-W ratios a gel-like translucent material was formed; at high SO-to-W 
ratios (high water contents) a low viscosity milky liquid was formed (Figure 3.7).  
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Examination of the SOW systems using optical microscopy indicated that surfactant type 
did have an appreciable influence on their microstructures (Figure 3.8).  The Tween 80 
sample was relatively homogeneous at low and high SO-to-W ratios, suggesting that 
large particles were not present in the oil or water continuous systems.  At high 
SO-to-W ratios, this corresponds to the transparent oily liquid observed at low water 
contents.  At low SO-to-W ratios, this corresponds to the milky liquid formed at high 
water contents.  A highly heterogeneous microstructure was observed under the 
microscope at intermediate SO-to-W ratios i.e. 7:3 (Figure 3.8), which corresponded to 
the gel-like structure observed visually (Figure 3.7).  The Tween 85 showed quite 
different behavior, with large heterogeneous structures being formed at all surfactant/oil 
to water ratios studied (Figure 3.8).  The precise nature of these structures is currently 
unknown, although it is likely that they are some kind of liquid crystalline phase.  Large 
heterogeneous structures were only observed in the Tween 80/85 system at a SO-to-W 
ratio of 8:2 (data not shown), otherwise there was no large structures formed (Figure 3.8).  
Observation of the same systems using cross-polarized optical microscopy indicated that 
they had some order, i.e., the structures rotated polarized light and gave a white 
appearance against a black background (data not shown).  This birefringent behavior 
suggests that the surfactants formed liquid crystalline structures at intermediate SO-to-W 
ratios.                  
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3.4 Conclusions 
This study has highlighted some of the advantages and disadvantages of low and 
high energy approaches for creating oil-in-water emulsions containing ultrafine oil 
droplets.  The high energy method (microfluidization) was able to produce emulsions 
with small droplets (r < 100 nm) using low surfactant-to-oil ratios (< 1:10), but it 
required relatively expensive specialized equipment and has relatively high operating 
costs.  On the other hand, the low energy method (spontaneous emulsification) is 
inexpensive and can be implemented using simple equipment (stirring), but it requires 
high surfactant-to-oil ratios (> 5:10) to produce small droplets.  The usage of relatively 
high surfactant levels may cause problems in some food and beverage products due to 
high ingredient costs, off flavors, and safety concerns.  In addition, high surfactant 
levels may lead to emulsion instability due to depletion flocculation or due to accelerated 
droplet growth through Ostwald ripening effects.  Further work is required to establish 
whether low energy methods can be developed that produce small droplet sizes without 
the need for high surfactant levels.   
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CHAPTER 4 
FORMATION AND STABILITY OF EMULSIONS USING A NATURAL SMALL 
MOLECULE SURFACTANT: QUILLAJA SAPONIN (Q-NATURALE®) 
4.1 Introduction 
Small molecule surfactants are widely used in the food industry to form and 
stabilize emulsion-based food and beverage products [67, 191].  Surfactants facilitate 
the formation of oil-in-water emulsions by adsorbing to oil-water interfaces during 
homogenization, thereby reducing the interfacial tension and enhancing further droplet 
disruption [59, 60].  In addition, adsorbed surfactants provide a protective coating 
around oil droplets, which inhibits their aggregation and improves the long-term stability 
of emulsions [24, 192].  A large number of surfactants are available for utilization 
within the food industry, which vary according to their molecular, physicochemical, and 
functional properties, as well as their ease of utilization, legal status, and costs [67].  
Some of the most important practical characteristics of surfactants for commercial use are: 
(i) the minimum amount required to produce small droplets; (ii) the smallest droplet size 
that can be achieved under specified homogenization conditions; (iii) the stability of the 
droplets formed to environmental stresses, such as pH, ionic strength, and temperature 
[193].  There are wide variations in the performance of surfactants depending on their 
molecular characteristics, e.g., head group and tail group structure [194].  Consequently, 
food and beverage manufacturers must select the most appropriate surfactant for a 
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particular application [193].         
Recently, there has been increasing interest within the food industry in replacing 
synthetic ingredients with natural “label friendly” alternatives [7, 13].  Consequently, 
there has been a focus on identifying and characterizing natural emulsifiers that can be 
successfully used in emulsion-based food and beverage products.  Biopolymer-based 
emulsifiers, such as proteins (whey, soy and egg) and polysaccharides (gum arabic and 
modified starch), have been shown to be effective at forming and stabilizing emulsions 
[9-11, 13].  Nevertheless, biopolymer emulsifiers often have limitations in their 
functional performance.  Protein-coated oil droplets are often unstable to aggregation at 
pH values around their isoelectric point, at high ionic strengths, and at elevated 
temperatures [12].  On the other hand, it is often difficult to produce oil droplets with 
very small sizes (d < 200 nm) using polysaccharide-based emulsifiers [9, 10, 13].  
Certain types of lecithin are also suitable for utilization as natural emulsifiers in food and 
beverage products, e.g., phospholipids derived from egg, soy, or milk [67, 76].  
However, natural lecithin (which has two non-polar tails) usually has to be chemically or 
enzymatically modified to lysolecithin (which has one non-polar tail) before it can be 
successfully used to stabilize oil-in-water emulsions.  In this study, we investigated the 
suitability of a natural saponin-based surfactant that has recently become commercially 
available as a food ingredient to form and stabilize oil-in-water emulsions. 
An extract isolated from the bark of the Quillaja saponaria Molina tree (an 
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evergreen native to Chile and Peru) has been found to contain surface active components 
that are capable of forming surfactant micelles and stabilizing oil-in-water emulsions 
[14-16]. The major components within this extract have been reported to be saponins [17, 
18] , which are high molecular weight glycosides consisting of a sugar moiety attached to 
a triterpene or a steroid aglycone [19].  The saponins are surface active substances 
(Figure 4.1) because they contain both hydrophilic regions (such as rhamnose, xylose, 
arabinose, galactose, fucose, and glucuronic acid) and hydrophobic regions (such as 
quillaic acid and gypsogenic acid) on the same molecule [16, 77].  A food ingredient 
based on the quillaja saponin extract has recently been marketed by the National Starch 
company (Bridgewater, NJ) under the trade name Q-Naturale®.   
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Figure 4.1 Structural representations of quillaja saponin – a proposed major surface 
active component of the food ingredient Q-Naturale. 
In this study, we characterized the interfacial properties of influence of 
homogenization conditions on the formation of oil-in-water emulsions using Q-Naturale®, 
and then studied the influence of environmental stresses (pH, ionic strength, and 
temperature) and long-term storage on the stability of the resulting emulsions to droplet 
growth and gravitational separation.  The performance of Q-Naturale® was compared to 
that of a synthetic surfactant (Tween 80) that is currently widely used in the food and 
beverage industry to formulate emulsion-based products.  
4.2 Materials and methods 
4.2.1 Materials 
The non-ionic surfactant polyoxyethylene (20) sorbitan monooleate (Tween 80) 
was purchased from Sigma-Aldrich Co. (St. Louis, MO). Quillaja saponin (Q-Naturale® 
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200) was provided by National Starch LLC (Bridgewater, N.J.).  The molecular weights 
of Tween 80 (Sigma-Aldrich, St. Louis, MO) and quillaja saponin [16] have been 
reported to be 1310 and 1650 g mol-1, respectively.  Medium chain triglyceride (MCT) 
oil (Miglyol 812) was purchased from Coletica (Northport, NY). 
4.2.2 Emulsion preparation 
Oil-in-water emulsions were prepared by homogenizing 10 wt% lipid phase 
(MCT) with 90 wt% aqueous phase.  The aqueous phase consisted of surfactant (Tween 
80 or Q-Naturale®) and buffer solution (10 mM sodium phosphate buffer, pH 7.0).  A 
coarse emulsion premix was prepared by blending the lipid and aqueous phases together 
using a high-speed mixer (Bamix, Biospec Products, Bartlesville, OK) for 2 min at room 
temperature. Fine emulsions were formed by passing the coarse emulsions through an 
air-driven microfluidizer (Microfluidics, Newton, MA, USA). The coarse emulsions were 
fed into the microfluidizer through a 100 ml glass reservoir, and were passed through the 
homogenization unit for different numbers of passes at various homogenization pressures.  
The type and amount of surfactant added to the aqueous phase prior to homogenization 
was varied in some experiments.  The commercial Q-Naturale® ingredient contained 14% 
of surfactant (active ingredient) dispersed within an aqueous solution, and therefore we 
reported its concentration based on the amount of active surfactant present (rather than 
the overall ingredient). 
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4.2.3 Emulsion stability testing 
The stability of the prepared emulsions to a series of environmental stresses that 
might be encountered in commercial practice was tested: 
Thermal processing: Emulsion samples were placed in glass test tubes and then 
incubated in water baths set at different temperatures (30 to 90 ºC) for 30 min.  The 
samples were then cooled to room temperature and stored for 24 hours at ambient 
temperature prior to analysis. 
pH and salt: The pH and ionic strength of emulsions was adjusted to a specified 
level using NaOH, HCl, and/or NaOH solutions.  Emulsion samples were then placed in 
glass test tubes and incubated for 24 hours at ambient temperature prior to analysis. 
Long-term storage: Emulsion samples were placed in glass test tubes and then 
incubated in temperature controlled rooms (5, 37, and 55 °C) for one month prior to 
analysis.   
4.2.4 Particle characterization  
The particle size distributions of the samples were measured using a static light 
scattering instrument (Mastersizer 2000, Malvern Instruments, Malvern, U.K.).  The 
droplet charge (ζ-potential) of emulsions was determined using a particle electrophoresis 
instrument (Zetasizer Nano ZS series, Malvern Instruments, Worcestershire, UK).  
Samples were diluted with buffer solutions of the appropriate pH prior to analysis to 
avoid multiple scattering effects.   
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4.2.5 Interfacial tension measurements 
The interfacial tension versus surfactant concentration was measured at the MCT 
oil – water interface using a drop shape analysis instrument (DSA 100, Kruss GmbH, 
Hamburg Germany).  The surface pressure (π) was calculated from the interfacial 
tension (γ) data using the following formula: π = γ – γ0, where γ and γ0 are the interfacial 
tensions measured in the presence and absence of surfactant.  
4.2.6 Optical microscopy measurements 
A Nikon optical microscope (Nikon Eclipse 80i, Nikon Instrument Inc., Melville, 
NY) with a 60× objective lens (NA 0.75) was used to capture images of emulsion 
samples.  
4.2.7 Statistical analysis 
All measurements were performed on at least two freshly prepared samples (i.e., 
new samples were prepared for each series of experiments) and were reported as means 
and standard deviations.  
4.3 Results and discussion 
4.3.1 Interfacial characteristics 
The interfacial activity of surfactants plays an important role in determining their 
ability to form and stabilize emulsions [195, 196], and therefore we measured the 
interfacial tension versus surfactant concentration profiles for the two surfactants used 
(Figure 4.2).  For both surfactants, the interfacial tension decreased appreciably with 
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increasing surfactant concentration indicating that the surfactants adsorbed to the 
oil-water interface.  A fairly constant interfacial tension was reached at high surfactant 
levels (γ∞ ≈ 5 mN m-1), which indicated that the interfaces had become saturated with 
surfactant [71].  Q-Naturale and Tween 80 both had fairly similar interfacial tension 
versus surfactant concentration profiles, which indicated that they had similar surface 
activities.  The critical micelle concentration (CMC) of the two surfactants was 
determined from the interfacial tension versus logarithm of surfactant concentration 
profiles using the method described previously, i.e., determining the intersect between 
linear plots extrapolated from high and intermediate surfactant concentrations [16].  We 
estimated the CMC values from the data shown in Figure 4.2 to be around 0.003 and 
0.01 wt% for the Tween 80 and Q-Naturale, respectively. These values is in reasonable 
agreement with reported values of 0.0022 wt% for Tween 80 [197] and 0.01 to 0.07 wt% 
for quillaja saponin from various sources [16]. 
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Figure 4.2 Influence of Tween 80 and Q-Naturale concentration on the interfacial tension 
measured at the MCT oil-water interface. 
The surface load (Γ) of a surfactant can be calculated from the interfacial tension 
(γ) versus surfactant concentration (c) data using the following formula [16]: 
               (1) 
Here R is the gas constant, T is the absolute temperature, and c is expressed in 
moles per liter [71].  We used this expression to determine the surface load of the two 
surfactants from the slope of the γ versus ln c data (Figure 4.2): Γ = 3.1 and 2.9 mg m-2 
for Tween 80 and Q-Naturale, respectively.  The area (A) occupied per molecule at the 
oil-water interface can be calculated from the surface load: A = 1/(ΓNA), where NA is 
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Avogadro’s number [16].  We obtained values of A = 72 and 96 Å2 per molecule for 
Tween 80 and Q-Naturale, respectively.  The value for Q-Naturale is in good agreement 
with the value of 83 Å-2 reported for quillaja saponin in previous studies [16].  
The surface activity (K) of an emulsifier can be conveniently characterized by the 
following relationship [26]:  
            (2) 
Here c½ is the surfactant concentration where half of the available adsorption sites 
on the oil-water interface are covered by surfactant, and ΔGads is the free energy change 
associated with surfactant adsorption.  To a rough approximation, c½ can be taken to be 
equal to the surfactant concentration where the surface pressure is half its maximum 
value (π∞).  In this study, we calculated the following parameters from the interfacial 
pressure versus surfactant concentration profiles: for Tween 80, c½ = 0.0014 wt% (10.7 
µM), K = 94,000, and ΔGads = -11.4 RT; for Q-Naturale, c½ = 0.0010 wt% (6.1 µM), K = 
165,000, and ΔGads = -12.0 RT.   
Overall, our measurements show that both surfactants were highly effective at 
reducing the interfacial tension at an oil-water interface, and that both had fairly similar 
interfacial characteristics (Figure 4.2).       
4.3.2 Influence of surfactant type and concentration on emulsion formation  
In this section, the influence of surfactant type and concentration on the particle 
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size of 10 wt% MCT oil-in-water emulsions produced using a high pressure homogenizer 
(microfluidizer) under standardized homogenization conditions (10,000 psi, 4 passes) 
was examined (Figure 4.3).  As expected, there was a decrease in mean particle 
diameter (d32) with increasing surfactant concentration for both types of surfactant used.  
This effect can be attributed to two main factors: (i) a higher surfactant concentration 
means that a larger surface area can be stabilized during homogenization; (ii) a higher 
surfactant concentration leads to faster coverage of the droplet surfaces by surfactant 
molecules, and therefore better protection against recoalescence [192]. The dependence 
of oil droplet size on surfactant concentration can be conveniently divided into two 
distinct regimes for emulsions prepared by high pressure homogenization [172, 173]: the 
“surfactant-limited zone” and the “surfactant-rich zone”. At low surfactant concentrations, 
there is insufficient surfactant present to cover the new surfaces created within the 
homogenizer when larger droplets are broken down to smaller ones.  Consequently, two 
or more small oil droplets that collide tend to coalesce because there is insufficient 
surfactant present at their surfaces to prevent them from coming into close contact. 
Coalescence tends to continue until all of the droplets are covered by sufficient surfactant 
to prevent them from merging together. Hence, the droplet size in the surfactant-limited 
zone is primarily determined by the type and amount of surfactant present.  At 
sufficiently high surfactant concentrations, the droplet size is primarily governed by the 
maximum disruptive energy that can be generated by the homogenizer, rather than the 
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amount of surfactant present.  Nevertheless, the droplet size may still depend somewhat 
on surfactant type since this will determine interfacial characteristics that influence 
droplet disruption such as interfacial tension and rheology. 
 
Figure 4.3 Influence of surfactant concentration on the mean particle diameter (d32) of 10 
wt% MCT oil-in-water emulsions containing either Tween 80 or Q-Naturale produced 
using standardized homogenization conditions (10,000 psi, 4 passes). 
There were appreciable differences in the particle size versus surfactant 
concentration profiles obtained for the two types of surfactants (Figure 4.3).  Smaller 
droplets could be produced at high surfactant concentrations using Tween 80 (d ≈ 120 nm) 
than using Q-Naturale (d ≈ 170 nm). In addition, a lower surfactant concentration was 
required to produce small droplets (d < 200 nm) for Tween 80 (≈ 0.3 to 0.5%) than for 
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Q-Naturale (≈ 0.8 to 1.1 %).  These experiments indicate that both types of surfactants 
were effective at producing small droplets, but that Tween 80 was more efficient than 
Q-Naturale.  The differences in the effectiveness of the two surfactants may be due to a 
number of factors that impact droplet disruption and coalescence within homogenizers, 
including the speed at which they adsorb to the oil-water interface, their ability to reduce 
the oil-water interface tension, their influence on the dynamic interfacial rheology, and 
their effectiveness at generating repulsive interactions between droplets [59, 60, 192].  
The surface activities of the two surfactants (measured under static conditions) were 
fairly similar (Section 3.1), which suggest that some of the other factors mentioned may 
be more important. 
The minimum droplet size that can be theoretically produced during 
homogenization given a fixed amount of surfactant can be calculated from the following 
expression [174]: 
            (3) 
Here, Γ is the surface load (in kg m-2), φ is the disperse phase volume fraction, cS 
is the concentration of emulsifier in the emulsion (in kg m-3) and c’S is the concentration 
of emulsifier in the continuous phase (in kg m-3).  In our study, the emulsions contained 
10 wt% of oil droplets (φ ~ 0.1) and a maximum surfactant concentration of 2 wt% in the 
aqueous phase (c’S ∼ 20 kg m-3).  The surface load of the two surfactants was calculated 
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from the interfacial measurements in the previous section to be around 3 mg m-2 (Γ = 3 × 
10-6 kg m-2). Hence, the minimum mean droplet diameter (d32) that could be achieved 
assuming that all of the surfactant adsorbed to the droplet surfaces during 
homogenization is about dmin = 100 nm.  The mean droplet diameters produced in our 
study were somewhat higher than this value, which suggested that there was more than 
enough emulsifier initially present to cover all of the droplets formed by the 
microfluidizer.  The fact that the observed minimum droplet diameter (∼120 - 170 nm) 
achieved was higher than the predicted value may have been because the surfactant did 
not adsorb quickly enough during homogenization, or because the homogenizer was 
incapable of generating sufficiently intense disruptive forces at the pressures used.     
4.3.3 Influence of homogenization conditions on emulsion formation  
Previous studies have shown that the size of the droplets in emulsions produced 
by high pressure homogenization depends on processing conditions such as 
homogenization pressure and number of passes [8, 33, 198, 199].  We therefore 
examined the influence of these experimental parameters on the size of the droplets 
produced by the two surfactants used in this study.  The mean droplet diameter 
decreased with increasing homogenization pressure (Figure 4.4) and number of passes 
(Figure 4.5) for both types of surfactant, which is in agreement with previous studies [13, 
41, 173, 200]. 
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Figure 4.4 Influence of number of passes through a high pressure homogenizer on the 
mean particle diameter (d32) of 10 wt% MCT oil-in-water emulsions containing either 1 
wt% Tween 80 or Q-Naturale produced at a constant homogenization pressure (10,000 
psi). 
At a fixed homogenization pressure, the mean droplet diameter decreased with 
increasing number of passes (Figure 4.4), which can be attributed to the fact that a higher 
proportion of the droplets will have had a chance to pass through the most disruptive 
zone within the homogenizer. The largest decrease in mean droplet diameter occurred 
when the coarse emulsion premix (zero passes) was initially passed through the 
homogenizer (one pass).  After one pass through the homogenizer, there was only a 
slight decrease in droplet size upon further passes indicating that this type of 
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homogenizer is highly effective at droplet disruption.  This is commercially important 
since food and beverage manufacturers aim to minimize the number of passes required to 
form an emulsion since this reduces processing time and cost.  The limiting droplet size 
obtained after a high number of passes is determined by the maximum disruptive energy 
that can be generated by the homogenizer at the pressure used (provided there is 
sufficient surfactant present to cover all the droplet surfaces produced). 
 
Figure 4.5 Influence of homogenization pressure on the mean particle diameter (d32) of 
10 wt% MCT oil-in-water emulsions containing either 1 wt% Tween 80 or Q-Naturale 
passed four times through the homogenizer. 
There was a linear decrease in the logarithm of the mean droplet diameter with the 
logarithm of the homogenization pressure for emulsions stabilized by either Tween 80 or 
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Q-Naturale (Figure 4.5), which is in agreement with previous studies that indicate there 
should be a linear relationship providing there is sufficient emulsifier present [201]. The 
slope determined from the log10(d) versus log10(P) plots was around -0.93 when Tween 
80 was used as the surfactant and around -0.86 when Q-Naturale was used (Figure 4.5).  
These values are somewhat higher than previously reported values of around -0.6 to -0.8 
for high pressure homogenizers [202, 203].  This difference may be due to differences in 
the homogenizer design, homogenization valve, or particle sizing methods used in 
different studies. 
4.3.4 Influence of environmental stresses on emulsion stability  
Practically, an emulsion-based food or beverage should remain stable throughout 
the anticipated shelf life of the final product.  Emulsions may become unstable through 
a number of different instability mechanisms (e.g., flocculation, coalescence, Ostwald 
ripening, and gravitational separation), which depend on storage conditions such as pH, 
ionic strength, and temperature [28].  We therefore examined the influence of 
environmental stresses on the stability of emulsions stabilized by the two different kinds 
of surfactant.   
4.3.4.1 Influence of Thermal Processing 
Emulsions prepared using either Tween 80 or Q-Naturale were both stable to 
thermal processing across the entire temperature range studied (30 to 90 ºC), with little 
change in mean particle diameter (Figure 4.6) or visible evidence of gravitational 
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separation, i.e., all the emulsions appeared white and homogeneous (data not shown).  
Lipid droplets stabilized by non-ionic surfactants may become unstable to droplet 
coalescence when they are heated close to a critical temperature (the “phase inversion 
temperature” or PIT) because of dehydration of the polar surfactant head groups [50, 204].  
Dehydration causes a change in the optimum curvature of the surfactant molecules at the 
oil-water interface, as well as their relative solubilities (and partitioning) in the oil and 
water phases, which favors droplet coalescence [205].  The PIT depends on the 
chemical structure of the surfactant, as well as the nature of the oil phase [177, 178].  
Our results suggest that both Tween 80 and Q-Naturale are stable to droplet coalescence 
during relatively short term heating when MCT is used as the oil phase, presumably 
because the PIT is sufficiently far above the highest temperature used in this study.  
Nevertheless, we did seem some instability in the Tween 80 stabilized emulsions when 
they were heated at elevated temperatures for prolonged times (see Section 4.3.4.4), 
which suggests that they may have been unstable to coalescence at elevated temperatures. 
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Figure 4.6 Influence of thermal processing on the mean particle diameter (d32) of 10 wt% 
MCT oil-in-water emulsions containing either 1 wt% Tween 80 or Q-Naturale. 
Emulsions were held for 30 minutes at the specified temperature, and then cooled to 
ambient temperature prior to analysis. 
4.3.4.2 Influence of pH  
The influence of pH on the mean particle diameter, ζ-potential, creaming stability, 
and microstructure of the emulsions stabilized by the two different surfactants was 
examined.  For the Tween 80 stabilized emulsions, the electrical charge on the droplets 
went from slightly negative (- 9 mV) at pH 9 to slightly positive (+ 2 mV) at pH 2 with a 
point of zero charge around pH 3.5 (Figure 4.7a).  Tween 80 is a non-ionic surfactant 
and would therefore not be expected to have any charge, although previous studies have 
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shown that droplets stabilized by non-ionic surfactants may be charged due to the 
presence of ionizable surface active impurities (such as free fatty acids) or due to 
preferential adsorption of hydroxyl ions (OH-) at high pH or hydrogen ions (H+) at low 
pH to the droplet surfaces [26]. Emulsions containing Tween 80 appeared to be stable to 
droplet aggregation and gravitational separation at all pH values studied, with no 
evidence of droplet growth in the light scattering data (Figure 4.7b), no change in 
microstructure in optical microscopy images (data not shown), and no visible evidence of 
creaming (data not shown).  The fact that the droplets had little net charge across the 
entire pH range studied suggests that droplet aggregation was mainly prevented by steric 
repulsion due to the relatively large hydrophilic (polyoxyethylene) head groups of the 
adsorbed Tween molecules [76]. 
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Figure 4.7a Influence of storage pH on the droplet charge (ζ-potential) of 10 wt% MCT 
oil-in-water emulsions containing either 1 wt% Tween 80 or Q-Naturale.   
 
Figure 4.7b Influence of storage pH on the mean particle diameter (d32) of 10 wt% MCT 
oil-in-water emulsions containing either 1 wt% Tween 80 or Q-Naturale.   
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Q-Naturale 
Figure 4.7c Influence of storage pH on the appearance of 10 wt% MCT oil-in-water 
emulsions containing either 1 wt% Tween 80 or Q-Naturale.  Note that extensive 
creaming occurred at pH 2 in the Q-Naturale stabilized system.   
 
Figure 4.7d Microstructure of 10 wt% MCT oil-in-water emulsions containing 1 wt% 
Q-Naturale at pH 2.  Extensive droplet flocculation can clearly be observed.  All other 
emulsions appeared uniform in appearance under the microscope. 
The Q-Naturale stabilized emulsions had a high negative charge (-69 mV) at pH 9, 
which decreased in magnitude as the pH was increased until it reached a value close to 
zero at pH 2 (- 1 mV) (Figure 4.7a).  The origin of the negative charge can be attributed 
to the presence of a carboxylic acid group within the structure of quillaja saponin (Figure 
  
 
 
85 
4.1).  Typically, carboxylic acid groups have pKa values around pH 3.5, which would 
account for the large decrease in ζ-potential observed around this value (Figure 4.7a).  
At high pH values (pH >> pKa) this group would be fully charged (-COO-) whereas at 
low pH values (pH << pKa) it would be uncharged (-COOH).  The presence of a strong 
negative charge on the droplets might play an important role in determining the 
functional properties of this surfactant for certain applications: (i) a high negative charge 
may make emulsions susceptible to flocculation due to electrostatic bridging by cationic 
multivalent ions (such as calcium) [206, 207]; (ii), a high negative charge may attract 
cationic pro-oxidants (such as transition metals) to the droplet surfaces and thereby 
promote lipid oxidation [208, 209]; (iii) a high negative charge may cause droplets to 
adhere to cationic surfaces [210].  Our light scattering measurements indicated that the 
droplets were stable to droplet aggregation across the entire pH range studied (Figure 
4.7b).  On the other hand, visual observation of the emulsions indicated that extensive 
creaming occurred at pH 2 (Figure 4.7c), and optical microscopy images showed that the 
emulsions containing Q-Naturale were highly aggregated at pH 2 (Figure 4.7d).  Taken 
together these results suggest that the emulsions were highly flocculated at pH 2, but that 
they were stable to coalescence (otherwise we would have seen an increase in the mean 
droplet diameter at pH 2 in the light scattering data).  The light scattering measurements 
were performed on highly diluted samples, and so any flocculated droplets may have 
become dissociated prior to analysis.  These results indicate that emulsions stabilized by 
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quillaja saponin are stable across most of the pH range present within food products (pH 
3 to 8), but that they might become unstable to flocculation in highly acidic products or 
within the human stomach after ingestion.  
4.3.4.3 Influence of ionic strength 
The influence of ionic strength was examined by adding different amounts of salt 
(0 to 500 mM NaCl) to the samples and then measuring their stability after storage 
overnight (Figure 4.8).  Emulsions containing Tween 80 were stable at all salt 
concentrations studied, exhibiting no change in mean particle diameter (Figure 4.8a), no 
evidence of creaming (data not shown), and no change in microstructure (data not shown).  
These results highlight the fact that the oil droplets in the Tween 80 emulsions are mainly 
stabilized against aggregation by steric (rather than electrostatic) repulsion [26].  
Emulsions containing Q-Naturale appeared to be stable to droplet aggregation at all salt 
concentrations studied when analyzed by light scattering, with no evidence of an increase 
in droplet diameter at any NaCl concentration (Figure 4.8b).  However, creaming 
stability and optical microscopy measurements indicated that Q-Naturale emulsions were 
stable at low salt concentrations (< 300 mM NaCl), but unstable to creaming (Figure 
4.8b) and aggregation (Figure 4.8c) at higher salt concentrations.  The fact that the 
mean particle size data determined by light scattering indicated that the droplets remained 
small at all salt concentrations studied suggests that droplet aggregation was due to 
flocculation rather than coalescence in the presence of high salt levels.  These results 
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suggest that both electrostatic and steric repulsion play an important role in stabilizing 
Q-Naturale® coated droplets against aggregation.  At low salt concentrations the 
long-range electrostatic repulsion between the droplets is strong enough to prevent 
aggregation, but at high salt concentrations the long-range attractive interactions (e.g., 
van der Waals) become stronger than the long-range repulsion interactions (e.g., 
electrostatic), leading to droplet association.  Nevertheless, at high salt concentrations 
the short-range steric repulsion between droplets still seems to be sufficiently strong to 
prevent the droplets from coming close enough together to merge together and coalesce.  
The fact that the Tween 80 emulsions were stable to flocculation at high salt 
concentrations whereas the Q-Naturale emulsions were unstable suggests that the 
polymeric head groups of Tween 80 are thicker than those of Q-Naturale. 
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Figure 4.8a Influence of salt concentration on the mean particle diameter (d32) of 10 wt% 
MCT oil-in-water emulsions containing either 1 wt% Tween 80 or Q-Naturale.   
 Tween 80        Q-Naturale      
    
Figure 4.8b Influence of salt concentration on the appearance of 10 wt% MCT 
oil-in-water emulsions containing either 1 wt% Tween 80 or Q-Naturale.  Creaming was 
observed at the higher salt concentrations in the Q-Naturale emulsions (arrow). 
 
Figure 4.8c Influence of high salt concentration (500 mM) on the microstructure of 10 wt% 
MCT oil-in-water emulsions containing 1 wt% Q-Naturale.   
4.3.4.4 Influence of storage time and temperature  
The long-term stability of emulsions is one of the most important factors 
determining their shelf life in commercial food and beverage applications [28].  We 
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therefore compared the stabilities of emulsions formed using Q-Naturale with those 
formed using Tween 80 during storage at different temperatures (5, 37, and 55 °C) for 
one month.  These experiments were carried out using emulsions at neutral pH in the 
absence of added salt.  We observed no change in the visible appearance of emulsions 
containing Q-Naturale at any of the storage temperatures (data not shown) and little 
change in particle size distribution (Figure 4.9).  We also found only a small increase in 
mean droplet diameter of the Q-Naturale emulsions after one month storage (Table 4.1), 
indicating that they were fairly stable to droplet growth and gravitational separation.  
We also did not observe any change in the appearance (data not shown) or mean particle 
diameter (Table 4.1) of the Tween 80 stabilized emulsions stored at 5 or 37 ºC for one 
month indicating that they were also stable to droplet growth and creaming.  On the 
other hand, we did observe a thin layer of oil on top of the Tween 80 stabilized emulsions 
stored at 55 °C for one month, and an appreciable increase in mean droplet diameter 
(Table 4.1).  Interestingly, we did not observe an appreciable change in mean droplet 
diameter or oiling off after heating the Tween 80 stabilized emulsions at high 
temperatures for short times (e.g., 60-90 ºC for 30 minutes) as described earlier (Section 
4.3.4.1).  These results suggest that emulsions stabilized by this non-ionic surfactant 
may be unstable to long-term storage at elevated temperatures, but may be stable during 
short-term thermal processing operations.  A possible explanation for this phenomenon 
is that Tween surfactants may chemically degrade (hydrolyze) when stored at elevated 
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temperatures for prolonged periods and therefore lose their surface activity [211].   
 
Figure 4.9 Influence of long-term storage (one month) on the particle size distribution of 
10 wt% MCT oil-in-water emulsions containing Q-Naturale.   
Table 4.1 Particle size changes of emulsions formed by Tween 80 and Q-Naturale 
respectively after one month storage 
 0 day One month later 
Tween 80 
5 °C 
133 nm 
129 nm 
37 °C 132 nm 
55 °C 155 nm 
Q-Naturale 
5 °C 
188 nm 
200 nm 
37 °C 204 nm 
55 °C 209 nm 
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4.4 Conclusions 
We have carried out a detailed study of the interfacial, emulsion forming, and 
emulsion stabilizing properties of Q-Naturale, a natural food-grade surfactant based on 
quillaja saponin that has recently become commercially available.  Q-Naturale was 
found to be highly surface active, and had similar interfacial properties as Tween 80 a 
synthetic non-ionic surfactant widely used in the food industry.  Q-Naturale-coated 
droplets had a large negative charge at neutral pH, which decreased in magnitude at 
acidic pH values, which was attributed to the presence of a carboxylic acid group.  
Q-Naturale was able to form oil-in-water emulsions with relatively small droplet sizes (d 
< 200 nm) at low surfactant-to-oil ratios (SOR ≈ 1:10), which were stable to a range of 
thermal treatments (30 to 90 ºC), salt concentrations (≤ 300 mM NaCl), and pH 
conditions (pH 3 to 8).  In addition, they had good long-term stability (one month) when 
stored at various holding temperatures (5, 37, and 55 °C).  The emulsions were unstable 
to flocculation and creaming (but stable to coalescence) when stored at highly acidic (pH 
2) or high ionic strength (400 or 500 mM NaCl) conditions, which was attributed to the 
reduction in the electrostatic repulsion operating between the droplets.  Overall, our 
results show that Q-Naturale is an effective natural surfactant that may be suitable for 
utilization in a variety of food and beverage products. 
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CHAPTER 5 
ENCAPSULATION OF VITAMIN E IN EDIBLE EMULSIONS FABRICATED 
USING A NATURAL SURFACTANT 
5.1 Introduction 
There is increasing interest within the food and biomedical industries in the 
creation of delivery systems to encapsulate, protect, and release lipophilic bioactive 
compounds, such as ω-3 fatty acids, phytosterols, flavonoids, carotenoids, vitamins, and 
drugs [3, 212-214].  These delivery systems should be designed so that they can 
incorporate appreciable amounts of the bioactive component, protect it from physical or 
chemical degradation during storage, and deliver it to the appropriate site of action after 
ingestion.  They should also be designed so that they are compatible with the delivery 
vehicle in which they are to be incorporated, e.g., for food and beverage products they 
should not adversely affect their appearance, stability, texture or flavor.  In addition, for 
food and beverage applications delivery systems must be fabricated entirely from 
food-grade ingredients using economic and commercially viable processing operations.  
Emulsion-based delivery systems are particularly suitable for this type of application, 
since they can be fabricated entirely from generally recognized as safe (GRAS) food 
ingredients and processing operations [128, 215].   
The term “vitamin E” refers to a group of fat-soluble vitamins that are widely 
used as functional ingredients in food, pharmaceutical, and cosmetic preparations [216]. 
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Vitamin E comes in eight different molecular forms that have a common structural 
feature: a chromanol ring and a phytol side chain [23].  The different molecular forms of 
vitamin E are classified as either tocopherols (α, β, γ, and δ) or tocotrienols (α, β, γ, and 
δ), with α-tocopherol being the most biologically active form [217]. The major biological 
function of Vitamin E appears to be as an oil-soluble antioxidant [218].  Various other 
health benefits of vitamin E have also been claimed, such as reducing cardiovascular 
disease, diabetes and cancer [219-221].  For these reasons, there has been interest in 
fortifying many processed foods and beverages with Vitamin E [22]. Some studies 
suggest that the bioavailability of Vitamin E may be increased when it is delivered in 
colloidal form rather than bulk form [222].  Vitamin E is unstable to oxidation in food 
many food products and may therefore be lost during processing, storage, and utilization 
[223, 224].   For this reason, vitamin E acetate (rather than vitamin E) is used in many 
food and beverage applications since it has a higher oxidative stability.  After 
consumption vitamin E acetate is broken down to vitamin E in the gastrointestinal tract 
by the action of pancreatic esterases [225].  The recommended daily intake (RDI) of 
Vitamin E is 15 mg/day, although deficiency only usually occurs in the case of 
individuals with diseases that inhibit fat absorption or in premature infants [23, 218].   
Vitamin E is a highly lipophilic molecule that cannot be directly dispersed into 
aqueous solutions [22].  Instead, it must be incorporated into an appropriate colloidal 
delivery system prior to dispersion [23].  A number of previous studies have shown that 
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vitamin E can be successfully incorporated into emulsion-based delivery systems, such as 
microemulsions [79, 216], nanoemulsions [80-82] and emulsions [23, 83].  
Encapsulation of vitamin E has been reported to improve its physicochemical stability 
during storage and its biological activity after consumption [226, 227]. In the current 
study, we focus on the development of oil-in-water emulsions suitable for incorporating 
vitamin E in functional food and beverage products designed to improve human health 
and wellness. 
 
 
Figure 5.1 Structure of Vitamin E acetate – a highly lipophilic bioactive molecule. 
Recently, there has been increasing interest within the food industry in replacing 
synthetic ingredients with natural “label friendly” alternatives [7, 8]. Consequently, there 
O
O
O
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has been a focus on identifying and characterizing natural emulsifiers that can be 
successfully used in emulsion-based food products.  In this study, we investigate the 
emulsifying properties of a recently developed compound extracted from the bark of the 
Quillaja saponaria Molina tree.  The major components within quillaja extract have 
been reported to be saponins [17, 18] , which are high molecular weight glycosides 
consisting of a sugar moiety attached to a triterpene or a steroid aglycone [19].  The 
surface activity of saponins arises from the fact that they contain both hydrophilic regions 
(sugar groups) and hydrophobic regions (such as quillaic and gypsogenic acids) on the 
same molecule [16, 77].  Saponins have previously been shown to form surfactant 
micelles in aqueous solutions and to stabilize oil-in-water emulsions [228, 229]. A food 
ingredient based on a quillaja saponin extract has recently been marketed by the National 
Starch Company (Bridgewater, NJ) under the trade name Q-Naturale®. 
We investigate a number of factors expected to influence the size of the oil 
droplets formed in oil-in-water emulsions produced by high pressure homogenization: oil 
phase composition (Vitamin E to medium chain triglyceride (MCT) ratio); aqueous phase 
composition (glycerol to water ratio); and, surfactant type (Q-Naturale® versus Tween 80 
®).  Our aim was to identify optimum conditions for fabricating all-natural 
emulsion-based delivery systems for encapsulating vitamin E.  These delivery systems 
may be suitable for application in a variety of industrial applications, including food, 
beverage, pharmaceutical, cosmetic, and healthcare products.    
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5.2 Materials and methods 
5.2.1 Materials 
The non-ionic surfactant polyoxyethylene (20) sorbitan monooleate (Tween 80) 
was purchased from Sigma-Aldrich Co. (St. Louis, MO). Quillaja saponin (Q-Naturale® 
200) was provided by National Starch LLC (Bridgewater, N.J.).  The molecular weights 
of Tween 80 (Sigma-Aldrich, St. Louis, MO) and quillaja saponin [228] have been 
reported to be 1310 and 1650 g mol-1, respectively.  Medium chain triglyceride (MCT) 
oil (Miglyol 812) was purchased from Coletica (Northport, NY).  Vitamin E acetate 
(Figure 1) was obtained from BASF (Florham Park, NJ).  
5.2.2 Emulsion preparation 
Oil-in-water emulsions were prepared by homogenizing 10 wt% lipid phase 
(MCT) with 90 wt% aqueous phase.  The aqueous phase consisted of surfactant (1 wt% 
Tween 80 or Q-Naturale®) and buffer solution (10 mM sodium phosphate buffer, pH 
7.0).  A coarse emulsion premix was prepared by blending the lipid and aqueous phases 
together using a high-speed mixer (Bamix, Biospec Products, Bartlesville, OK) for 2 min 
at room temperature. Fine emulsions were formed by passing the coarse emulsions 
through an air-driven microfluidizer (Microfluidics, Newton, MA, USA). The coarse 
emulsions were passed through the homogenization for 4 passes at 9,000 psi.  The 
commercial Q-Naturale® ingredient contained 14 % of surfactant (active ingredient) 
dispersed within an aqueous solution, and therefore we reported its concentration based 
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on the amount of active surfactant present (rather than the amount of overall ingredient). 
5.2.3 Particle characterization 
The particle size distributions of the samples were measured using a static light 
scattering instrument (Mastersizer 2000, Malvern Instruments, Malvern, UK) after 
samples had been diluted with buffer solution.   
5.2.4 Rheological properties measurements 
The rheological behavior of samples was measured using a dynamic shear 
rheometer (Kinexus Rotational Rheometer, Malvern Instruments, Malvern, U.K). A cup 
and bob geometry consisting of a rotating inner cylinder (diameter 25 mm) and a static 
outer cylinder (diameter 27.5 mm) was used in viscosity and oscillation measurements. 
The samples were loaded into the rheometer measurement cell and allowed to equilibrate 
at 25 °C for 5 min before beginning all experiments.  Shear viscosity (η) measurements 
were carried out at different shear rates (0.01 to 10 s-1). 
5.2.5 Interfacial tension measurements 
The interfacial tension was measured at oil – water interfaces using a drop shape 
analysis instrument (DSA 100, Kruss GmbH, Hamburg Germany).   
5.2.6 Turbidity measurement 
The turbidity of selected samples was measured using a UV-visible 
spectrophotometer (Agilent 7010 Particle Size Analyzer, Agilent Technologies. Inc, CA, 
USA). Samples were diluted in buffer solution to a range of different oil droplet 
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concentrations, and the turbidity was determined at 600 nm using buffer solution as a 
blank. 
5.2.7 Statistical analysis 
All measurements were performed on at least two freshly prepared samples (i.e., 
new samples were prepared for each series of experiments) and were reported as means 
and standard deviations. 
5.3 Results and discussion 
5.3.1 Impact of droplet composition: Vitamin E to MCT ratio 
Initially, we examined the influence of oil phase composition on the formation of 
oil-in-water emulsions by high-pressure homogenization.  Ideally, we aimed to produce 
emulsions containing a high percentage of vitamin E acetate within the oil phase so as to 
increase their loading capacity.  However, vitamin E acetate is an oily material that is 
difficult to homogenize alone due to its relatively high viscosity.  We therefore 
examined the effect of mixing it with medium chain triglycerides (MCT), which is edible 
oil with a relatively low viscosity.  The influence of oil phase composition on emulsion 
formation was compared for systems prepared using either Q-Naturale or Tween 80.  
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Figure 5.2 Influence of Vitamin E acetate concentration in the oil phase (Vitamin E 
acetate + MCT) on the particle size distributions of 10 wt% oil-in-water emulsions 
produced using high pressure homogenization.  Emulsions were created using either 
Tween 80 or Q-Naturale or as surfactant 
A series of 10 wt% oil-in-water emulsions with different oil phase compositions 
were produced using the microfluidizer (9,000 psi, 4 passes) and then the particle size 
distributions (Figure 5.2) and mean particle diameters (Figure 5.3) were measured.  
Monomodal particle size distributions were observed for both surfactant types when the 
oil phase contained from 0 to 80% vitamin E acetate, i.e., 100 to 20% MCT (Figure 5.2).  
On the other hand, broad bimodal distributions were observed for the two surfactants 
when the oil phase contained 100% vitamin E acetate.  For both surfactants, there was a 
slight increase in mean droplet diameter (d32) with increasing vitamin E acetate 
concentration from 0 to 80%, followed by a much steeper increase from 80 to 100% 
(Figure 5.3). Tween 80 appeared to be more effective at forming small droplets at 
relatively low vitamin E acetate concentrations (≤ 40 wt%), but Q-Naturale was more 
effective at relatively high vitamin E acetate concentrations (60 - 80 wt%).  
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Figure 5.3 Influence of Vitamin E acetate concentration in oil phase (Vitamin E acetate + 
MCT) on mean particle diameter (d32) of 10 wt% oil-in-water emulsions produced using 
high pressure homogenization.  Emulsions were created using either Q-Naturale or 
Tween 80 as surfactant 
Previous research has shown that droplet disruption becomes more difficult as the 
viscosity of the disperse phase increases for various types of mechanical homogenizers 
[201, 230, 231].  This effect can be attributed to the increase in time required for the 
droplets to become deformed within the disruption zone of a homogenizer as the disperse 
phase viscosity increases [201, 203].  Hence, more viscous oil droplets are difficult to 
breakup within a homogenizer because they may leave the disruption zone before they 
have had time to become deformed and disrupted.  
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An empirical expression has been proposed to relate measurements of mean 
droplet diameter (d) to disperse phase viscosity (ηD) for emulsions produced by high 
pressure homogenizers [232, 233]: 
B
DAd η=                (1) 
A and B are empirically determined constants, with B being reported to lie 
between 0.2 and 0.9 for high pressure homogenizers with the actual value depending on 
the major disruption mechanism involved [232]. To examine the influence of disperse 
phase viscosity on droplet size we measured the viscosities of a series of oil phases 
containing different amounts of Vitamin E acetate and MCT (Figure 5.4).  The shear 
viscosity of all the oil phases was Newtonian over the shear rates studied (data not 
shown).  The shear viscosity of pure vitamin E acetate (η ≈ 2.95 Pa.s) was over two 
orders of magnitude higher than that of pure MCT (η ≈ 0.028 Pa.s).  The viscosity 
increased with increasing vitamin E acetate concentration, particularly steeply between 
80 and 100%.  The relationship between droplet diameter and the disperse phase 
viscosity for emulsions prepared using the two different surfactants is shown in Figure 
5.5.  The empirical parameters in Equation 1 were calculated from linear regression 
analysis of the log[d] versus log[ηD] data: A = 0.681, B = 0.476 for Tween 80; A = 0.622, 
B = 0.335 for Q-Naturale.  The B values lie within the range reported previously for 
high pressure homogenizers [232]. The observation that the droplet diameter was 
somewhat less dependent on disperse phase viscosity for Q-Naturale® than for Tween 80 
  
 
 
103 
may be due to a number of physicochemical phenomena. First, since the molecule of 
Q-Naturale® is a little bigger than Tween 80, Q-Naturale® may have been adsorbed more 
slowly to the surfaces of droplets than Tween 80 and therefore more droplet 
re-coalescence may occurre within the homogenizer.  Second, Q-Naturale® may have 
formed a coating around the oil droplets that was more resistant to disruption within the 
homogenizer, therefore retarding droplet breakup within the disruption zone.  
 
Figure 5.4 Shear viscosities and interfacial tensions of oil phases containing different 
amounts of vitamin E acetate and MCT.  The interfacial tension was measured against 
buffer solution. 
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Figure 5.5 Influence of disperse phase viscosity (ηD) on the mean droplet diameter of 10 
wt% oil-in-water emulsions produced using high pressure homogenization.  Emulsions 
were created using either Q-Naturale or Tween 80 as surfactant.   
Interfacial tension also plays an important role in the formation of small droplets 
during homogenization, since it is proportional to the force required to deform and 
disrupt droplets within the homogenization zone [234, 235].  We therefore measured the 
interfacial tension at the oil-water interface of oil phases with different compositions 
(Figure 5.4). The interfacial tension increased appreciably as the Vitamin E acetate 
concentration in the oil phase increased, changing from ≈ 25.8 mN m-1 for pure MCT to ≈ 
30.3 mN m-1 for pure vitamin E acetate.  This increase suggests that vitamin E acetate is 
a more hydrophobic molecule than MCT, i.e., there is a greater free energy penalty to 
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increase the oil-water interface.  The observed increase in mean droplet diameter with 
increasing vitamin E acetate concentration in the oil phase may therefore be partly due to 
this increase in interfacial tension, since this would make it harder to disrupt the droplets 
in the homogenizer.  However, one also has to consider how quickly the surfactants 
adsorb to the oil-water interface during homogenization, since this will determine the 
actual interfacial tension at the droplet surfaces.   
5.3.2 Impact of aqueous phase properties on particle size 
The size of the droplets in an oil-in-water emulsion produced using high pressure 
homogenization also depends on aqueous phase properties, such as viscosity and 
interfacial tension.  Previous studies have found that smaller droplets can be formed 
when the disperse-to-continuous phase viscosity ratio (ηD/ηC) is close to unity and the 
disperse-to-continuous phase interfacial tension is lowered [60, 199, 236].  We therefore 
examined the possibility of producing smaller vitamin E droplets by changing the 
composition of the aqueous phase to alter the viscosity ratio and interfacial tension.  
And this aim was achieved by adding different amounts of glycerol to the aqueous phase.   
The shear viscosity of the aqueous phase increased as the glycerol concentration 
increased, with their being over a 5-fold increase when the glycerol level was raised from 
0 to 50% (Figure 5.6).  This effect can be attributed to the fact that the viscosity of pure 
glycerol is much higher than that of pure water.  On the other hand, there was a decrease 
in the interfacial tension of the aqueous phase as the glycerol concentration increased 
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(Figure 5.7), which occurs because glycerol is less polar than water.  
 
Figure 5.6 Shear viscosities and interfacial tensions of aqueous phases containing 
different glycerol concentrations. The interfacial tension was measured between an oil 
phase (60 % Vitamin E: 40% MCT) and aqueous phase 
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Figure 5.7a Influence of aqueous phase concentration (glycerol:water) on the mean 
particle diameter of 10 wt% oil-in-water emulsions (pH 7) stabilized by 1 wt% 
Q-Naturale. 
 
Figure 5.7b Influence of aqueous phase concentration (glycerol:water) on the mean 
particle diameter of 10 wt% oil-in-water emulsions (pH 7) stabilized by 1 wt% Tween 80. 
The influence of aqueous phase properties on droplet size was studied by 
preparing a series of 10 wt% oil-in-water emulsions with the same oil phase compositions 
(60 or 80% vitamin E acetate) and same concentrations of emulsifier (1 wt% Tween 80 or 
Q-Naturale), but different aqueous phase compositions (0 to 50% glycerol) using fixed 
homogenization conditions (9,000 psi, 4 passes). For all systems studied, there was a 
decrease in the mean particle diameter with increasing glycerol concentration (Figure 
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5.8).  This decrease can be attributed to two different effects of glycerol on the 
physicochemical properties of the aqueous phase: as the glycerol concentration increases, 
the viscosity ratio decreases and the interfacial tension decreases, both of which favor the 
formation of smaller droplets.  At the same glycerol concentration, smaller droplets 
were produced using Q-Naturale than using Tween 80, which supports the experiments 
described in Section 3.1 at high vitamin E acetate concentrations.  Smaller droplets were 
produced when the dispersed phase contained 60% rather than 80% vitamin E acetate, 
which can be attributed to the lower viscosity of the former system facilitating droplet 
disruption within the homogenizer (Section 5.3.1).        
An expression similar to Equation 1 can be used to model the influence of 
disperse phase viscosity on droplet size produced by high pressure homogenization [233]: 
'' BCAd η=                (2) 
Here A’ and B’ are empirical constants and ηC is the continuous phase viscosity. 
In homogenizers where droplet disruption is primarily due to turbulence, droplet size is 
not believed to be strongly dependent on continuous phase viscosity, i.e., B’ < -0.03 [237].  
On the other hand, in homogenizers where shear forces play an important role in droplet 
disruption, the droplet diameter should decrease with increasing continuous phase 
viscosity [203]. In this study, we found B’ ≈ -0.32 for Tween 80 and ≈ -0.13 for 
Q-Naturale (at 60% vitamin E acetate) and B’ ≈ -0.30 for Tween 80 and ≈ -0.18 for 
Q-Naturale (at 80% vitamin E acetate).  The fact that the B’ values are appreciably  
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smaller than -0.03 suggests that shear forces played an appreciable role in droplet 
disruption [203].   The emulsions containing Q-Naturale as a surfactant appeared to be 
less sensitive to changes in continuous phase viscosity than those containing Tween 80.  
The values measured in this study are in reasonable agreement with those reported 
previously of B’ ≈ -0.24 for an anionic surfactant (SDS) using a similar homogenizer 
[236].   
 
 
 
Figure 5.8 Foaming problem observed during emulsion preparation when Q-Naturale® 
was used solely as a surfactant. From left to right: Images of 10 wt% oil-in-water 
emulsions prepared using Q-Naturale dissolved in buffer solution, buffer + 50% glycerol, 
or buffer + 50% glycerol + 0.1% lecithin, respectively.   
Overall, the ability to produce smaller droplets at higher glycerol concentrations 
can be attributed to a number of different physicochemical mechanisms [28, 201]. First, 
ease of droplet disruption within the homogenizer decreases as the viscosity ratio tends 
  Q-Naturale      Q-Naturale    Q-Naturale 
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towards unity [238].  Second, the amount of re-coalescence occurring within the 
homogenizer decreases as the continuous phase viscosity increases since this retards 
droplet encounters [45, 231].  Third, the ease of droplet disruption decreases as the 
interfacial tension decreases since the Laplace pressure resisting droplet deformation is 
reduced [60].   
Despite the advantages of using glycerol to produce smaller droplets in the 
Q-Naturale stabilized emulsions, we should note a practical difficulty that we 
encountered that could limit its commercial application.  We found that adding glycerol 
to the continuous phase caused foaming of the emulsions containing Q-Naturale®, which 
sometimes caused the homogenizer to be become blocked.  This effect was attributed to 
the ability of the high viscosity aqueous phase to trap air bubbles formed during the 
mixing and homogenization stages.  We observed that this effect could be greatly 
reduced by adding a small amount of lysolecithin (0.1%) as an antifoaming agent to the 
aqueous phase prior to homogenization (Figure 5.8). 
5.3.3 Influence of viscosity ratio on particle size 
Our previous experiments indicated that both the dispersed phase and continuous 
phase viscosities had a major impact on the size of the droplets formed.  In this section, 
we directly examined the influence of the viscosity ratio (ηD/ηC) on the droplet size 
produced during homogenization. The mean droplet diameters were plotted against the 
viscosity ratio for the various emulsions studied (Figure 5.9). We included data for 
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emulsions that had different oil phase compositions (60 % & 80 % Vitamin E) as well as 
different aqueous phase compositions (0 to 50 wt% glycerol). All the systems studied 
were 10 wt% oil-in-water emulsions stabilized by 1 wt% emulsifier prepared using fixed 
homogenization conditions (9,000 psi, 4 passes).  
 
Figure 5.9 Influence of ratio of oil-to-aqueous phase viscosity ratio on the mean particle 
diameter for 10 wt% oil-in-water emulsions (pH 7) prepared by high pressure 
homogenization (9,000 psi, 4 passes) for systems stabilized by 1 wt% Tween 80 or 
Q-Naturale. 
Previous studies suggest that there is an optimum range of disperse-to-continuous 
phase viscosity ratios (0.1 < ηD/ηC < 5) for producing small droplets in various kinds of 
homogenizers [201, 239, 240]. In this study, we were able to cover a viscosity ratio 
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ranging from about ηD/ηC = 35 to 600 by in the vitamin E acetate emulsions.  It was not 
possible to reach lower viscosity ratios due to the very high viscosity of the disperse 
phase.  The slope of a log(d) versus log(ηD/ηC) was around 0.34 for emulsions 
containing Tween 80 and around 0.16 for emulsions containing Q-Naturale® (Figure 5.9).  
These results again highlight that emulsions containing Tween 80 are more sensitive to 
viscosity changes of the dispersed and continuous phases than those containing 
Q-Naturale®.  The smallest droplets that we could prepare were for emulsions 
containing 60 % Vitamin E in the oil phase and 50% glycerol in the aqueous phase: d = 
179 nm for Tween 80 and d = 215 nm for Q-Naturale®.  The smallest droplets that we 
could prepare for emulsions containing 80 % Vitamin E in the oil phase and 50% 
glycerol in the aqueous phase were: d = 260 nm for Tween 80 and d = 237 nm for 
Q-Naturale®.  These droplet sizes are relatively small and should lead to the formation 
of stable colloidal dispersions of vitamin E.  Indeed, storage tests showed no increase in 
the mean particle diameter of any of the emulsions after being kept at ambient 
temperature for one month (data not shown).   
5.3.4 Optical properties of emulsions 
For many practical applications, the optical properties of emulsion-based delivery 
systems are important. For example, for the application in clear beverage, it is necessary 
to use an optically transparent delivery system, whereasto opaque foods this is 
unimportant  and to impart cloudiness to some soft drinks it may even be desirable to 
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have a turbid delivery system.  The overall appearance of emulsion-based products is 
determined by the way in which they interact with light waves through absorption and 
scattering phenomenon [241, 242].  
In this section, the optical properties of the vitamin E emulsions were 
characterized in terms of their turbidity increments, i.e., the increase in turbidity per unit 
increase in droplet concentration.  Emulsions were prepared using 60 wt% Vitamin E in 
the oil phase and either 0 % or 50 % glycerol in the aqueous phase, using both Tween 80 
and Q-Naturale.  The turbidity of these emulsions was then measured at 600 nm as a 
function of droplet concentration (Figure 5.10). These emulsions were diluted with 
buffer solution (at least 1:100) so that the final glycerol concentration (< 0.5%) would not 
affect the refractive index of the aqueous phase and therefore the overall light scattering 
characteristics of the final emulsions.  For both surfactants, the turbidity increment was 
higher for emulsions containing 0% glycerol than those containing 50% glycerol during 
homogenization, which can be attributed to differences in droplet size.  The emulsions 
prepared at higher glycerol concentrations had smaller droplet sizes, which therefore 
scattered light less strongly in this particle size range [167].  The differences in the 
turbidity increments between emulsions containing 0% and 50% glycerol were greater for 
Tween 80 than for Q-Naturale, which is because the size of the droplets in Tween 80 
emulsions was more sensitive to changes in continuous phase composition (Section 3.2).  
At 0% glycerol, the turbidity increment was higher for Tween 80 (d = 0.35 µm) than for 
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Q-Naturale (d = 0.28 µm) emulsions because Tween 80 produced the largest droplets.  
On the other hand, at 50% glycerol the turbidity increment was higher for Q-Naturale (d 
= 0.22 µm) than for Tween 80 (d = 0.18 µm) emulsions because Tween 80 produced the 
smallest droplets.  Thus, there was a close correlation between the particle size data and 
the turbidity data for these systems.   
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Figure 5.10 Impact of glycerol content and surfactant type on turbidity of 10 wt% 
oil-in-water emulsions diluted to different droplet concentrations (1 wt% Tween 80 or 
Q-Naturale, 9,000 psi, 4 passes). 
To prepare beverage emulsions that appear visually transparent the turbidity 
should be < 0.05 cm-1 [243].  The turbidity increments reported in Figure 5.10 can be 
used to estimate the oil droplet concentrations required to reach this level: 0.0018 and 
0.0022 wt% for Q-Naturale and 0.0017 and 0.0026 wt% for Tween 80, for emulsions 
prepared from aqueous phases initially containing either 0 or 50% glycerol, respectively.  
These emulsions contained 60% vitamin E acetate in the oil phase, and so the maximum 
amount of the vitamin that can be incorporated into a transparent beverage is around 
0.0010 to 0.0016%.  If we assume that the serving size for a typical beverage product is 
8 ounces (240 mL), then this amount would correspond to about 2.4 to 3.8 mg of vitamin 
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E acetate per serving.  The daily recommended intake of vitamin E for adults is 15 mg 
[218], and therefore it should be possible to prepare clear beverages containing 
biologically active amounts of vitamin E using the emulsions described in this work. 
5.4 Conclusions 
The purpose of this study was to determine whether a natural surfactant 
(Q-Naturale®) based on quillaja saponin isolated from tree bark could be used to form 
and stabilize oil-in-water emulsions containing vitamin E acetate.  We compared the 
performance of Q-Naturale® with a synthetic non-ionic surfactant that is currently used in 
the food, pharmaceutical and cosmetic industries to form emulsions (Tween 80).  Tween 
80 was more effective at producing small droplets at relatively low vitamin loadings (≤ 
40%), whereas Q-Naturale® was more effective at relatively high vitamin loadings (60% 
- 80%). The size of the droplets in the emulsions could be reduced by decreasing the 
vitamin concentration in the oil phase, or increasing the amount of glycerol in the 
aqueous phase.  These effects were attributed to changes in the viscosities and 
interfacial tensions of the dispersed and continuous phases, since these parameters are 
known to influence droplet disruption and coalescence during homogenization.  This 
study has important implications for the development of “label friendly” delivery systems 
for incorporating lipophilic nutraceuticals (such as oil-soluble vitamins) into foods and 
beverages, as well as other commercial products. 
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CHAPTER 6 
VITAMIN E BIOACCESSIBILITY: INFLUENCE OF CARRIER OIL TYPE ON 
DIGESTION AND RELEASE OF EMULSIFIED ΑLPHA-TOCOPHEROL 
ACETATE 
6.1 Introduction 
Vitamin E is known to be an essential micronutrient for maintaining the health 
and wellbeing of humans and other animals due to its antioxidant and non-antioxidant 
biological activities [244-246]. Nevertheless, the precise biological mechanisms by which 
it exerts its beneficial effects are still unclear, and are currently the focus of extensive 
research efforts [246, 247].  The term “vitamin E” actually refers to a group of related 
fat-soluble molecules that are found in many natural sources and are widely used as 
functional ingredients in food, pharmaceutical, and cosmetic preparations [216, 248]. The 
most important biologically active form of Vitamin E is α-tocopherol, and therefore this 
form tends to be used in commercial products.  There has been considerable interest in 
fortifying foods, beverages, and supplements with vitamin E due to its beneficial 
nutritional qualities [215, 249].  However, there are a number of challenges associated 
with incorporating vitamin E into commercial products due to its chemical instability, 
poor water-solubility, and variable bioavailability. 
The α-tocopherol form of Vitamin E is highly unstable to oxidation and may 
therefore be lost during the processing, storage, and utilization of commercial products 
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due to its chemical degradation [223, 224].  For this reason, a more chemically stable 
esterified form (α-tocopherol acetate) is typically used in commercial products rather than 
the free form [250].  Another challenge associated with the utilization of vitamin E is 
that it is a highly lipophilic molecule with a low very water-solubility, which means that 
it cannot be directly dispersed into aqueous media [163, 251].  Instead it must either be 
dispersed into a lipid phase or incorporated into a suitable delivery system [23, 215].  A 
well-designed delivery system can encapsulate lipophilic nutraceuticals in a form that 
that does not adversely affect product quality (such as appearance, taste, texture, or 
stability), protect them from chemical degradation during storage, and increase their 
bioavailability after ingestion [215, 252].  A wide variety of delivery systems have been 
developed for encapsulating lipophilic nutraceutical ingredients, including 
microemulsions, nanoemulsions, emulsions, solid lipid nanoparticles, and polymer 
particles [128, 163, 212, 253, 254].  Each of these delivery systems has specific 
advantages and disadvantages related to the nature of the nutraceutical to be encapsulated, 
the food matrix that it is to be dispersed within, and the processing, storage, and transport 
conditions it is exposed to.   
After ingestion, it is important that a nutraceutical component has a high 
bioavailability so that it can effectively deliver its beneficial biological effects.  Previous 
studies have shown that the bioavailability of vitamin E may be highly variable (ranging 
from < 1% to 100%) depending on its chemical form and the nature of the food matrix it 
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is incorporated within [119, 255].  Typically, vitamin E must be first released from the 
food matrix, then incorporated into mixed micelles, and then transported across the 
mucous layer before it is absorbed by epithelium cells in the small intestine [248, 256]. 
The mixed micelles are comprised of bile salts and phospholipids from the bile and 
pancreatic juices, as well as lipid digestion products (free fatty acids and 
monoacylglycerols) from the action of lipases on ingested triacylglycerol oils [257].  
The bioaccessibility of lipophilic nutraceuticals and drugs has previously been shown to 
increase as the total amount of mixed micelles increases, as well as to depend on nature 
of the mixed micelles formed after lipid digestion [257-259], which may account for 
some of the observed variations in vitamin E bioavailability. It has also been reported that 
the esterified form of vitamin E (α-tocopheryl acetate) is less bioaccessible than the free 
form (α-tocopherol) [260-263], and so it has to be converted into α-tocopherol by 
digestive enzymes (e.g., pancreatic esterases) within the gastrointestinal tract prior to 
absorption [244, 264].  However, studies using an in vitro digestion model have shown 
that α-tocopheryl acetate may be absorbed by Caco-2 cells to a similar extent as 
α-tocopherol [225].  Some of the observed variations in vitamin E bioaccessibility may 
therefore also be due to differences in the chemical nature of the ingested form, e.g., free 
versus esterified.  The wide variability reported in the bioavailability of vitamin E 
makes it difficult to interpret the results of clinical trials on the efficacy of vitamin E 
supplementation, and to develop appropriate guidelines on the consumption levels of 
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vitamin E [248]. The development of suitable delivery systems for vitamin E may be able 
to overcome some of the challenges associated with its varying bioavailability.  
In this study, we utilized an emulsion-based delivery system fabricated from a 
natural surfactant (quillaja saponin) that we have recently shown to be suitable for 
encapsulating vitamin E acetate [265].  There is a major drive in the food industry 
towards developing consumer friendly labels e.g., “all natural”.  There are few natural 
surfactants currently available for utilization within the food industry.  Hence, the 
availability of a natural surfactant to form and stabilize emulsions would be an advantage 
for many functional food and beverage applications.  Our primary focus was to examine 
the influence of carrier oil composition (medium chain versus long chain fatty acids) on 
the bioaccessibility of vitamin E acetate using an in vitro gastrointestinal tract (GIT) 
model, since previous studies have shown that the nature of the ingested fatty acids 
influences the bioaccessibility of lipophilic nutraceuticals and drugs [266-269].  We 
measured the change in the microstructure and properties of vitamin E-enriched fat 
droplets throughout the simulated GIT (mouth, stomach, and small intestine)C.  We also 
monitored the bioaccessibility and conversion of α-tocopherol acetate to α-tocopherol 
after the small intestine stage.  The results of this study provide valuable information 
about the potential biological fate of ingested emulsion-based delivery systems for 
vitamin E, as well as their potential for controlling the bioavailability of this important 
nutrient in functional foods and beverages.  
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6.2 Materials and methods 
6.2.1 Materials 
Quillaja saponin (Q-Naturale® 200) was provided by National Starch LLC 
(Bridgewater, NJ). Corn oil (Mazola, ACH Food Companies, Inc., Memphis, TN) was 
used as an example of a long chain triglyceride (LCT) and was purchased from a local 
supermarket.  Corn oil we used in our experiment contains 2 g saturated fat, 8 g 
polyunsaturated fat and 4 g monounsaturated fat in every serving size (14 g).  Medium 
chain triglyceride (MCT) oil (Miglyol 812) was purchased from Coletica (Northport, NY).  
Vitamin E acetate was kindly supplied by BASF (Florham Park, NJ).  Lipase (from 
porcine pancreas pancreatin, activity>2.0 USP units/mg, Type II, L3126, Batch # 
020M1589) and bile extract (porcine) were also obtained from the Sigma Chemical 
Company (St. Louis, MO).  Type II lipase contains amylase and protease, as well as 
lipases.  Lipase activity is one unit will hydrolyze 1.0 microequivalent of fatty acid from 
triacetin in 1 hr at pH 7.4 at 37°C.  All other chemicals used were of analytical grade.  
Double distilled water was used for the preparation of all solutions and emulsions.  
Double distilled water was got by using Milli-Q®.  
6.2.2 Emulsion preparation 
Oil-in-water emulsions were prepared by homogenizing 10 wt% lipid phase and 
90 wt% aqueous phase.  The lipid phase consisted of vitamin E acetate dispersed in 
either corn oil (LCT) or medium chain triglyceride oil (MCT).  The aqueous phase 
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consisted of surfactant (1 wt% Q-Naturale®) and buffer solution (10 mM sodium 
phosphate buffer, pH 7.0).  A coarse emulsion premix was prepared by blending the 
lipid and aqueous phases together using a high-speed mixer (Bamix, Biospec Products, 
Bartlesville, OK) for 2 min at room temperature. Emulsions containing fine droplets were 
formed by passing the coarse emulsions through an air-driven microfluidizer 
(Microfluidics, Newton, MA, USA) four times at 9,000 psi.  The Q-Naturale® ingredient 
contained 14 % of surfactant (active ingredient) dispersed within an aqueous solution, 
and therefore we reported its concentration based on the amount of active surfactant 
present (rather than the amount of overall ingredient). 
6.2.4 Particle characterization  
The particle size distributions of the samples were measured using a static light 
scattering instrument (Mastersizer 2000, Malvern Instruments, Malvern, U.K.).  The 
droplet charge (ζ-potential) of emulsions was determined using a particle electrophoresis 
instrument (Zetasizer Nano ZS series, Malvern Instruments, Worcestershire, UK).  
Samples were diluted with buffer solutions of the appropriate pH prior to analysis to 
avoid multiple scattering effects.   
6.2.5 In vitro digestion 
Each emulsion sample was passed through a three-step simulated GIT model, 
which includes a mouth, gastric, and small intestine stage. 
Mouth stage:  Simulated saliva fluid (SSF) was prepared according to a 
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previous study [270].  10 mL of emulsion (1 w/w% oil) was placed in a 250 mL flask 
containing 10 mL of SSF.  This mixture was adjusted to pH 6.8 and then shaken 
continuously at the rate of 100 rpm in a temperature controlled incubator (37 ºC) for 10 
min (Innova Incubator Shaker, Model 4080, New Brunswick Scientific, New Jersey, 
USA). 
Gastric stage:  Simulated gastric fluid (SGF) was prepared by placing 2 g NaCl, 
7 mL HCl, and 3.2 g pepsin into a flask, adding water to make up to 1 L, and then 
adjusting the pH to 1.2 using 1.0 M HCl (United States Pharmacopeial Convention, 2000).  
The sample from the mouth stage was then mixed with SGF at a 1:1 mass ratio so that the 
final mixture contained 0.5 % (w/w) oil.  The mixture was then adjusted to pH 2.5 by 
using 1M NaOH and incubated with continuous shaking at 100 rpm at 37 ºC for up to 2 h 
to mimic stomach conditions.  
Small intestinal stage: Digesta samples (30 mL) from the simulated gastric stage 
were added to a clean beaker, then incubated in a water bath (37 ºC) for 10 min, and then 
adjusted to pH 7 using NaOH solution (range from 0.05 to 1 M).  The mixture was then 
incubated for 2 h at 37 ºC with simulated small intestinal fluid (SIF) containing 2.5 mL 
pancreatic lipase (4.8 mg mL-1), 4 mL bile extract solution (5 mg mL-1) and 1 mL 
calcium chloride solution (750 mM).  A pH-stat (Metrohm, USA Inc.) was used to 
monitor and control the pH (at pH 7.0) of the digestion solution after the SIF was added 
[271]. The amount of alkali solution (0.25 M NaOH) that had to be added to the reaction 
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chamber to maintain the pH at 7.0 was recorded, and used to determine the percentage of 
free fatty acids (FFA) released from the system [148].  Samples were also taken for 
physicochemical and structural characterization after 2 h in vitro digestion in the small 
intestinal stage.   
6.2.6 Bioaccessibility Determination 
The bioaccessibility of lipophilic bioactive components is normally defined as the 
fraction that is solubilized within the mixed micelle phase after lipid digestion [119, 272].  
After the full in vitro digestion was completed, 10 ml of sample was collected and 
centrifuged (4000 rpm, Thermo Scientific, CL10 centrifuge) at 25 ºC for 40 min.  The 
emulsions separated into an opaque sediment phase at the bottom, a clear micelle phase 
in the middle, and sometimes a thin oily or creamed phase at the top.  An aliquot (0.5 ml) 
of the micelle phase or the raw digesta was vortexed with an organic solvent mixture (1:3 
isopropanol and isooctane) at 1:5 to extract the vitamin E and then centrifuged at 1750 
rpm for another 10 min.  1 mL of the top layer was removed and dried using a vacuum 
centrifuge drier and stored in the -80 ºC refrigerator prior to further analysis.  Before 
detection by HPLC, samples were dissolved in 200 µL methanol.  
HPLC Detection: Vitamin E concentrations in the samples were determined 
using HPLC (Shimadzu, Kyoto, Japan).  A C18 reverse-phase column (150 - 4.6 mm, 5 
µm, Beckman Coulter) was used for the chromatographic separation of α-tocopherol 
acetate and α-tocopherol.  The flow rate of the mobile phase was 1.0 mL/min and the 
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sample injection volume was 20 µL.  An isocratic elution was carried out using 
HPLC-grade solvent (95 % methanol and 5 % double distilled water containing 0.5 % 
phosphoric acid).  The α-tocopherol acetate and α-tocopherol contents were determined 
using a PDA detector at 295 nm.  Tocopherol quantification was determined using 
external standards.  The overall bioaccessibility of vitamin E was estimated using the 
following expression: 
%100×=
Total
micelle
C
CbilityBioaccessi            (1) 
Here Cmicelle and CTotal represent the total concentration of vitamin E (α-tocopherol 
acetate + α-tocopherol) in the micelle phase and in the overall system after digestion, 
respectively.  The percentage of specific forms of vitamin E solubilized within the 
micelle phase was also calculated using the same expression, but for α-tocopherol acetate 
and for α-tocopherol separately.  The conversion of α-tocopherol acetate to α-tocopherol 
in the overall system after digestion was calculated from the following expression: 
%100×=
Total
VE
C
CConversion              (2) 
Here CVE and CTotal represent the concentration of α-tocopherol and the total 
concentration of vitamin E (α-tocopherol acetate + α-tocopherol) in the overall system 
after digestion, respectively.   
6.2.7 Statistical analysis 
All measurements were performed on at least two freshly prepared samples (i.e., 
  
 
 
126 
new samples were prepared for each series of experiments) and are reported as means and 
standard deviations. 
6.3 Results and discussion 
6.3.1 Impact of carrier oil type on biological fate of emulsions 
6.3.1.1 Influence on particle size 
Initially, we studied the impact of vitamin E encapsulation and carrier oil type on 
the potential biological fate of emulsion-based delivery systems using a simulated 
gastrointestinal tract (GIT) model.  A series of emulsions containing 2.5 wt% lipid 
phase were produced using either long chain triglycerides (LCT) or medium chain 
triglycerides (MCT). Emulsions containing lipid phases with four different compositions 
were prepared: LCT (100% LCT); vitamin E in LCT (25% α-tocopherol acetate + 75% 
LCT); MCT (100% MCT); and, vitamin E in MCT (25% α-tocopherol acetate + 75% 
MCT).   
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Figure 6.1a Influence of vitamin E encapsulation and carrier oil type on the mean 
particle diameter (d32) of oil-in-water emulsions passing through different stages of a 
simulated gastrointestinal tract.  Key: LCT = 100% LCT; LCT-VE = 25% α-tocopherol 
acetate + 75% LCT; MCT = 100% MCT; MCT-VE = 25% α-tocopherol acetate + 75% 
MCT. 
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Figure 6.1b Influence of vitamin E encapsulation and carrier oil type on the particle size 
distributions of emulsions after passage through the small intestinal stage of a simulated 
gastrointestinal model.  See caption to Figure 6.1a for Key. 
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Figure 6.1c Particle size distributions of emulsions containing LCT at different stages of 
a simulated gastrointestinal tract. 
The influence of vitamin E encapsulation and carrier oil type on the mean particle 
diameter after each stage of the simulated GIT model was measured (Figure 6.1a).  The 
full particle size distributions of selected samples were also compared: (i) emulsions 
containing different carrier oil types after the small intestine stage (Figure 6.1b); 
emulsions containing LCT at different stages of the GIT model (Figure 6.1c).  All the 
initial emulsions had monomodal particle size distributions and relatively small mean 
particle diameters (d32 = 228 to 270 nm).  The droplets in the LCT emulsions were 
slightly larger than those in the MCT emulsions, and the droplets in the emulsions 
containing vitamin E were slightly larger than those containing no vitamin E, which may 
have been due to differences in oil phase viscosities.  The size of the droplets produced 
by high pressure homogenization is known to increase as the viscosity of the oil phase 
increases [60, 273].  After passage through the simulated mouth and gastric stages, the 
mean particle diameter remained relatively small (d32 < 400 nm), suggesting that the oil 
droplets were fairly stable to aggregation under these conditions (Figures 6.1a and 6.1c).  
Recent studies have shown that oil droplets coated by the same quillaja saponin extract 
used in this work (Q-Naturale®) were relatively stable to changes in pH and salt 
concentration [274].  Any saponin molecules adsorbed to fat droplet surfaces would not 
be expected to be hydrolyzed by proteases (pepsin) in the gastric juices, which can cause 
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instability of protein-coated fat droplets.  In addition, we would not have expected any 
saponin molecules adsorbed to the fat droplets surfaces to be displaced due to 
competitive adsorption processes since the oral and gastric fluids used in this study did 
not contain any highly surface-active substances. 
After passage through the simulated small intestinal stage there was a large 
increase in mean particle diameter (Figure 6.1a) and evidence of large particles in the 
particle size distributions (Figure 6.1b) for all emulsions studied.  These results indicate 
that there was a marked reduction in the physical stability of the emulsions after exposure 
to small intestinal conditions.  Several physicochemical phenomena may explain the 
observed reduction in emulsion stability in the small intestinal stage.  First, the intestinal 
juices contained bile salts and phospholipids that are highly surface active molecules that 
may have displaced some or all of the quillaja saponins from the oil droplet surfaces.  
Second, the intestinal juices contained pancreatic lipase that is capable of adsorbing to oil 
droplet surfaces and converting triacylglycerols (such as those in LCT or MCT oils) into 
free fatty acids (FFAs) and monoacylglycerols (MAGs).  The digestion products of 
lipolysis may accumulate at the oil-water interface or move into the surrounding aqueous 
phase depending on their molecular weight and the presence of bile salts, phospholipids, 
and calcium [257, 259].  The oil droplet size may therefore change appreciably as a 
result of alterations in their internal and interfacial compositions.  One would expect that 
the removal of FFA and MAG digestion products from the fat droplet surfaces would 
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lead to a reduction in particle size [275, 276].  On the other hand, one would expect that 
droplet coalescence promoted by lipid digestion would lead to an increase in droplet size 
[275, 276].  Consequently, the overall influence of lipid digestion on fat droplet size 
may be complicated.  It should also be noted that particle size measurements made on 
complex colloidal systems containing mixtures of different particles (such as those 
produced by lipid digestion) should be treated with some caution.  The software used by 
commercial particle sizing instruments to analyze light scattering measurements usually 
assumes that the particles are spherical, dilute, and have well-defined refractive indices.  
In practice, the colloidal suspension resulting from lipid digestion may contain 
undigested fat droplets, partially digested fat droplets, mixed micelles and various other 
colloidal structures.  
6.3.1.2 Influence on particle charge characteristics 
Changes in the electrical characteristics of the particles in the emulsions were also 
measured after each stage in the simulated gastrointestinal tract to provide some 
information about changes in interfacial properties (Figure 6.2).  Initially, all of the oil 
droplets coated by quillaja saponin were highly negatively charged (-40 to -46 mV), 
which has previously been attributed to the ionization of carboxyl groups (-COO-) on the 
saponins at neutral pH [274].  All of the droplets remained highly negative after passage 
through the simulated oral stage, although there was some reduction in the magnitude of 
their negative charge (Figure 6.2).  The fact that the charge remained highly negative 
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can be attributed to the neutral conditions within the mouth, whereas the slight changes in 
charge may be due to adsorption of some ionized components from the simulated saliva 
to the droplet surfaces, e.g., minerals or mucin [270]. 
 
Figure 6.2 Influence of vitamin E encapsulation and carrier oil type on the electrical 
characteristics ζ-potential of the particles in oil-in-water emulsions passed through 
different stages of a simulated gastrointestinal tract.  See caption to Figure 6.1a for Key. 
The magnitude of the electrical charge on the droplets decreased appreciably after 
they were incubated in simulated gastric fluid, and the charge depended somewhat on 
carrier oil type (Figure 6.2).  The emulsions containing MCT had a slightly negative 
charge (≈ -6 mV), whereas those containing LCT had a slightly positive charge (≈ +0.5 
mV).  The origin of this difference in the charge on droplets containing different types 
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of oils is currently unknown.  One possible explanation is that the different oils phases 
contained different types and concentrations of ionic impurities (such as free fatty acids 
or phospholipids).  Previous studies have shown that the electrical charge on oil droplets 
coated by quillaja saponin goes from highly negative at pH 7 to close to zero at pH 2, 
which was attributed to protonation of the carboxyl groups (-COOH) at pH values below 
their pKa values [274]. The low net charge on the oil droplets under gastric conditions 
can therefore be largely attributed to this effect.  The fact that there was little change in 
the mean particle diameter of the droplets under simulated gastric conditions (Figure 
6.1a), suggests that the droplets were still coated by a layer of surface active material that 
prevented aggregation.   
  The electrical charge on the particles in all of the emulsions became strongly 
negative after they were incubated within simulated small intestinal fluid, and the charge 
depended somewhat on encapsulation of vitamin E and carrier oil type (Figure 6.2).  
The negative charge on the droplets in the small intestine can be attributed to a number of 
different factors.  First, the quillaja saponin has a relatively high negative charge at 
neutral pH [274], so if any of these molecules remained at the particle surfaces they 
would impart a negative charge.  Second, the small intestinal fluids contained 
phospholipids and bile salts which are anionic surface active substances that may adsorb 
to particle surfaces and generate a negative charge.  Third, lipase converts neutral 
triacylglycerol molecules into anionic free fatty acids, so if any of these molecules remain 
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at the droplet surfaces they will also produce a negative charge.  As mentioned earlier, it 
is not clear exactly what types of particles are detected by an electrophoresis instrument 
in a complex medium that contains many different types of charged particles that can 
scatter light.  
6.3.2 Impact of encapsulation and carrier oil type on lipid digestion 
The influence of vitamin E encapsulation and carrier oil type on the rate and 
extent of lipid digestion was measured using a pH-stat method. This approach is widely 
used by pharmaceutical and food researchers for the in vitro characterization of lipid 
digestion under simulated small intestinal conditions [148, 277, 278].  The pH-stat 
method measures the amount of alkali (0.25 M NaOH) that had to be titrated into the 
digestion mixture to maintain neutral pH after addition of simulated small intestinal fluids 
containing lipase, bile salts, and CaCl2.  
In general, there was a rapid initial production of free fatty acids during the first 
few minutes of the digestion reaction, followed by a more gradual increase at longer 
times (Figure 6.3), indicating that lipase was able to rapidly interact with the emulsified 
TAGs and convert them into FFAs and MAGs.  Nevertheless, there were some distinct 
differences between emulsions prepared using different oil phases: (i). The extent of lipid 
digestion was higher for MCT- than LCT-emulsions; (ii) the extent of lipid digestion was 
higher for emulsions containing vitamin E than those containing no vitamin E.  A 
number of earlier studies have reported that lipids containing medium-chain fatty acids 
  
 
 
135 
are digested more rapidly and extensively than those containing long-chain fatty acids 
[257, 259, 279].  A number of physiochemical explanations have been proposed to 
account for this phenomenon.  First, medium-chain FFAs have a higher water 
dispersibility than long-chain FFAs [257, 259].  Consequently, the medium-chain FFAs 
produced during MCT digestion rapidly migrate into the aqueous phase surrounding the 
droplets, thereby allowing lipase to continue reacting with undigested MCT molecules 
within the oil droplet core. Conversely, the long-chain FFAs produced during LCT 
digestion tend to accumulate at the droplet surfaces, thereby inhibiting the ability of 
lipase to interact with the undigested LCT molecules within the droplet core [266].  
Efficient digestion of LCT requires that there are enough bile salts and free calcium ions 
present within the aqueous phase to ensure that the long-chain fatty acids are effectively 
removed from the droplet surfaces through solubilization or precipitation [279].  The 
fact that the measured FFAs released was higher for the emulsions containing vitamin E 
than the equivalent emulsions containing no vitamin E may be attributed to the ability of 
lipase to cleave the ester bond of the α-tocopherol acetate molecule, thereby releasing 
α-tocopherol (Figure 6.4).   
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Figure 6.3 Effect of vitamin E encapsulation and carrier lipid type on rate and extent of 
lipid digestion measured using an in vitro digestion model. 
Figure 6.4 Conversion of α-tocopherol-acetate to α-tocopherol during in vitro digestion. 
Our results suggest that >100% of FFAs were released from the MCT samples at 
longer digestion times (Figure 6.3).  This apparent discrepancy can be attributed to the 
way that the percentage of FFAs released from the lipid droplets during in vitro digestion 
was calculated.  There are two main assumptions underlying this calculation: (i) only 
two FFA molecules are released per TAG molecule; (ii) there are no other components 
within the system that release protons during the in vitro digestion process.  In practice, 
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these assumptions may not be completely valid [269].  Some of the MAGs produced 
during digestion may have been further hydrolyzed to FFAs and glycerol, so that more 
than two FFA molecules were formed from each initial TAG.  There may have been 
other components within the system that produced protons during the digestion reaction 
(e.g., proteins, phospholipids, or vitamin E), which would require the addition of extra 
alkali to neutralize them.    
6.3.3 Impact of carrier oil type on vitamin E bioaccessibility 
In this section, we examined the impact of carrier oil type on the bioaccessibility 
of vitamin E after passage through the simulated GIT.  After the small intestine stage, 
digesta were collected and centrifuged, which led to the formation of two distinct layers: 
a white “sediment” phase at the bottom and a watery “micelle” phase above it. Visually, 
the micelle phases were either optically transparent (MCT & MCT-VE) or slightly turbid 
(LCT & LCT-VE).  The micelle phase was collected and its particle size distribution 
was measured before and after filtration.  The bioaccessibility of the vitamin E was 
determined by measuring the concentrations of α-tocopherol and α-tocopherol acetate in 
the micelle phase and the total digesta using solvent extraction and HPLC.  
The particle size distribution of the micelle phase isolated from the digesta of the 
LCT-emulsion before and after filtration using a 0.45 µm pore size filter is shown in 
Figure 6.5.  In the unfiltered samples, a broad range of differently sized particles was 
observed with diameters ranging from around 140 to 5,500 nm, which could have been 
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due to the presence of mixed micelles, vesicles, and non-digested oil droplets.  As 
expected, there was an appreciable decrease in the number of large particles present in 
the micelle phase after filtration.  In practice, the mixed micelles and vesicles containing 
lipid digestion products must pass through the mucous layer that coats the epithelium 
cells prior to absorption.  The mucous layer can be considered to act like a biological 
filter, with a critical cut-off point for particle penetration being reported to be around 400 
nm [280].  Filtering the micelle layer prior to analysis may therefore provide a more 
accurate representation of the potential bioavailability of a lipophilic compound that must 
be carried by colloidal structures through the mucous layer to the epithelium cells.  For 
this reason, we filtered the micelle phases collected from the digesta prior to further 
analysis.  
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Figure 6.5 Particle size distribution of the “micelle” phase collected after digestion and 
centrifugation of LCT-emulsions. Measurements were made before and after filtration 
(0.45 µm pore size) of the micelle phase. 
The mean particle diameters and turbidities of the micelle phases collected from 
the LCT-emulsions were larger than those collected from the MCT-emulsions (Figure 
6.6), which indicates that they contained larger particles.  These larger particles may 
have been comprised of non-digested triacylglycerol oil, since the pH-stat measurements 
indicated that not all of the LCT was digested after the small intestine stage (Figure 6.3).  
Alternatively, they may have been due to the formation of larger colloidal structures by 
the LCT digestion products.  The mean droplet diameters were slightly smaller for 
emulsions containing vitamin E than for emulsions containing no vitamin E, which 
suggested that the presence of this lipophilic molecule altered the structure of the 
non-digested oil droplets or the colloidal particles formed from digestion products 
(Figure 6.6). 
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Figure 6.6 Influence of carrier oil type on the mean particle diameter (measured after 
filtration) and appearance of the micelle phase after in vitro digestion. 
The concentrations of α-tocopherol acetate and α-tocopherol in the micelle phase 
and within the total digesta were measured after in vitro digestion (Figure 6.7).  These 
measurements indicated that some of the α-tocopherol acetate was converted to 
α-tocopherol during the in vitro digestion process, and that the amount of vitamin E 
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solubilized within the micelle phase depended on carrier oil type and the molecular form 
of the vitamin E.  The influence of carrier oil type on the overall bioaccessibility of 
vitamin E and the total amount of α-tocopherol acetate converted to α-tocopherol is 
shown in Figure 6.8.  The overall bioaccessibility of vitamin E was around 17 % when 
MCT was used as the carrier oil but around 39 % when LCT was used.  The 
solubilization of lipophilic components in the micelle phase usually increases as the total 
amount of mixed micelles available increases.  Our lipid digestion experiments 
indicated that MCT was actually digested to a greater extent than LCT (Figure 6.3) and 
therefore the total concentration of FFAs and MAGs that could form mixed micelles 
should have been larger for MCT.  On the other hand, the solubilization capacity of 
mixed micelles also depends on the nature of the FFAs and MAGs present.  Long chain 
fatty acids can form mixed micelles that have a larger solubilization capacity for some 
lipophilic substances than medium chain fatty acids, presumably because they can 
accommodate larger non-polar molecules.  Corn oil contains relatively long chain fatty 
acids (e.g., C16 and C18) while MCT contains medium chain ones (e.g., C8 and C10), 
which would therefore account for the observed difference in solubilization capacity for 
vitamin E.  The α-tocopherol molecule has a non-polar chain that is 14 carbon atoms in 
length (Figure 6.4).  This non-polar chain may be too long to easily be accommodated 
within the monolayers formed by the medium chain fatty acids resulting from MCT 
digestion, but it may be able to fit within the monolayers formed by the long chain fatty 
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acids resulting from LCT digestion.  The fact that the colloidal structures were larger in 
the LCT-emulsions than in the MCT-emulsions after lipid digestion (Figure 6.6) 
provides some support for the differences in the structure of the mixed micelles formed. 
Our results are in agreement with research in the pharmaceutical industry that has shown 
that many highly lipophilic drugs have a higher bioaccessibility when administered with 
LCT than with MCT [281, 282]. 
 
Figure 6.7 Influence of carrier oil type on the concentrations of α-tocopherol and 
α-tocopherol acetate within the micelle phase and the total digesta after in vitro digestion 
of emulsions. 
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Figure 6.8 Influence of carrier oil type on the total bioavailability of Vitamin E 
(α-tocopherol + α-tocopherol acetate) and the conversion of α-tocopherol acetate to 
α-tocopherol after in vitro digestion of emulsions.  
There were appreciable amounts of sediment formed in many of the samples after 
centrifugation (Figure 6.6).  This sediment contains dense insoluble matter formed 
during the passage of the samples through the simulated gastrointestinal tract, such as 
aggregated digestive enzymes, bile salts, minerals, and calcium salts of free fatty acids.  
It is possible that some of the vitamin E acetate or vitamin E was trapped within the 
sediment phase.  
6.3.4 Impact of carrier oil type on α-tocopheryl acetate to α-tocopherol conversion 
As mentioned earlier, vitamin E is often used in an esterified form within foods 
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and other commercial products because the free form is highly unstable to oxidation [223, 
224].  Previous studies suggest that the bioaccessibility of vitamin E may depend on its 
molecular form, i.e., α-tocopherol versus α-tocopherol acetate [260-263]. We therefore 
calculated the amount of α-tocopherol acetate that had been converted to α-tocopherol 
after in vitro digestion (Figure 6.8). Carrier oil type had an appreciable influence on this 
process, with the extent of conversion being about 29% for the LCT-emulsion and 17% 
for the MCT-emulsion.  This result suggests that the conversion of α-tocopherol acetate 
to α-tocopherol occurred more readily when LCT was used as the carrier oil than when 
MCT was used.  Interestingly, there was a close correlation between the extent of 
conversion and overall vitamin E bioaccessibility (Figure 6.8).  A possible explanation 
for this phenomenon is that vitamin E acetate incorporated into mixed micelles is more 
susceptible to de-esterification by lipase than vitamin E acetate encapsulated within oil 
droplets. The fact that a greater fraction of vitamin E was present within the micelle 
phase for the LCT-emulsion would then account for the observed increase in the 
hydrolysis of the acetate form.  Alternatively, there may have been a competition 
between the triacylglycerol and the vitamin molecules for hydrolysis by lipase.  The 
MCT molecules were digested more readily than the LCT molecules (Figure 6.3), and 
therefore the rate of vitamin E acetate hydrolysis may have been less when MCT 
molecules were present in the oil phase due to this competitive effect. 
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Table 6.1. Percentage of vitamin E present in the micelle phase after lipid digestion and 
centrifugation of the emulsions. 
 
MCT LCT 
Vitamin E 8.6 ± 0.1 60.3 ± 3.4 
Vitamin E Acetate 18.9 ± 0.9 29.9  ± 4.3 
 
The data presented in Figure 6.7 was used to calculate the fraction of vitamin E 
present in the micelle phase for α-tocopherol and α-tocopherol acetate for both the LCT- 
and MCT-emulsions (Table 6.1).  This data showed that a higher fraction of the free 
form (α-tocopherol) was present in the micelle phase than the esterified form 
(α-tocopherol acetate) for LCT, but the opposite was true for MCT.  At present the 
molecular or physicochemical basis of this phenomenon is unknown, but it may be 
related to the compatibility of vitamin E molecules for mixed micelles and other different 
kinds of colloidal structures.  For example, the removal of the acetate group may change 
the interaction of the vitamin E molecule with the polar head groups of the surface-active 
molecules that form the palisade layer of the mixed micelles.      
6.4 Conclusions 
The purpose of this study was to determine the influence of carrier lipid type on 
the bioaccessibility and hydrolysis of emulsified α-tocopherol acetate using a simulated 
gastrointestinal tract.  We have shown that α-tocopherol acetate can be effectively 
encapsulated within oil-in-water emulsions using either medium chain triacylglycerols 
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(MCT) or long chain triacylglycerols (LCT) as a carrier oil.  The rate and extent of lipid 
digestion was higher for MCT-emulsions than for LCT-emulsions, which was attributed 
to differences in the water dispersibility of the medium and long chain fatty acids formed 
during lipolysis.  On the other hand, the total bioaccessibility of vitamin E after 
digestion was higher for LCT-emulsions than for MCT-emulsions, which was attributed 
to the greater solubilization capacity of mixed micelles formed from long chain fatty 
acids due to their ability to better accommodate lipophilic vitamin E molecules.  
Moreover, the conversion of α-tocopherol acetate to α-tocopherol after in vitro digestion 
was also considerably higher for LCT-emulsions than for MCT-emulsions.   
In summary, our results suggest that LCT was a more effective carrier lipid than 
MCT for increasing the overall bioaccessibility of emulsified vitamin E.  These results 
have important implications for designing effective emulsion-based delivery systems for 
oil-soluble vitamins. 
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CHAPTER 7 
VITAMIN E AND VITAMIN E ACETATE SOLUBILIZATION IN MIXED 
MICELLES: PHYSICOCHEMICAL BASIS OF BIOACCESSIBILITY 
7.1 Introduction 
Vitamin E has various antioxidant and non-antioxidant biological activities that 
have been reported to provide health benefits to humans, such as reducing cardiovascular 
disease, diabetes, and cancer [244-246]. However, the physiological basis of many of 
these claimed health effects have still not been clearly elucidated [246, 247].  Vitamin E 
is widely used as an ingredient by the pharmaceutical, food, and supplement industries 
due to its perceived health benefits [216, 248].   
The expression “vitamin E” actually refers to a class of molecules that have 
related chemical structures and biological activities, with the most widely used being 
α-tocopherol (Figure 7.1). The incorporation of α-tocopherol into commercial products is 
often challenging due to its chemical instability, poor water-solubility, and highly 
variable bioavailability [215, 249]. α-Tocopherol is a polyunsaturated lipid that is highly 
susceptible to oxidation and it may therefore be lost during the processing, transport, 
storage, or utilization of commercial products [223, 224].  Consequently, the esterified 
form of α-tocopherol (α-tocopherol acetate) is often used as a source of vitamin E in 
pharmaceutical, food, and supplement products because it has better chemical stability 
than the free form [250].  Both the free and esterified forms of α-tocopherol are highly 
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non-polar molecules that have low water-solubilities, which means they cannot simply be 
dispersed within aqueous-based products [163, 251].  Instead, they must be encapsulated 
within a suitable delivery system, such as a microemulsion, nanoemulsion, or emulsion 
[23, 212, 215].  After a product has been ingested, it is important that the vitamin E has 
a high oral bioavailability so that it can deliver its potentially beneficial health effects.  
However, the oral bioavailability of vitamin E may vary widely (< 1% to 100%) 
depending on the chemical form ingested and the nature of the delivery system used [119, 
255].  This wide variability causes problems in determining an appropriate level of 
vitamin E to incorporate into a commercial product, and so it is critical to understand the 
major factors influencing bioavailability.   
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Figure 7.1 Structures of the various molecules used to form mixed micelles in this study. 
The oral bioavailability of vitamin E depends on a number of physicochemical 
and physiological processes that occur within the human gastrointestinal tract.  Initially, 
the vitamin E should be released from the delivery system, then incorporated into “mixed 
micelles” in the small intestine, and then transported across the mucus layer where it is 
absorbed by epithelium cells [248, 256]. The solubilization of vitamin E into mixed 
micelles plays a critical role in determining its overall oral bioavailability.  The term 
“mixed micelles” actually refers to a group of different colloidal species that are capable 
of solubilizing lipophilic components, such as micelles, vesicles, bilayers, and liquid 
crystals [283-285].  Mixed micelles are formed from bile salts and phospholipids 
present in the bile and pancreatic juices secreted by the small intestine, as well as from 
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any free fatty acids (FFA) and monoacylglycerols (MAG) produced due to hydrolysis of 
ingested triacylglycerol molecules by lipase [257].  Studies have shown that the 
bioaccessibility of highly lipophilic components tends to increase as the total amount of 
mixed micelles available in the small intestine increases, but also depends on the 
structural organization of the mixed micelles formed after lipid digestion [257-259].  
The chemical form of the vitamin E has also been shown to play an important role in its 
bioaccessibility.  Some studies have reported that α-tocopheryl acetate is less 
bioaccessible than α-tocopherol [260-263], whereas others have reported little difference 
[225].   
In a recent study using a simulated gastrointestinal tract model, we found that the 
bioaccessibility of vitamin E was higher in emulsions prepared using a long chain 
triglyceride (LCT) than those prepared using a medium chain triglyceride (MCT) (Yang 
and McClements, 2013).  We also found that the bioaccessibility of α-tocopheryl acetate 
was lower than that of α-tocopherol.  These differences were attributed to differences in 
the ability of the mixed micelles formed by lipid digestion to solubilize the vitamin E 
molecules: long chain fatty acids form larger mixed micelles than medium chain fatty 
acids, and can therefore solubilize larger lipophilic molecules; α-tocopheryl acetate is 
longer than α-tocopherol and is therefore more difficult to be incorporated into smaller 
mixed micelles.  The purpose of the current study was to better understand the role of 
the chemical state of vitamin E (α-tocopherol versus α-tocopheryl acetate) and the 
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composition of the mixed micelles (bile salts, phospholipids, and fatty acids) on vitamin 
bioaccessibility.  A well-defined in vitro model (emulsion titration assay) was used to 
quantify the kinetics and extent of vitamin solubilization in mixed micelles so as to 
provide a more detailed mechanistic understanding of the physicochemical processes 
involved [286, 287].  A number of previous researchers have also used mixed micelle 
solutions as model systems for solubilization of lipophilic components, such as free fatty 
acids [288], carotenoids [289-291] and vitamin E [154].  The current study should 
provide information about the major factors influencing the bioaccessibility of vitamin E 
that will facilitate the rational design of more effective delivery systems. 
7.2 Materials and methods 
7.2.1 Materials 
Sodium cholate (NaC), sodium deoxycholate (NaDC), vitamin E, oleic acid, and 
linoleic acid (Figure 7.1) were purchased from the Sigma Chemical Company (St. Louis, 
MO).  1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) was purchased from Avanti 
Polar Lipids, Inc. (Alabaster, AL).  All other chemicals used were of analytical grade.  
Double distilled water was used for the preparation of all solutions and emulsions.  
7.2.2 Mixed micelle solution preparation 
7.2.2.1. Optimization of Preparation Method 
Initially, a series of experiments was carried out to determine the optimum 
method for preparing mixed micelle solutions to use in the emulsion titration assay.  All 
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the final mixed micelle solutions contained a bile salt concentration of 20 mM (40% 
NaDC and 60% NaC), but they varied in the preparation method used and in the presence 
of other constituents: bile salts (BS); phospholipids (PL); long chain fatty acids (LCFA); 
medium chain fatty acids (MCFA).  
BS: Bile salts (20 mM) were dispersed within an aqueous buffer solution (PBS 
buffer, pH 7.0).   
BS+PL (After): Phospholipid (1.6 g/L lecithin, lysolecithin, or DOPC) was 
dissolved in an organic solvent (methanol ∶	  chloroform, 1∶1,	  v/v), placed in a glass flask, 
and then the organic solvent was removed by nitrogen evaporation.  An aqueous bile 
salt solution (20 mM, pH 7.0) was then added to the flask and the system was sonicated 
for 30 min. 
BS+PL (Before): Phospholipid (1.6 g/L lecithin, lysolecithin, or DOPC) and bile 
salt (10 mM) were dissolved in an organic solvent (methanol ∶	   chloroform, 1∶1,	   v/v), 
placed in a glass flask, and then the organic solvent was removed by evaporation.  An 
aqueous bile salt solution (10 mM, pH 7.0) was then added to the flask and the system 
was sonicated for 30 min.   
BS+PL + LCFA or MCFA (Before). In this case, phospholipid (2 mM, 1.6 g/L 
DOPC), bile salt (10 mM) and fatty acid (2 mM, 1.6 g/L linoleic acid or octanoic acid) 
were dissolved in an organic solvent (methanol ∶	  chloroform, 1∶1,	  v/v), placed in a glass 
flask, and then the organic solvent was removed by evaporation.  An aqueous bile salt 
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solution (10 mM, pH 7.0) was then added to the flask and the system was sonicated for 
30 min. 
7.2.2.2. Optimized System 
Once an optimum system had been identified, this was used in the remainder of 
the studies.  The type and levels of constituents used to prepare the mixed micelle 
solutions were based on those previously reported in the literature [292-294], with some 
slight modifications as reported below.  First, a solution of 10 mM bile salt (NaC, 
NaDC), 2 mM DOPC and 4 mM FAs in chloroform:methanol (1:1, v/v) solvent was 
prepared.  The organic solvent was then removed by blowing nitrogen on the sample at 
ambient temperature so as to form a thin lipid film on the glass vessel. Phosphate buffer 
(10 mM, pH 7.4) was then added to the glass vessel containing the lipid film, and the 
resulting mixture was sonicated for 30 min at room temperature, which resulted in the 
formation of a transparent aqueous solution containing the mixed micelles. 
7.2.3 Vitamin emulsion preparation 
Vitamin emulsions were prepared by homogenizing 10 wt% lipid phase (Vitamin 
E or Vitamin E acetate) with 90 wt% aqueous phase.  The aqueous phase consisted of 
surfactant (2 wt% bile salt) and buffer solution (10 mM sodium phosphate buffer, pH 7.0).  
A coarse emulsion premix was prepared by blending the lipid and aqueous phases 
together using a high-speed mixer (Bamix, Biospec Products, Bartlesville, OK) for 2 min 
at room temperature. Fine vitamin emulsions were formed by passing the coarse 
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emulsions through an air-driven microfluidizer (Microfluidics, Newton, MA, USA).  
The coarse emulsions were passed through the homogenization for 4 passes at 9,000 psi. 
7.2.4 Particle characterization 
The mean particle diameter, particle size distribution, and electrical charge of 
mixed micelles were determined.  The mean particle diameter and particle size 
distribution were measured using dynamic light scattering (Nano-ZS, Malvern 
Instruments, Malvern, UK).  The electrical charge (ζ-potential) was determined using 
electrophoretic mobility measurements (Nano-ZS, Malvern Instruments, Worcestershire, 
UK).  Samples were placed in a capillary test tube that was loaded into the instrument.  
Samples were equilibrated for 1 min inside the instrument before data were collected 
over at least 10 sequential readings and analyzed using the Smoluchowski model. 
7.2.5 Emulsion titration assay 
An emulsion titration assay [286] was used to quantify the rate and extent of 
vitamin solubilization in mixed micelle solutions (Figure 7.2).  Aliquots of vitamin 
emulsion were injected into mixed micelle solutions and then the turbidity was measured 
over time, or after 3 h storage (mixed micelles containing fatty acids) or overnight 
storage (mixed micelles without fatty acids) at room temperature. 
7.2.6 Turbidity measurements 
Turbidity measurements were used to monitor the solubilization of the injected 
vitamin emulsions after they were added to the mixed micelle solutions. The turbidity 
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was determined using an UV-visible spectrophotometer at 600 nm (Ultra-spec 3000 pro, 
Biochrom Ltd, Cambridge, UK). The turbidity was measured over time after an aliquot of 
vitamin E emulsion was added to the micelle solution (solubilization kinetics) or after a 
specified storage period. 
7.2.7 Optical microscopy measurements 
A Nikon optical microscope (Nikon Eclipse 80i, Nikon Instrument Inc., Melville, 
NY) with a 40× objective lens was used to capture images of selected emulsion samples.  
An aliquot of sample was placed on a glass microscope slide and then a digital image was 
captured and stored.  
7.2.8 Statistical analysis 
All measurements were performed on at least two freshly prepared samples (i.e., 
new samples were prepared for each series of experiments) and were reported as means 
and standard deviations. 
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Figure 7.2 Schematic representation of emulsion titration assay used to monitor the 
solubilization of vitamin droplets in mixed micelle solutions. A: Stock vitamin emulsion 
(1 wt% bile salt, 10 wt% vitamin, 89 wt% aqueous phase). B: mixed micelle solution. 
Regime I: vitamin concentration < CSat - all vitamin solubilized in swollen micelles; 
Regime II: vitamin concentration ≈ CSat - mixture of swollen micelles and 
non-dissolved vitamin droplets; Regime III: vitamin concentration > CSat – predominance 
of non-dissolved vitamin droplets [295] 
7.3 Results and discussion 
7.3.1 Influence of preparation method on mixed micelle properties 
The purpose of this series of experiments was to determine the most appropriate 
method of preparing mixed micelle solutions for studying vitamin solubilization using the 
emulsion titration assay.  For this method it is important that the initial mixed micelle 
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solution is optically transparent, and so we examined the influence of composition and 
preparation method on the formation of clear mixed micelle solutions.   
The mixed micelles formed in the human body are compositionally and 
structurally complex, and their properties depend strongly on the nature of an ingested 
food, particularly the type and amount of lipids present [257, 296].  Mixed micelles 
contain bile salts, phospholipids, and cholesterol from the small intestinal fluids, as well 
as monoacylglycerols (MAG) and free fatty acids (FFA) from any lipid digestion 
products.  These surface-active lipids self-assemble into a “mixed micelle” colloidal 
dispersion, which may contain micelles, vesicles, and liquid crystalline phases that vary 
in composition, dimensions, and structure [297, 298].   
For fundamental studies of the physicochemical phenomenon associated with the 
solubilization process it is advantageous to use simulated mixed micelle solutions with 
well-defined properties.  A number of different methods of preparing simulated mixed 
micelle solutions have been reported in the literature [292-294, 299, 300].  These 
methods differ in the types and amounts of constituents used, as well as in the methods 
used to prepare the mixed micelles.  The composition of model mixed micelle systems 
is usually chosen to be much simpler than that of real mixed micelles for a number of 
reasons: (i) to improve the ease and reproducibility of sample preparation; (ii) to facilitate 
data interpretation; (iii) to enable comparison of data between different research groups.  
Hence, they typically contain one or two bile salt components, a single phospholipid 
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component, and a limited number of lipid digestion products (such as FFA and MAG), 
rather than a highly complex mixture of many different components.  Previous studies 
indicate that the properties of the mixed micelle phase formed also depend on the 
preparation method.  In this study, we therefore examined the influence of composition 
and preparation method on the formation of mixed micelle solutions.  In particular, we 
investigated the influence of order of bile salt addition (before or after solvent 
evaporation) and phospholipid type (lecithin, lysolecithin, or DOPC) on the appearance, 
particle size, and electrical charge of mixed micelles.   
7.3.1.1 Influence of order of addition 
Initially, we examined the influence of adding the bile salts to the phospholipids 
(lecithin) before or after evaporation of the organic solvent.  In the absence of 
phospholipids, the bile salt solution was optically transparent (Figure 7.3a).  When the 
bile salt solution was added to a vessel containing dried phospholipids (i.e., after solvent 
evaporation), the resulting solution was highly turbid (Figure 7.3a) and contained a 
population of relatively large particles, i.e., d > 100 nm (Figure 7.3b). On the other hand, 
when the bile salts were mixed with the phospholipids first and then the mixture was 
dried (i.e., before evaporation), the resulting solution was fairly clear (Figure 7.3a) and 
the majority of particles were relatively small, i.e., d < 10 nm (Figure 7.3b).  These 
results indicate that mixing a portion of the bile salts with the phospholipids prior to 
solvent evaporation leads to the formation of smaller colloidal particles in the system.  
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Presumably, the bile salts and phospholipids intermingled more easily when they were 
dispersed in organic solvent and then dried together, thus enabling them to form mixed 
micelles upon reconstitution with an aqueous solution.  When the bile salts were added 
after the phospholipids had been dried, it may have been difficult for them to be 
incorporated into the colloidal structures formed when the phospholipids were rehydrated 
(e.g., vesicles). 
 
Figure 7.3a Electrical characteristics and appearance of mixed micelle solutions formed 
by mixing bile salts with phospholipids (lecithin) either after or before evaporation of the 
organic solvent.   
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Figure 7.3b Particle size distributions (measured by dynamic light scattering) of mixed 
micelle solutions formed by mixing bile salts with phospholipids (lecithin) either after or 
before evaporation of the organic solvent. 
The electrical characteristics of the colloidal structures formed also depended on 
the preparation method (Figure 7.3a).  In the absence of phospholipids, the bile salts 
had an appreciable negative charge, which can be attributed to the presence of anionic 
carboxyl groups (-COO-) [301].  The negative charge on the mixed micelles containing 
bile salts and phospholipids (≈ -30 to -40 mV) was appreciably higher than that on the 
bile salts alone (≈ -14 mV), which is due to the fact that lecithin contains anionic 
components such as phosphatidic acid.  The mixed micelles formed by adding the bile 
salts before solvent evaporation were considerably more negatively charged than those 
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formed by adding bile salts after solvent evaporation, suggesting that there were some 
changes in the structural organization of the ionized groups in the different types of 
colloidal particles formed. 
Similar results were found when lysolecithin or DOPC were used as the 
phospholipid rather than lecithin, i.e., the mixed micelle solutions were turbid and 
contained large particles when the bile salts were added before solvent evaporation, but 
were clear and contained small particles when the bile salts were added after solvent 
evaporation (data not shown).  For this reason, we determined that adding the bile salts 
to the phospholipids prior to solvent evaporation was the most suitable approach for 
preparing clear mixed micelle solutions.                       
7.3.1.2 Influence of phospholipid type 
We then compared the influence of phospholipid type on the properties of mixed 
micelle solutions.  In this case, a fraction of the bile salts were mixed with the 
phospholipids before solvent evaporation to facilitate the formation of clear mixed 
micelle solutions containing small particles.  Mixed micelle solutions prepared using a 
pure phospholipid (DOPC) were less turbid (Figure 7.4a) and contained smaller particles 
(Figure 7.4b) than those prepared using either lecithin or lysolecithin.  This 
phenomenon may have been due to some water-insoluble impurities in the lecithin and 
lysolecithin samples (e.g., triacylglycerols and sterols) that could not easily be 
incorporated into the mixed micelle structures [302].  In addition, lecithin and 
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lysolecithin contain a number of different types of phospholipids and some of these may 
promote the formation of colloidal structures other than simple micelles, e.g., 
phosphatidylethanolamine, phosphatidylinositol, and phosphatidic acid [303].  For this 
reason, we concluded that DOPC was the most suitable phospholipid for preparing 
transparent mixed micelle solutions. 
 
Figure 7.4a Influence of phospholipid type on electrical characteristics and appearance 
of mixed micelle solutions formed by mixing bile salts and phospholipids (lecithin, 
lysolecithin, or DOPC) before solvent evaporation. 
-60 
-50 
-40 
-30 
-20 
-10 
0 
BS BS-Lecithin BS-Lysolecithin BS-DOPC 
ζ-
po
te
nt
ia
l (
m
V
)  
  
 
 
163 
 
Figure 7.4b Influence of phospholipid type on particle size distributions of mixed 
micelle solutions formed by mixing bile salts and phospholipids (lecithin, lysolecithin, or 
DOPC) before solvent evaporation.   
The electrical characteristics of the colloidal structures formed when bile salts 
were added before solvent evaporation also depended on phospholipid type (Figure 7.4a).  
Mixed micelles containing lecithin or lysolecithin had relatively high negative charges (≈ 
-40 to -50 mV), whereas those containing DOPC had much smaller negative charges (≈ 
-14 mV).  As mentioned earlier, DOPC has a net neutral charge whereas lecithin and 
lysolecithin contain anionic phospholipids (such as phosphatidic acid).   
7.3.2 Influence of fatty acid type on mixed micelle properties 
In a previous study using a simulated gastrointestinal tract (GIT) model, we found 
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that the bioaccessibility of vitamin E was considerably higher when it was encapsulated 
in emulsions prepared using corn oil (LCT) than in medium chain triglyceride (MCT) oil 
(Ying and McClements, 2013).  This difference was attributed to the fact that the mixed 
micelles containing long chain fatty acids (LCFA) generated by digestion of corn oil had 
a higher solubilization capacity than those formed from the medium chain fatty acids 
(MCFA) resulting from digestion of MCT.  One of the main purposes of the present 
study was therefore to examine the influence of fatty acid type on the solubilization 
properties of mixed micelles.  The dominant fatty acids in corn oil are 18-carbon 
unsaturated fatty acids and therefore we used linoleic acid (C18:1) to represent them [304, 
305], whereas the dominant fatty acids in MCT are 8- and 10-carbon saturated fatty acids 
and therefore we used octanoic acid (C8:0) to represent them [306].  Mixed micelles 
were prepared by mixing bile salts, DOPC, and fatty acids in organic solvent, evaporating 
the solvent, and then rehydrating them using an aqueous bile salt solution.  All mixed 
micelle solutions were passed through a 440 nm filter prior to analysis to mimic passage 
through the mucus layer that coats the epithelium cells, since the pore size of the mucus 
layer has been determined to be around this dimension [280].      
The mean particle diameter and full particle size distribution of mixed micelle 
solutions with different compositions were measured (Figures 7.5a and 7.5b).  All the 
mixed micelle solutions had a monomodal particle size distribution and contained 
relatively small particles (d ≈ 5 nm) suggesting that simple micelles were present (rather 
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than vesicles or other colloidal structures).  There was an appreciable increase in the 
mean particle diameter of the mixed micelles when both types of free fatty acids were 
added to the bile-phospholipid system, with the increase being larger for the long chain 
fatty acids (C18:1) than for the medium chain fatty acids (C8:0).  This increase in the 
diameter of the micelles may account for the increase in solubilization capacity of mixed 
micelles in the presence of free fatty acid digestion products observed using simulated 
gastrointestinal models (Yang and McClements, 2013).  Nevertheless, the overall 
increase in the mixed micelle size due to the presence of the free fatty acids was 
relatively small.  The influence of fatty acid type on the electrical characteristics of the 
particles in the mixed micelle solutions were also measured (Figure 7.5c).  The negative 
charge on the mixed micelles was appreciably higher in the systems containing fatty 
acids (-36 to -40 mV) than in their absence (-15 mV), which can be attributed to the 
anionic nature of the free fatty acid head groups (-COO-). 
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Figure 7.5a  Influence of mixed micelle composition on volume-weighted particle size 
distribution measured by dynamic light scattering.  Key: BS = bile salts (NaC and 
NaDC); PL = phospholipid (DOPC); MCFA = medium chain fatty acid (C8:0); LCFA = 
large chain fatty acid (C18:1). 
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Figure 7.5b Influence of mixed micelle composition on the mean particle diameter 
measured using dynamic light scattering.  Key: BS = bile salts (NaC and NaDC); PL = 
phospholipid (DOPC); MCFA = medium chain fatty acid (C8:0); LCFA = large chain 
fatty acid (C18:1). 
 
Figure 7.5c Influence of composition on the electrical characteristics of mixed micelles.  
Key: BS = bile salts (NaC and NaDC); PL = phospholipid (DOPC); MCFA = medium 
chain fatty acid (C8:0); LCFA = large chain fatty acid (C18:1). 
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Figure 7.5d Appearances of mixed micelle solutions with different compositions before 
and after one day storage 
The mixed micelle solutions containing free fatty acids remained transparent for a 
few hours after preparation, but they did become turbid after they were stored overnight 
at refrigerated or ambient conditions (Figure 7.5d).  Examination of these samples 
using an optical microscope showed that they contained some large liquid crystalline 
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structures, suggesting that some self-association of the lipid molecules had occurred 
during storage.  Thus, the emulsion titration assay should be carried out within a few 
hours of preparing the mixed micelle solutions containing fatty acids to ensure they 
remain transparent. 
7.3.3 Influence of structure and composition on solubilization capacity of mixed 
micelles  
Previous research has reported that the presence of mixed micelles in the 
intestinal lumen improves the solubility and adsorption of lipophilic bioactive 
components [307, 308].  As mentioned earlier, we previously found that vitamin E 
(α-tocopherol) and vitamin E acetate (α-tocopheryl acetate) had a higher solubility in 
mixed micelles formed from long chain fatty acids than medium chain fatty acids (Yang 
and McClements, 2013). In this section, we examined the influence of mixed micelle 
structure and compositions on the solubilization of vitamin E and vitamin E acetate in 
mixed micelles using the emulsion titration assay.  This method involves titrating 
aliquots of vitamin emulsions into an aqueous mixed micelle solution (Figure 7.2), and 
then measuring the change in turbidity.   
Immediately, after an aliquot of vitamin emulsion was added to the mixed micelle 
solution the turbidity was relatively high due to light scattering from the vitamin droplets 
(Figure 7.6a).  When the vitamin emulsion was added to a buffer solution (containing 
no mixed micelles) the turbidity remained high over time, indicating that no 
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solubilization occurred.  However, when the vitamin emulsion was added to a mixed 
micelle solution the turbidity decreased over time (Figure 7.6a), indicating that 
solubilization occurred, i.e., vitamin molecules moved from the droplets into the mixed 
micelles causing a reduction in the number and/or size of the droplets thereby reducing 
the degree of light scattering.  The solubilization process was relatively slow, taking 
over an hour for the turbidity to reach a final constant level for the vitamin E systems.  
The rate and extent of solubilization was slower for the vitamin E acetate systems (data 
not shown).  The solubilization process was also confirmed using optical microscopy 
measurements.  Immediately after a vitamin emulsion was added to a mixed micelle 
solution large fat droplets could be observed, but after 3 hours of solubilization they had 
disappeared (Figure 7.6b).  
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Figure 7.6a. Change in turbidity over time after 25 µl of vitamin E emulsion was injected 
into 3 mL of mixed micelle solutions with different compositions (pH 7.4). 
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Figure 7.6b Optical microscopy images of vitamin droplets immediately after injection 
into mixed micelle solutions (BS+PL) and after 3 hours. 
 
Figure 7.6c Change in turbidity with increasing vitamin E acetate concentration in mixed 
micelle solutions with different compositions. 
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Figure 7.6d Change in turbidity with increasing vitamin E acetate concentration in mixed 
micelle solutions with different compositions. 
The solubilization capacity of the mixed micelle solutions was determined by 
measuring the turbidity of solutions containing different types and amounts of vitamin 
after overnight storage to ensure that full solubilization had occurred (Figure 7.6c,d).  
The solubilization capacity depended on the composition of the mixed micelles as well as 
on the molecular form of the vitamin.  For both vitamin E and vitamin E acetate, the 
turbidity increased linearly when the fat droplets were added to pure buffer solution (no 
mixed micelles), which can be attributed to the fact that no solubilization occurred.  
Hence, the amount of light scattering by the mixed systems increased as the fat droplet 
concentration increased.  When vitamin E acetate was titrated into any of the mixed 
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micelle solutions the increase in turbidity with vitamin concentration was somewhat less 
than for titration into pure buffer solution, which suggested that a small amount of the 
vitamin was solubilized within the micelles (Figure 7.6c).  On the other hand, when 
vitamin E was titrated into the mixed micelle solutions they initially remained transparent 
over a range of vitamin concentrations suggesting that all of the vitamin droplets had 
dissolved.  Once a certain vitamin concentration was exceeded the turbidity of the 
mixed micelle solutions increased, which suggested that the micelles had become 
saturated with vitamin and the vitamin droplets no longer dissolved. The vitamin E 
concentration where this increase in turbidity was first observed depended on mixed 
micelle composition: BS + PL > BS + PL + MCFA ≈ bile + BS + PL + LCFA > BS 
(Figure 7.6d).   
The maximum solubilization capacity (Csat) of the mixed micelles was estimated 
by finding the intersection point of two straight lines drawn through the data at relatively 
low and at high vitamin concentrations [295].  The low concentration range included 
those solutions where there was little change in turbidity with increasing vitamin, 
whereas the high concentration range included those solutions where there was an 
approximately linear increase in turbidity with increasing vitamin.  In general, we found 
that the solubilization capacity of the mixed micelles was higher for vitamin E than that 
for vitamin E acetate (Figure 7.7), which is consistent with our previous experiments 
using a simulated GIT model (Yang and McClements, 2013).  The origin of this effect 
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can be attributed to the smaller molecular dimensions of the non-esterified form of 
α-tocopherol making it easier to be accommodated within the hydrophobic core of the 
mixed micelles.  The solubilization of vitamin E acetate in mixed micelles containing 
fatty acids was slightly higher than in those containing no fatty acids, which is again in 
agreement with our previous studies.  On the other hand, the influence of mixed micelle 
composition on the solubilization capacity of vitamin E did not follow the expected trend.  
The solubilization capacity was actually higher in the mixed micelles containing bile and 
phospholipids than in those containing bile, phospholipids, and fatty acids.  In addition, 
the solubilization capacity of the mixed micelles containing LCFAs was fairly similar to 
those containing MCFAs, whereas in the simulated GIT experiments we found a 
considerably higher bioaccessibility of vitamin E in emulsions prepared using LCFAs 
rather than MCFAs (Yang and McClements, 2013).  One reason for this effect may have 
been because the mixed micelles containing MCFAs or LCFAS prepared in this study 
had fairly similar dimensions (Figure 7.5), and might therefore be expected to 
accommodate fairly similar sized lipophilic molecules.  Previous studies have also 
reported that the solubilization of α-tocopherol was fairly similar in mixed micelles in the 
absence and presence of free fatty acids (MCFAs or LCFAS) [300].   
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Figure 7.7 Solubilization capacity of mixed micelle solutions with different compositions 
for vitamin E and vitamin E acetate. 
There are a number of possible physicochemical mechanisms that might account 
for the difference between the results of the emulsion titration assay and experiments 
carried out using GIT models.  First, the mixed micelles used in this study contained 
free fatty acids (FFA), but they did not contain monoacylglycerols (MAG), which are 
also digestion products of triacylglycerols.  Studies in the pharmaceutical industry have 
shown that the solubilization of α-tocopherol in mixed micelles containing MAGs was 
appreciably higher than mixed micelles containing FFAs [300].  Second, when a GIT 
model is used to study the bioaccessibility of lipophilic bioactive components there will 
be various other types of colloidal structures formed during lipid digestion, such as 
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vesicles and liquid crystals that may play an important role in the solubilization of 
oil-soluble vitamins.  Third, in the emulsion titration assay the oil-soluble vitamins must 
move from vitamin droplets into micelles, but in the simulated gastrointestinal model the 
vitamins are trapped within fat droplets that also contain triacylglycerols that are 
hydrolyzed by lipase during the lipid digestion process.  The continuous formation of 
FFAs and MAGs at the fat droplets during digestion, and their subsequent movement into 
the surrounding aqueous phase, may also play an important role in the solubilization of 
oil-soluble vitamins.  Finally, the simulated intestinal fluids used within GIT models 
contain various other components that may impact the solubilization process, such as 
calcium ions that form insoluble calcium soaps with long chain FFAs [309].  Clearly, 
further research is needed to establish the molecular basis for differences in the 
solubilization capacities of mixed micelle phases with different compositions and 
structures.            
7.4 Conclusions 
The purpose of this study was to utilize a well-defined model system to determine 
the influence of mixed micelle composition and structure on the solubilization of 
oil-soluble vitamins.  Initially, we establish an appropriate procedure for preparing 
transparent mixed micelle solutions containing bile salts, phospholipids, and free fatty 
acids.  Mixed micelle solutions were formed that contained relatively small particles (d 
≈ 5 nm) whose precise size depended on system composition.  An emulsion titration 
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assay was then used to study the solubilization of vitamin E and vitamin E acetate 
emulsions in the mixed micelle solutions.  The solubilization capacity of the mixed 
micelle solutions was higher for vitamin E than for vitamin E acetate, which was 
attributed to differences in the ability of the vitamin molecules to be incorporated into the 
micelle structures.  We did not find a strong influence of free fatty acid type (C8:0 versus 
C18:1) on the solubilization capacity of the mixed micelles, which was different from 
results obtained using a simulated gastrointestinal model.  This study provides an 
improved understanding of the influence of mixed micelle composition and structure on 
the solubilization of α-tocopherol and α-tocopheryl acetate, which may be useful for the 
design of emulsion-based delivery systems for oil-soluble vitamins.  
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CHAPTER 8 
ENHANCING VITAMIN E BIOACCESSIBILITY: FACTORS IMPACTING 
SOLUBILIZATION AND HYDROLYSIS OF Α-TOCOPHEROL ACETATE 
ENCAPSULATED IN EMULSION-BASED DELIVERY SYSTEMS 
8.1. Introduction 
 The term “vitamin E” refers to a group of naturally occurring compounds that 
have common molecular, physicochemical, and biological features, with α-tocopherol 
being the most biological active form [310].  As well as its important role as an essential 
nutrient, vitamin E may also provide additional health benefits, such as reducing 
cardiovascular disease, diabetes, and cancer due to its antioxidant and non-antioxidant 
biological activities [244, 311, 312].  Vitamin E can also protect lipids in foods against 
oxidation due to the ability of α-tocopherol to trap peroxyl radicals, which are responsible 
for the initiation of lipid oxidation [87, 88].  The food industry is therefore interested in 
fortifying functional foods and beverages with vitamin E due to its antioxidant activity 
and potential health benefits [22].  However, the incorporation of α-tocopherol into 
many commercial products is a challenge because of its relatively low chemical stability, 
water-solubility, and bioavailability [244, 311, 312].   
 Emulsion-based delivery systems are especially suitable for encapsulating, 
protecting and delivering lipophilic bioactive components, such as ω-3 fatty acids, 
carotenoids, curcuminoids phytosterols, and oil-soluble vitamins [3, 22, 163].  A 
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considerable amount of research has already been carried out to identify the major factors 
affecting the bioavailability of lipophilic bioactive molecules encapsulated within 
emulsion-based delivery systems, such as particle size, physical state, and interfacial 
properties [313-316].  It is important that any encapsulated bioactive component has a 
high oral bioavailability so that it can effectively deliver its health benefits after ingestion.  
However, a number of physicochemical and physiological processes occur within the 
human gastrointestinal tract that impact the oral bioavailability of lipophilic vitamins 
[275, 276].  After ingestion, vitamin E is usually released from the food matrix, 
solubilized within mixed micelles in the small intestine, and then transported to the 
epithelium cells where it is absorbed [256, 317].  Mixed micelles are complex colloidal 
structures formed from bile salts and phospholipids present in the intestinal fluids, as well 
as free fatty acids and monoacylglycerols generated by lipid hydrolysis.  The 
bioaccessibility of oil-soluble nutraceuticals, vitamins and drugs has previously been 
shown to increase when the amount of mixed micelles present within the intestinal fluids 
increases, which typically occurs as the amount of co-ingested digestible lipids 
(triacylglycerols) increases [257, 296]. The bioaccessibility also depends on the nature of 
the mixed micelles formed after lipid digestion, i.e., the composition and nature of the 
colloidal structures formed [257-259].  Indeed, highly lipophilic components 
encapsulated using delivery systems containing long chain triglycerides (LCT) have been 
reported to have a higher bioaccessibility than those containing medium chain 
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triglycerides (MCT) (Figure 8.1), which can be attributed to the ability of the mixed 
micelles formed by LCT to incorporate larger lipophilic molecules [318, 319].   
 
Glyceryl trioleate (C18:1) 
 
Glyceryl trioctanoate (C8:0) 
Figure 8.1 Structures of long chain triglyceride (glyceryl trioleate, C18:1) and medium 
chain triglyceride (glyceryl trioctanoate, C8:0) used in this study 
 The chemical form of the vitamin E present within a food or beverage product 
also influences its bioavailability.  Vitamin E is often incorporated into foods in an 
esterified form (α-tocopherol acetate) because it has a higher chemical stability than the 
non-esterified form (α-tocopherol) [250].  However, the esterified form of vitamin E has 
a lower bioaccessibility than the free form, presumably because it is more difficult to 
incorporate into mixed micelles [260-263].  Consequently, the bioavailability of vitamin 
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E would be increased if there were greater conversion of α-tocopherol acetate to 
α-tocopherol in the gastrointestinal tract due to the presence of digestive enzymes. 
 Numerous factors influence the digestion of emulsified triglycerides by 
pancreatic lipase and the subsequent formation of mixed micelles, including droplet 
surface area, interfacial composition, carrier oil type, calcium ions, bile salts, and 
phospholipids [271, 279, 320].  Calcium ions have been identified as playing a 
particularly important role in the digestion of emulsified LCTs.  In the absence of 
calcium, long-chain free fatty acids (FFAs) accumulate at the oil-water interface and 
inhibit further lipid digestion, presumably by preventing lipase from reaching 
non-digested lipids at the core of the emulsion droplets [321].  The presence of calcium 
ions facilitates lipid digestion due to the formation of insoluble calcium soaps that 
remove long-chain FFAs from the emulsion droplet surfaces, thereby allowing the lipase 
to remain in close contact with the non-digested lipids [322-327].  One might expect the 
bioaccessibility of oil-soluble vitamins to increase in the presence of calcium ions since 
then more LCTs would be digested, leading to the release of more vitamin molecules 
from the lipid droplets and to the formation of more mixed micelles capable of 
solubilizing them.  On the other hand, calcium ions may interact with mixed micelles 
and form insoluble complexes that actually reduce the bioaccessibility of oil-soluble 
vitamins by preventing them from being absorbed [328].  The rate and extent of lipid 
digestion in emulsion-based delivery systems comprised of MCT (rather than LCT) have 
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been shown to be much less sensitive to calcium ions [271].  Research is therefore 
needed to determine the potential effect of carrier oil type and calcium ions on the 
bioaccessibility of emulsified oil-soluble vitamins.   
 In a recent study using a simulated gastrointestinal tract (GIT) model, we found 
that the bioaccessibility of vitamin E was higher in emulsions prepared using LCTs than 
in those prepared using MCTs [318].  The LCT (corn oil) and MCT used in that study 
were food-grade oils containing a mixture of different triacylglycerols.  In a follow up 
study, we used model mixed micelles assembled from well-defined fatty acids (C8:0 or 
C18:1) to provide further insights into the impact of MCT and LCT digestion products on 
vitamin E solubilization [329]. However, we did not find an appreciable difference 
between the vitamin E solubilization capacity of mixed micelles prepared from C8:0 or 
C18:1.  The apparent discrepancy between these two studies may have been due to 
differences in the nature of the lipids used or due to differences in the simulated 
gastrointestinal conditions used.   
 The purpose of the current study was therefore to use a simulated GIT model to 
establish the influence of carrier oil type (C8:0 versus C18:1) and small intestinal 
composition (bile, calcium, and phospholipids) on the bioaccessibility of emulsified 
vitamin E. The information gained from this study will be useful for designing more 
effective emulsion-based delivery systems for these important lipophilic bioactive 
components.  
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8.2 Materials and methods 
8.2.1 Materials 
 Sodium cholate (NaC), sodium deoxycholate (NaDC), glyceryl trioleate, and 
glyceryl trioctanoate were purchased from the Sigma Chemical Company (St. Louis, 
MO).  1, 2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) was purchased from Avanti 
Polar Lipids, Inc. (Alabaster, AL).  Vitamin E acetate was kindly supplied by BASF 
(Florham Park, NJ).  Lipases from porcine pancreas pancreatin and bile extract (porcine) 
were also obtained from the Sigma Chemical Company (St. Louis, MO).  All other 
chemicals used were of analytical grade.  Double distilled water was used for the 
preparation of all solutions and emulsions.  
8.2.2 Vitamin E emulsion preparation 
 Vitamin E emulsions were prepared by homogenizing 2.5 wt% lipid phase 
(Vitamin E acetate : triacylglycerol = 1:1) with 97.5 wt% aqueous phase.  The aqueous 
phase was comprised of surfactant (0.5 wt% bile salt) and buffer solution (10 mM sodium 
phosphate buffer, pH 7.0).  A coarse emulsion premix was prepared by blending the 
lipid and aqueous phases together using a high-speed mixer (Bamix, Biospec Products, 
Bartlesville, OK) for 2 min at room temperature.  Fine vitamin E emulsions were 
formed by passing the coarse emulsions through an air-driven microfluidizer 
(Microfluidics, Newton, MA, USA).  The coarse emulsions were passed through the 
homogenizer for 4 passes at 9,000 psi. 
  
 
 
185 
8.2.3 Particle characterization 
 Mean particle sizes and particle size distributions of initial emulsions and 
samples exposed to GIT conditions were measured using static light scattering 
(Mastersizer 2000, Malvern Instruments, Malvern, UK), while their electrical charge 
(ζ-potential) was measuring by electrophoretic mobility (Nano-ZS, Malvern Instruments, 
Worcestershire, UK).  The mean particle diameter, particle size distribution, and 
electrical charge of mixed micelles were determined by dynamic light scattering and 
electrophoretic mobility (Nano-ZS, Malvern Instruments, Malvern, UK).  Samples were 
equilibrated for 1 min inside the instrument before data were collected over at least 10 
sequential readings and analyzed using the Smoluchowski model. 
8.2.4 In vitro small intestine digestion 
 Each emulsion sample was passed through a simulated small intestine model.  
Samples (10 ml) were added to a clean beaker, mixed with 20 mL pH 7.0 PBS buffer and 
then incubated in a water bath (37 ºC) for 10 min, and then adjusted to pH 7 using NaOH 
solution (range from 0.05 to 1 M).  The mixture was then incubated for 2 h at 37 ºC with 
simulated small intestinal fluids (SSIF) of different compositions (Table 8.1). SSIFs with 
five different compositions were prepared: bile extract without CaCl2; bile extract with 
CaCl2; bile salts (NaC and NaDC) without CaCl2; bile salts (NaC and NaDC) with CaCl2; 
bile salts (NaC and NaDC) with CaCl2 and DOPC. A pH-stat (Metrohm, USA Inc.) was 
used to monitor and control the pH (at pH 7.0) of the digestion solution after the sample 
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and SSIF were mixed [271].  The amount of alkali solution (0.25 M NaOH) that had to 
be added to the reaction chamber to maintain the pH at 7.0 was recorded, and used to 
determine the percentage of free fatty acids (FFA) released from the system (McClements 
& Li, 2010a).  A control (containing bile salts but no oil) was run under the same 
conditions as the samples, and the amount of alkali titrated into the reaction chamber for 
the control was subtracted from that for the samples before calculating the FFA released. 
Samples were also taken for physicochemical and structural characterization after 2 h 
incubation in the small intestinal stage. 
Table 8.1 Compositions of the simulated small intestinal fluids (SSIFs) used in the study: 
NaC = sodium cholate; NaDC = sodium deoxycholate; DOPC = 1, 
2-dioleoyl-sn-glycero-3-phosphocholine (phospholipid). 
SSIF Bile Extract NaC NaDC DOPC CaCl2 Lipase 
Bile Extract 
4 mL (187.5 
mg) 
0 0 0 0 
2.5 mL (60 
mg) 
Bile Extract 
& Ca2+ 
4 mL (187.5 
mg) 
0 0 0 
1m L (110 
mg) 
2.5 mL (60 
mg) 
Bile Salts 0 
4 mL (73.22 mg NaC and 
114.06 mg NaDC) 
0 0 
2.5 mL (60 
mg) 
Bile Salts & 
Ca2+ 
0 
4 mL (73.22 mg NaC and 
114.06 mg NaDC) 
0 
1m L (110 
mg) 
2.5 mL (60 
mg) 
Bile Salts & 
Ca2+ & 
DOPC 
0 
4 mL (73.22 mg NaC, 114.06 mg NaDC and 
36 mg DOPC) 
1m L (110 
mg) 
2.5 mL (60 
mg) 
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8.2.5. Bioaccessibility determination 
 Vitamin E is solubilized within mixed micelles consisting present in the 
intestinal lumen before uptake into intestinal epithelial cells [330].  The fraction of 
lipophilic bioactive compounds solubilized within the mixed micelle phase is usually 
regarded as the bioaccessibility [119, 331].  The bioaccessibility of vitamin E was 
determined using a method described previously [318].  Briefly, the digesta resulting 
from small intestine digestion of the samples was collected and then centrifuged (4000 
rpm; CL10 centrifuge, Thermo Scientific, Waltham, MA, USA) at 25 ºC for 40 min.  
Samples after centrifugation separated into an optically opaque sediment phase at the 
bottom, a relatively clear aqueous phase in the middle, and sometimes a thin oily or 
creamed phase at the top.  The middle phase was assumed to be the “micelle” phase that 
solubilized the vitamin E.  Vitamin E was extracted from the middle phase using an 
organic solvent mixture (1:3 isopropanol and isooctane) at 1:5 and then centrifuged at 
1750 rpm for another 10 min.  1 mL of the top layer was removed and dried using 
nitrogen evaporation and stored in the -80 ºC refrigerator prior to further analysis.  
Before detection by HPLC, samples were dissolved in 200 µL methanol.  The vitamin E 
concentrations in the samples were determined using HPLC (Shimadzu, Kyoto, Japan). A 
C18 reverse phase column (150 - 4.6 mm, 5 µm, Beckman Coulter) was used for the 
chromatographic separation of α-tocopherol acetate and α-tocopherol.  The flow rate of 
the mobile phase was 1.0 ml/min.  An isocratic elution was carried out using 
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HPLC-grade solvent (95% methanol and 5% double distilled water containing 0.5 % 
phosphoric acid).  The α-tocopherol acetate and α-tocopherol contents were determined 
using a PDA detector at 295 nm. Tocopherol quantification was determined using 
external standards.  The overall bioaccessibility of vitamin E was estimated using the 
following expression:  
   
Here Cmicelle and CTotal represent the total concentration of vitamin E (α-tocopherol 
acetate + α-tocopherol) in the micelle phase and in the overall system after digestion, 
respectively.  The percentage of specific forms of vitamin E solubilized within the 
micelle phase was also calculated using the same expression, but for α-tocopherol acetate 
and for a-tocopherol separately.  The conversion of α-tocopherol acetate to α-tocopherol 
in the overall system after digestion was calculated from the following expression: 
 
Here CVE and CTotal represent the concentration of α-tocopherol and the total 
concentration of vitamin E (α-tocopherol acetate + α-tocopherol) in the overall system 
after digestion, respectively. A preliminary experiment was carried out to estimate the 
recovery of the total tocopherols using the solvent extraction and HPLC analysis method 
described above. The recovery of the total tocopherols (VE + VE acetate) was always > 
90%, which indicates that the methods used were appropriate. 
%100×=
Total
micelle
C
CbilityBioaccessi
%100×=
Total
VE
C
CConversion
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8.2.8 Statistical analysis 
 All measurements were performed on at least two freshly prepared samples (i.e., 
new samples were prepared for each series of experiments) and were reported as means 
and standard deviations. 
8.3 Results and discussion 
8.3.1 Impact of SSIF composition and carrier oil on gastrointestinal fate of 
emulsions 
 Initially, we studied the influence of SSIF composition and carrier oil type on the 
potential gastrointestinal fate of emulsion-based delivery systems using a simulated small 
intestine model (pH-stat).  Vitamin-fortified emulsions containing 2.5 wt% lipid phase 
were produced using either long chain triglycerides (C18:1) or medium chain 
triglycerides (C8:0) as carrier oil.  The emulsions were then mixed with SSIFs with 
different compositions: bile extract (with and without CaCl2); pure bile salts (with and 
without CaCl2); and, pure bile salts with CaCl2 and phospholipids (DOPC).  The 
influence of SSIF composition and carrier oil type on particle characteristics after 
digestion were then measured.  
8.3.1.1 Influence on particle size 
 For both MCT-VE and LCT-emulsions, the initial systems (before digestion) 
had monomodal particle size distributions (PSDs) and relatively small mean particle 
diameters (d = 140-150 nm) (Figures 8.3a-c).  The properties of the vitamin-fortified 
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emulsions were also measured after they were exposed to the simulated small intestinal 
model: mean particle diameters (Figure 8.3a) and PSDs (Figures 8.3b and 8.3c).   
 
DOPC 
 
NaC 
 
NaDC 
Figure 8.2 Structures of the various molecules used for the simulated small intestine fluid 
(SIF) in this study: Sodium cholate (NaC); Sodium deoxycholate (NaDC) and 
phospholipid (DOPC). 
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Figure 8.3a Influence of carrier oil type and simulated small intestine fluid composition 
on the mean particle diameter (d32) of oil-in-water emulsions after passing through a 
simulated small intestine tract.  
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Figure 8.3b Influence of carrier oil type and simulated small intestine fluid composition 
on the particle size distribution of MCT-VE emulsions passing through the simulated 
small intestine tract.  
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Figure 8.3c Influence of carrier oil type and simulated small intestine fluid composition 
on the particle size distribution of LCT-VE emulsions passing through the simulated 
small intestine tract. 
 After passage through the simulated small intestinal stages, the mean particle 
diameters of all samples increased and there was evidence of large particles in the PSDs 
(Figures 8.3a-c).  The composition of the simulated small intestinal fluids (SSIFs) had a 
pronounced influence on the particle size of the emulsions after digestion.  The presence 
of bile extract in the SSIF caused little change in particle size, but the presence of pure 
bile salts (NaC and NaDC) caused an appreciable increase in particle size.  The presence 
of calcium ions in the SSIFs caused a large increase in mean particle diameter (Figure 
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8.2a) and there was evidence of large particles in the PSDs for both MCT- and 
LCT-emulsions (Figures 8.2b and 8.2c).  The presence of these large particles indicates 
a marked change in the structure of the systems after exposure to small intestinal 
conditions, which may be due to several physicochemical phenomena.  The pancreatic 
lipase in the SSIFs will adsorb to the lipid droplet surfaces and convert the 
triacylglycerols (TAGs) into free fatty acids (FFAs) and monoacylglycerols (MAGs).  
The products of lipid hydrolysis may move into the surrounding aqueous phase or remain 
at the droplet surfaces depending on their water-dispersibility, which is related to their 
chain length [257, 259].  Long chain FFAs tend to remain at the droplet surface (in the 
absence of bile salts or calcium), whereas short and medium chain FFAs tend to move 
into the aqueous phase.  Lipid digestion may therefore reduce the size of the initial lipid 
droplets due to removal of FFA and MAG digestion products from their surfaces [275, 
276].  On the other hand, partially digested lipid droplets may be more prone to droplet 
coalescence due to the change in their interfacial properties, which would lead to an 
increase in particle size [275, 276].  It should also be noted that the light scattering 
instrument is sensitive to all kinds of particles that scatter light within the sample, which 
includes any mixed micelles or insoluble calcium complexes formed after digestion 
[327].  
 The measured particle size did not change much after MCT-VE or 
LCT-emulsions were exposed to SSIFs in the absence of calcium, regardless of whether 
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bile extract or pure bile salts were used (Figures 8.3a-c).  This may have occurred 
because some of the lipid droplets were not digested and retained their original size, but 
this is unlikely since the pH-stat measurements (described below) indicated that lipid 
digestion had occurred.  It is therefore possible that the mixed micelles formed by lipid 
digestion were of a similar size to the original lipid droplets in the system.   
 In general, the droplet sizes were appreciably larger when the SSIFs contained 
bile salts than when they contain bile extract (Figure 8.3a).  Bile extract from porcine is 
a complex mixture that contains various bile salts, phospholipids and other components, 
whereas the bile salts only contained pure NaC and NaDC.  Hence, the concentration of 
actual bile salts in the system would be higher for the pure bile salts than for the bile 
extract, which may have led to the formation of more insoluble complexes with calcium.  
In addition, the mixed micelles formed by pure bile salts may have been larger than those 
formed by bile extract.   
 Another complication associated with interpreting the results of light scattering 
measurements in complex colloidal dispersions is associated with data analysis.  The 
software used to calculate the particle size distribution of a colloidal dispersion from its 
light scattering pattern usually assumes that the particles are spherical, dilute, and have 
well-defined refractive indices.  However, the colloidal dispersions resulting from lipid 
digestion contain a complex mixture of particles with different compositions and 
structures, such as undigested lipid droplets, partially digested lipid droplets, micelles, 
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vesicles, and various other colloidal structures. Light scattering results should therefore 
be treated with some caution for this type of complex colloidal dispersion.   
8.3.1.2 Influence on particle charge characteristics 
 In this section, changes in the electrical charge on the particles in the samples 
after digestion were measured to provide some information about possible changes in 
interfacial composition (Figure 8.4).  Initially, all of the oil droplets coated by bile salts 
were highly negatively charged (-61.6 mV for MCT emulsions and -63.7 mV for LCT 
emulsions), which can be attributed to ionization of the bile salts.  At neutral pH, bile 
salts have an appreciable negative charge due to the presence of anionic carboxyl groups, 
i.e., -COO- [301].  The particles in all the samples were negative after exposure to the 
simulated small intestine stage, although there was some reduction in the magnitude of 
their negative charge (Figure 8.4).  The negative charge on the particles may be a result 
of some of the initial bile salts remaining at the droplet surfaces, as well as due to the 
absorption of other anionic surface active species from the digestion medium.  The 
reduction in droplet charge may have been because some of the bile salts were displaced 
by FFAs or because of the increase in ionic strength in the system [332]. 
 The charge on the particles present in the digesta was less negative in the 
presence of calcium ions (-21 to -32 mV) than in their absence (-44 to -52 mV) for both 
carrier oil types, which can be attributed to binding of cationic Ca2+ ions to the surfaces 
of the anionic droplets and mixed micelles, as well as some electrostatic screening effects 
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[332].  The negative charge was higher on the particles present in LCT-emulsions than 
those present in MCT-emulsions after digestion (Figure 8.4) which may be due to the 
fact that glyceryl trioleate contains long chain fatty acids (C18:1) that accumulate at 
oil-water interfaces, whereas glyceryl trioctanoate contains medium chain fatty acids 
(C8:0) that tend to move into the surrounding aqueous phase [333]. 
 
Figure 8.4 Influence of carrier oil type and SSIF composition on the electrical 
characteristics (ζ-potential) of the particles in oil-in-water emulsions passed through 
simulated small intestine.  
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types of charged particles that scatter light.  Moreover, since measurements were made 
on diluted and stirred samples, the nature of the particles in the measurement cells might 
be different from the particles in the original undiluted samples.  One should therefore 
be cautious when interpreting the results from electrophoresis measurements on this type 
of complex colloidal dispersion.  
8.3.2 Impact of SSIF composition and carrier oil type on lipid digestion 
 In this part of the study, the influence of carrier oil type and SSIF composition 
on the rate and extent of lipid digestion was measured using the pH-stat method, which is 
widely used in pharmaceutical and food research for this purpose [271, 277, 322, 
334-337].  The principle of the pH-stat method is to measure the volume of alkaline 
solution (0.25 M NaOH) required to neutralize the free fatty acids (FFAs) released from a 
sample when incubated in SSIFs containing lipase.  This information is then used to 
calculate the percentage of FFAs released from the sample, assuming that a maximum of 
two FFAs are released per triglyceride molecule.  
 Generally, there was a rapid initial increase in the volume of NaOH added to the 
emulsions during the first few minutes of incubation in SSIFs, followed by a more 
gradual increase at longer times (Figure 8.5).  This result suggests that lipases in the 
SSIFs were able to quickly adsorb to the lipid droplet surfaces and convert encapsulated 
TAGs into FFAs and MAGs.  Nevertheless, vitamin-fortified emulsions prepared using 
different types of carrier oil exhibited quite different behavior.  In the absence of 
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calcium, the rate and extent of lipid digestion was appreciably higher for MCT-emulsions 
than for LCT-emulsions (Figure 8.5e), which is in good agreement with previous studies 
[257, 259, 279]. As mentioned earlier, long-chain FFAs accumulate at lipid droplet 
surfaces in the absence of calcium ions [333], which inhibits digestion by preventing 
lipase molecules from reaching non-digested TAGs at the core of the lipid droplets [321]. 
 
Figure 8.5a Effect of calcium (CaCl2) on the rate and extent of lipid digestion in 
MCT-VE emulsions determined using a pH-stat method with SSIF containing bile extract 
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Figure 8.5b Effect of calcium (CaCl2) and phospholipids (DOPC) on the rate and extent 
of lipid digestion in MCT-VE emulsions determined using a pH-stat method with SSIF 
containing pure bile salts (NaC and NaDC). 
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Figure 8.5c Effect of calcium (CaCl2) on the rate and extent of lipid digestion in 
LCT-VE emulsions determined using a pH-stat method with SSIF containing bile extract. 
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Figure 8.5d Effect of calcium (CaCl2) and phospholipids (DOPC) on the rate and extent 
of lipid digestion in LCT-VE emulsions determined using a pH-stat method with SSIF 
containing pure bile salts (NaC and NaDC).   
 
Figure 8.5e Influence of carrier oil type and bile salt type on the rate and extent of lipid 
digestion in vitamin E fortified emulsions measured using a pH-stat method.  The SSIFs 
all contained calcium. 
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have a major impact on lipid digestion in LCT-emulsions but not in MCT-emulsions, 
which is in agreement with previous research [327].  This result may be explained by a 
number of physicochemical mechanisms.  First, a certain amount of calcium is required 
as a co-factor to activate pancreatic lipase [338, 339].  Thus, the lower extent of FFA 
production in the absence of calcium may be partly due to the fact that the enzyme was 
not in its most active form.  However, this is unlikely to be important because lipid 
digestion still occurred in the MCT-emulsions in the absence of calcium.  Second, 
calcium ions bind to long-chain FFAs generated during the digestion of emulsified LCT 
and form insoluble calcium soaps that remove them from the droplet surfaces [322, 323, 
326, 327].  The precipitation of these long-chain fatty acids enables lipase molecules to 
come into close contact with the remaining non-digested lipids and facilitate their 
digestion [340].  The digestion of emulsified MCT is less dependent on calcium ions 
because the lipid digestion products (medium-chain FFAs) are more water-dispersible 
and rapidly move into the surrounding aqueous phase, thereby enabling lipase to continue 
operating at the droplet surfaces.  Calcium ions may also impact lipid digestion by 
affecting other characteristics of emulsions, such as droplet aggregation [341, 342].  
Anionic lipid droplets may become flocculated in the presence of cationic calcium ions 
due to ion binding and electrostatic scattering screening effects, which may reduce the 
ability of lipase to interact with the lipid droplet surfaces [145, 343].   
 For both MCT-VE and LCT-emulsions, the addition of phospholipids (DOPC) 
  
 
 
204 
into the SSIFs increased the final extent of lipid digestion.  This may have occurred 
because phospholipids facilitated the ability of the lipase to interact with the emulsified 
TAGs, or because the phospholipids were themselves hydrolyzed and released FFAs.  
Based on the amount of DOPC (36 mg) present in the SSIF, and the assumption that one 
FFA is released per phospholipid molecule, we calculated that about 1.8 mL of 0.25 M 
NaOH would be required to neutralize any fatty acids produced due to phospholipid 
hydrolysis.  This value is quite close to the difference between the volumes of NaOH 
required to neutralize calcium-containing samples in the presence and absence of DOPC 
(Figures 8.5b and 8.5d).  We therefore conclude that the increased amount of alkali 
required for the samples containing DOPC is mainly due to the hydrolysis of the 
phospholipid by digestive enzymes in the SSIFs. 
8.3.3 Impact of SSIF composition and carrier oil type on vitamin E bioaccessibility 
 The impact of SSIF composition and carrier oil type on the bioaccessibility of 
vitamin E after passage through the simulated small intestine was also examined.  The 
bioaccessibility was determined by incubating the emulsions in SSIFs for 2 hours, 
centrifuging the resulting digesta, and then determining the concentration of vitamin E in 
the micelle phase and overall digesta using HPLC.       
 The overall appearance of the digesta after exposure to SSIFs depended on 
calcium content (Figure 8.6).  In the absence of calcium, samples separated into a thick 
white layer at the top (“cream”), a clear or slightly turbid layer in the middle (“micelle 
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phase”), and a thin white layer at the bottom (“sediment”).  The white layer at the top 
probably consisted of non-digested fat droplets and possibly some large mixed micelle 
structures (which are less dense than water), while the white layer at the bottom probably 
contained insoluble matter such as bile salt or protein complexes (which are denser than 
water).  In the presence of calcium, we only observed a single white layer (“sediment”) 
at the bottom of the samples with a clear or slightly turbid layer above (“micelle phase”).  
The fact that a cream layer was not observed in the samples containing calcium can be 
attributed to two factors.  First, calcium promoted digestion of the lipid phase (Figure 
8.5), and so there would be less non-digested lipid droplets present.  Second, cationic 
calcium ions (Ca2+) formed dense insoluble aggregates with anionic species, such as bile 
salts and free fatty acids, which sedimented to the bottom of the tubes.   
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Figure 8.6 Influence of carrier oil type and SSIF composition on the appearance of the 
micelle phase after in vitro digestion of vitamin E fortified emulsions. 
 
Figure 8.7 Influence of carrier oil type and SSIF composition on the mean particle 
diameter of the micelle phase after in vitro digestion of vitamin E fortified emulsions.  
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fatty acids (FFAs) from any lipid digestion products.  These surface-active lipids 
self-assemble into the mixed micelle phase, which may contain micelles, vesicles, and 
liquid crystalline phases that vary in composition, dimensions, and structure [297, 298].  
The micelle phase was therefore passed through a 450 nm pore size filter before 
measuring the bioaccessibility to more closely simulate gastrointestinal conditions [280, 
344].  Lipophilic bioactive components solubilized within mixed micelles must pass 
through the mucus layer before they can be absorbed by the human body.  The mucus 
layer acts as a biological filter that only allows particles smaller than about 400 nm to 
pass through [280].  Filtering the micelle layer prior to analysis may therefore provide a 
more accurate representation of the potential bioavailability of a lipophilic compound that 
needs to be transported by mixed micelles through the mucus layer.   
 In the presence of calcium ions, the size of the particles in the micelle phases 
collected from the LCT-emulsions were slightly larger than those collected from the 
MCT-emulsions (Figures 8.7), which suggests that that the colloidal structures in the 
micelle phase formed by LCT digestion products were larger than these formed by MCT 
digestion products.   
 The nature of the bile salts present in the SSIFs also had an influence on the size 
of the structures formed in the mixed micelle phase. The particle size was larger when the 
SSIF contained bile extract, than when it contained pure bile salts (Figure 8.7).  Bile 
extract contains a mixture of bile salts, phospholipids, and other components [327, 345], 
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which may have led to the formation of larger mixed micelles.  Indeed, when 
phospholipids (DOPC) were added to the SSIF containing bile salts and calcium ions 
there was an appreciable increase in the size of the colloidal structures present in the 
micelle phase (Figure 8.7).  In addition, bile extract may have contained some insoluble 
matter that also contributed to the light scattering signal.   
 The bioaccessibility of the vitamin E was determined by measuring the 
concentrations of α-tocopherol acetate and α-tocopherol in the micelle phase and within 
the total digesta after in vitro digestion (Figure 8.8).  Calcium ions had a major impact 
on the bioaccessibility of vitamin E, which depended strongly on the nature of the carrier 
oil used.  For the MCT-emulsions, the addition of calcium ions to the SSIF led to an 
appreciable decrease in the bioaccessibility of vitamin E, regardless of the nature of bile 
salts used.  For example, the vitamin bioaccessibility decreased from around 24% to 9% 
when calcium was added to SSIFs containing bile extract, whereas it decreased from 
around 31% to 1% when calcium was to SSIFs containing pure bile salts.  It is possible 
that cationic calcium ions formed insoluble precipitates with mixed micelles containing 
solubilized vitamin E, thereby reducing the amount of vitamin E present within the 
micelle phase.  Conversely, for the LCT-emulsions, the addition of calcium ions to the 
SSIF led to an appreciable increase in the bioaccessibility of vitamin E.   For example, 
the vitamin bioaccessibility increased from around 22% to 32% when calcium was added 
to SSIFs containing bile extract, whereas it increased from around 11% to 37% when 
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calcium was to SSIFs containing pure bile salts.  In addition, there was a further 
increase (to around 66%) when phospholipids (DOPC) were incorporated into the SSIFs 
for the LCT-emulsions. Previous researchers have also reported that phospholipids can 
increase the bioavailability of lipophilic bioactive components [346-349].   The 
solubilization of lipophilic components in the micelle phase usually depends on the total 
amount of mixed micelles available for transporting them across the mucus layer.  Our 
pH-stat experiments show that a higher amount of lipid digestion products (FFAs and 
MAGs) are formed when calcium is present during the digestion of LCT-emulsions, and 
so there should be a greater amount of mixed micelles present to solubilize the vitamin E.  
In addition, a greater amount of vitamin E should have been released from the lipid 
droplets when more TAGs were digested.  The addition of calcium ions to the 
LCT-emulsions may therefore increase the amount of vitamin E in the mixed micelle 
phase.  Nevertheless, one might still expect the calcium ions to cause some precipitation 
of the mixed micelles (as with the MCT-emulsions), which would reduce the amount of 
vitamin E in the micelle phase.  Our results suggest that the greater release of vitamin E 
from the lipid droplets and the higher amount of mixed micelles formed in the presence 
of calcium, outweigh the precipitation effect for the LCT-emulsions.  These results may 
have important implications for the design of effective emulsion-based delivery systems 
for vitamin E.  Calcium is normally present within the fluids secreted by the human 
gastrointestinal tract.  This calcium may reduce the bioavailability of vitamin E 
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delivered in MCT-emulsions, which might be overcome by incorporating some calcium 
chelating agents in the delivery system (such as EDTA or alginate).  On the other hand, 
calcium may increase the bioavailability of LCT-emulsions, and therefore it may be 
advantageous to avoid the presence of calcium chelating agents in these delivery systems 
or to supplement them with additional calcium. 
 
Figure 8.8 Influence of carrier oil type and simulated small intestine fluid composition 
on the overall bioaccessibility of Vitamin E (α-tocopherol + α-tocopherol acetate) in 
emulsion-based delivery systems after digestion. 
 Under realistic digestion conditions (i.e., samples containing bile salts, calcium 
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encapsulated in LCT-emulsions than in MCT-emulsions (Figure 8.8).  The long-chain 
free fatty acids (C18:1) arising from the lipolysis of glycerol trioleate (LCT) can 
presumably form larger colloid structures with a larger solubilization capacity than the 
medium chain fatty acids (C8:0) generated from the hydrolysis of glycerol trioctanoate 
(MCT).  The α-tocopherol molecule has a non-polar chain with 14 carbon atoms (C14), 
which is presumably too long to be accommodated into the micelles or vesicles formed 
by medium-chain fatty acids, but short enough to be incorporated into those formed by 
long chain fatty acids.  Researchers in the pharmaceutical area have also reported that 
the bioaccessibility of some highly oil-soluble drugs is greater when LCT was used as a 
carrier oil rather than MCT [281, 282]. 
8.3.4. Impact of SSIF composition and carrier oil type on vitamin E conversion 
 The esterified form of α-tocopherol is often used in foods and other commercial 
products rather than the free form because it is more stable to oxidation during processing, 
transportation and storage [223, 224].  Previous research has shown that the molecular 
form of vitamin E has a major impact on the bioaccessibility of vitamin E, i.e., 
α-tocopherol versus α-tocopherol acetate [260-263].  Thus, we determined the amount 
of α-tocopherol acetate converted to α-tocopherol after in vitro digestion (Figure 8.9).  
Our previous research using food-grade oils showed that carrier oil type had an 
appreciable impact on the hydrolysis of α-tocopherol acetate to α-tocopherol, with the 
extent of conversion being about 29% for LCT-emulsions and 17% for MCT-emulsions 
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[318].  This result suggests that the conversion of α-tocopherol acetate to α-tocopherol 
occurred more readily when LCT was used as the carrier oil than when MCT was used 
[318].  In the current study, we used purified LCT and MCT carrier oils to provide 
further insights into this important effect.      
 
Figure 8.9 Influence of carrier oil type and SSIF composition on the conversion of 
α-tocopherol acetate to α-tocopherol after in vitro digestion of vitamin E fortified 
emulsions 
 For MCT-emulsions, the SSIF composition did not have an appreciable impact 
on the conversion of α-tocopherol acetate to α-tocopherol (Figure 8.9).  Conversely, for 
LCT-emulsions, the SSIF composition had a major impact on α-tocopherol acetate 
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hydrolysis.  For the LCT-emulsions, the conversion of α-tocopherol acetate to 
α-tocopherol increased when calcium and phospholipid were incorporated into the SSIFs 
(Figure 8.9).  There therefore appeared to be a correlation between the bioaccessibility 
of vitamin E and the hydrolysis of α-tocopherol acetate.  It is likely that α-tocopherol 
acetate can only be hydrolyzed by digestive enzymes after it is released from the interior 
of the fat droplets.  Hydrolysis may occur at the lipid droplet surfaces or after the 
α-tocopherol acetate is incorporated into mixed micelles, which would account for the 
increase in hydrolysis with increasing bioaccessibility.  This effect may also account for 
that fact that the extent of hydrolysis was greater for the LCT-emulsions than the 
MCT-emulsions in the presence of calcium ions (Figure 8.9).   
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Figure 8.10a Influence of carrier oil type and simulated small intestine fluid composition 
on the conversion of α-tocopherol acetate to α-tocopherol after in vitro digestion of 
MCT-VE emulsions. 
 
Figure 8.10b Influence of carrier oil type and simulated small intestine fluid composition 
on the conversion of α-tocopherol acetate to α-tocopherol after in vitro digestion of 
LCT-VE emulsions. 
 Finally, we calculated the bioaccessibility of the different forms of vitamin E 
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the MCT-emulsions when the SSIF contained bile extract and calcium is currently 
unknown.  A schematic representation of the important physicochemical events 
occurring with the gastrointestinal tract based on our results is shown in Figure 8.11. 
 
Figure 8.11a Schematic representation of influence of calcium on physicochemical 
phenomena occurring within gastrointestinal tract during lipid digestion, vitamin release, 
and solubilization. 
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Figure 8.11b Schematic illustration of the influence of free fatty acid chain length on the 
bioaccessibility of vitamin E. Long chain FFAs form mixed micelles that can easily 
accommodate large VE molecules, whereas mediuc chain FFAs do not. 
8.4 Conclusions 
 The purpose of this study was to identify the key factors impacting the 
bioaccessibility of emulsified α-tocopherol acetate using a simulated small intestine 
model.  We have shown that the rate and extent of lipid digestion was higher for 
MCT-emulsions than for LCT-emulsions, which was attributed to differences in the 
water-dispersibility of the medium and long chain fatty acids formed during lipolysis.  
The addition of calcium ions to the SSIFs greatly increased the extent of lipid digestion 
for LCT-emulsions, but had little effect on MCT-emulsions, which was attributed to the 
ability of calcium ions to remove long-chain fatty acids from droplet surfaces.  The 
addition of calcium ions and phospholipids into the SSIFS also had a major impact on the 
bioaccessibility of vitamin E depending on carrier oil type.  The addition of calcium 
ions greatly improved the bioaccessibility of vitamin E in LCT-emulsions, but reduced it 
in MCT-emulsions.  Finally, calcium addition increased the conversion of α-tocopherol 
acetate to α-tocopherol after in vitro digestion of LCT-emulsions, but had little effect on 
α-tocopherol acetate hydrolysis in MCT-emulsions.  
 In summary, our results suggest that the bioaccessibility of vitamin E 
encapsulated in emulsion-based delivery systems is strongly influence by carrier oil type, 
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bile salt type, calcium ions, and phospholipids.  This information is important for 
developing effective emulsion-based delivery systems for oil-soluble vitamins and testing 
their potential efficacy. 
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CHAPTER 9 
CONCLUSION 
The overall aim of this work was to create food grade nanoemulsion-based 
delivery systems for encapsulating lipophilic bioactive components, such as vitamin E, 
β-carotene etc., which can be applied into function foods and beverage products.  Stable 
nanoemulsion-based delivery system could be successfully prepared using both low 
energy and high energy methods.  The high energy method (microfluidization) was able 
to produce emulsions with small droplets (r < 100 nm) using low surfactant-to-oil ratios 
(< 1:10), but it required relatively expensive specialized equipment and has relatively 
high operating costs.  Conversely, the low energy method (spontaneous emulsification) 
is inexpensive and can be implemented using simple equipment (stirring), but it requires 
high surfactant-to-oil ratios (> 5:10) to produce small droplets.  High concentrations of 
surfactant levels may lead to problems in some food and beverage products, such as high 
ingredient costs, off flavors, and safety concerns.  Moreover, high surfactant levels may 
also cause depletion flocculation or Ostwald ripening effects.  
Q-Naturale® is a natural food-grade surfactant isolated from the bark of the 
Quillaja saponaria Molina tree.  Q-Naturale® was found to be highly surface active, and 
had similar interfacial properties as Tween 80， a synthetic non-ionic surfactant widely 
used in the food industry.  Q-Naturale® was able to form oil-in-water emulsions with 
relatively small droplet sizes (d < 200 nm) at low surfactant-to-oil ratios (SOR ≈ 1:10).  
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These emulsions formed by Q-Naturale® were stable to droplet coalescence over a range 
of pH values (2 to 8), salt concentrations (0 to 500 mM NaCl) and temperatures (20 to 90 
ºC).  In addition, they had good long-term stability (one month) when stored at various 
holding temperatures (5, 37, and 55 °C).  However, some droplet flocculation was 
observed under highly acidic (pH 2) and high ionic strength (≥ 400 mM NaCl) conditions, 
which was attributed to screening of electrostatic repulsion.  As Q-Naturale® is an 
effective surfactant, it was then used to form “all natural” oil-in-water emulsions 
containing α-tocopherol acetate.  Tween 80 was more effective at producing small 
droplets at relatively low vitamin loadings (≤ 40%), whereas Q-Naturale® was more 
effective at relatively high vitamin loadings (60% - 80%).  The size of the droplets in 
the emulsions could be reduced by decreasing the vitamin concentration in the oil phase, 
or increasing the amount of glycerol in the aqueous phase.   
The carrier lipid type had great impacts on the bioaccessibility and hydrolysis of 
emulsified α-tocopherol acetate during the in vitro digestion study.  LCT was a more 
effective carrier lipid than MCT for increasing the overall bioaccessibility of emulsified 
vitamin E.  The total bioaccessibility of vitamin E after digestion was higher for 
LCT-emulsions than for MCT-emulsions, which was attributed to the greater 
solubilization capacity of mixed micelles formed from long chain fatty acids due to their 
ability to better accommodate lipophilic vitamin E molecules.  Moreover, the 
conversion of α-tocopherol acetate to α-tocopherol after in vitro digestion was also 
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considerably higher for LCT-emulsions than for MCT-emulsions.  The influence of 
mixed micelle composition and structure on the solubilization of oil-soluble vitamins was 
further studied by utilizing a well-defined model system.  Mixed micelle solutions were 
formed that contained relatively small particles (d ≈ 5 nm) whose precise size depended 
on system composition.  An emulsion titration assay was then used to study the 
solubilization of α-tocopherol and α-tocopherol acetate emulsions in the mixed micelle 
solutions.  The solubilization capacity of the mixed micelle solutions was higher for 
α-tocopherol than for α-tocopherol acetate, which was attributed to differences in the 
ability of the vitamin molecules to be incorporated into the micelle structures.  However, 
there was no strong influence of free fatty acid type (C8:0 versus C18:1) on the 
solubilization capacity of the mixed micelles, which was different from results obtained 
using a simulated gastrointestinal model.   
Finally, overall study of all the key factors impacting the bioaccessibility of 
emulsified α-tocopherol acetate, such as calcium ions, phospholipids, carrier oil type etc., 
was taken by using a simulated small intestine model.  Calcium addition to the SSIFs 
greatly improved the extent of lipid digestion for LCT-emulsions, but had little effect on 
MCT-emulsions, which could be attributed to the ability of calcium ions to remove 
long-chain fatty acids from interface of the oil phase and the water phase.  The addition 
of calcium and phospholipids (DOPC) increased vitamin E bioaccessibility in 
LCT-emulsions, but decreased vitamin E bioaccessibility in MCT-emulsions.  The 
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addition of calcium also increased the conversion ratio of α-tocopherol acetate to 
α-tocopherol during in vitro digestion of LCT-emulsions, but had little impact on 
α-tocopherol acetate hydrolysis in MCT-emulsions.  
In summary, nanoemulsions may be a highly effective delivery system for 
encapsulating, transporting and protecting lipophilic bioactive components.  The 
knowledge gained from this research will guide the rational design of food-grade 
nanoemulsion that can be used in the future fortified foods.  
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